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Balloons are related to youth and to festivities. 
The elastic recoil pressure of an inflated balloon is the driving 
pressure for its 'expiratory' flow. This flow is limited by the elas-
tic properties of the neck (the 'airway') of the balloon. In this 
way the balloon represents flow limitation during forced expira-
tion in humans. 
The Perspex model on the right shows the intrathoracic airway 
compression during forced expiration. The left one shows the 
static situation. 
Dit hoek en het werk is voor 
.wlarianne, Caroline, Annemieke en Bart 
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General introduction 
ASTHMA 
Asthma is one of the most common chronic diseases in children 
and adults in the Netherlands and in other countries with a 
'Western Lifestyle'. It is characterized by recurrent excessive, 
mostly reversible, narrowing of airway caliber, in response to a 
variety of endogenous and exogenous stimuli. Increased 
bronchial responsiveness to the inhalation of non specific irri-
tants is a hallmark of asthma (33) and includes an increase in 
reactivity as well as in sensitivity of the airway (34;39). Asthma 
is considered to be a life long disease: it starts at a very young age 
(17;40) and persists in approximately 40% - 60% of the children 
into adulthood (9;30). More than 50% of the adult patients with 
asthma still have symptoms after 25 years (18). 
Decreased airway patency in asthma is mainly caused by bron-
choconstriction caused by an increased bronchial smooth muscle 
tone, hypersecretion and edema of the airway wall. These are the 
result of (chronic) inflammation of the airway wall, nowadays 
considered to be the major factor in the pathogenesis of asthma 
in association with bronchial hyperresponsiveness and the level 
of severity of the disease (3;6). 
Acute H Chronic -+ Remodeling 
reversible (partially/not reversible) 
'Provokers' of asthma, such as inhaled allergens can lead to acute 
andlor chronic and persistent inflammatory reactions. The acute 
phase of the initial inflammatory response is usually reversible. 
However, when the stimulus is large or prolonged, airway 
inflammation may become chronic resulting in ongoing activa-
tion of resident airway cells and the generation of infiammator), 
mediators (3). This may lead to permanent changes of the airway 
(6;27-29). The process of asthmatic airway remodeling is at pres-
ent not c01l1pletely understood but involves most likely thicken-
ing of the airway wall and subepithelial deposition of fibrous 
material (1;2;12). Structural alterations may lead to enhanced 
bronchial hyperresponsiveness (4;12) and to permanent irre-
versible limitations in airflow (8;37). The natural history of asth-
ma, however, is very variable: symptoms persist not in all 
Chapter 1 
patients, nor does a progressive obstructive lung function disor-
der develop in all subjects with asthma (9;18;30). The long term 
evolution of the airway inflammation and lung function in asth-
ma need to be established and their relationship with structural 
remodeling need to be investigated. 
FLOW LIMITATION 
The flow volume curve of a forced expiration (the maximal expi-
ratory flow volume (MEFV) curve) is based on the principle that 
expiratory flow at a given volume is (almost) independent of 
pressure (and therefore of expiratory effort) and markedly 
dependent on volume: the lower the volume, the lower is expira-
tory flow. In other words: expiratory flow is affected by a flow 
limiting process during forced expiration. The explanation of this 
process is as follows: coupling of elastic properties of the airways 
with pressure distribution leads to the formation of a choke point 
in the intrathoracic airways during forced expiration (chapter 3). 
The shape of the MEFV curve can thus be considered as a blue-
print of the mechanical properties of the lung and airways. The 
fact that the MEFV curve is highly reproducible within one sub-
ject, explains why it could develop into the most widely used pul-
monary function test, especially in subjects with airway obstruc-
tion. 
The shape of the MEFV curve enables us to obtain instantaneous 
and reliable information about the condition of the lungs and the 
patency of the airways. However, to give a detailed pathophysio-
logical interpretation of the shape of the MEFV curve is another 
matter. We understand how the elastic properties of the lung, the 
resistance of the peripheral airways and the elastic properties of 
more central airways in general contribute to lnaximum flows 
(Chapter 3). However, we are e.g. not informed to what extent 
the elastic properties of the airways vary in healthy individuals 
and in patients with obstructive airway disease. This can be 
explained by the great difficulty in obtaining information, partic-
ularly from in vivo experiments. \Y/e also have to cope with this 
problem ,,,hen we want to establish whether peak expiratory 
flow (PEF) reflects the resistance of the airlVa ys from alveoli to 
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mouth, what the contribution of rapid air compression is to PEF, 
or whether PEF reflects 'choke flow' plus some compression. 
Usually the MEFY curve can be characterized by reproducible 
configurational details, such as concavities, convexities, and sud-
den decreases in expiratory flow ('knees') at a given lung volume 
(35). A number of mechanisms are believed to contribute to the 
MEFY shape. One is a change in the site of flow limitation with-
in the airways. Studies in a mechanical model and in dogs indi-
cated that a plateau knee configuration occurs when a rather nar-
row and stiff central airway limits the flow during the initial part 
of expiration and that at the knee the flow limiting site (FLS) 
moves (jumps) towards more peripheral airways. Although stud-
ies by Smaldone and Smith (32) indicated that the FLS went not 
much farther than beyond the segmental bronchi in human sub-
jects, it is unknown to what site into the periphery the FLS 
moves. 
By applying the 'waterfall concept' of Pride et al. (26), Smaldone 
and Bergofski (31) described that the FLS is the most down-
stream point in the airway, where the transmural pressure is 
uninfluenced by changes in expiratory effort. FLS mal' also be 
defined as the most upstream point where actual airway flow 
equals the wave speed flow, being the maximum flow permitted 
through the airway due to the elastic properties of the airway. 
The latter can be determined from the tube law of the airways. 
Jones et al. (11) obtained tube laws under static conditions from 
the relationship between measured transmural pressure and cross 
sectional area determined optically. An almost similar method 
was used by Hyatt et al. (10) in excised human lungs. 
The wave speed concept of flow limitation (5) has provided 
insight into the mechanisms determining maximal expiratory 
flow from the lungs by establishing the relationship between air· 
way elastic properties, lung elastic recoil pressure and frictional 
pressure losses peripheral to the flow limiting sites. These rela· 
tionships have been tested in experiments with mechanical mod-
els (19-22), in dogs (23), and in excised human lungs (10). 
However, no data have been obtained in living humans. 
In addition to the above mentioned mechanisms, also viscous 
flow limitation is important, especially at low lung volume (38). 
Elaborate computer models have been developed to predict the 
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behavior of the human lung (7;13) but their predictability 
depends very much on the validity of the data used for the calcu-
lations. Reliable and appropriate experimental data are not avail-
able on airway elastic properties (tube laws, i.e. airway compli-
ance curves establishing the relationship between the distending 
airway pressure and the cross sectional area), and/or their varia-
tion with airway generation (7). To interpret the configurational 
details of the MEFV curve, knowledge of supercritical velocity is 
important. Therefore, the occurrence of flow with supercritical 
velocity needs to be studied. 
Although wave speed flows, predicted from static tube laws, may 
agree fairly well with the overall maximal flows determined from 
the rvIEFV curve, such tube laws are not ideal because they possi-
bly do not reflect the dynamic condition during forced expira-
tim!. Firstly, tube laws are volume dependent (15;23) and second-
ly, they may change during expiration probably due to pressure 
distribution within the airway (23). 
Tube laws may he determined dynamically from intra bronchial 
pressures, esophageal pressure taken as a measure of pleural 
pressure (Ppl), and expiratory flow (15;23). Intrabronchial pres-
sures can be measured using a intra bronchially positioned Pitot 
static probe. This is a device with an endhole for measurement of 
local impaction pressure and with several sideholes for measure-
ment of lateral airway pressure. In principle, air velocity is deter-
mined by use of the Bernoulli equation, stating that the difference 
(i.e. Pca) between impaction pressure and lateral pressure at a 
certain point in the airway is proportional to air velocity (v) 
squared: (Pca = 1:2opoV2, p = density of air). Next, airway cross 
sectional area (A) is determined by dividing airflow (V') by veloc-
ity (A = V'/v), and finally A is related to transmural pressure 
(Ptm), obtained as the difference between airway lateral pressure 
and esophageal pressure. 
Frictional pressure loss (Pfr), from the alveoli down to the Pitot 
static probe, can be determined as the pressure difference 
between lung elastic recoil pressure (Pel), (assumed to be identi-
cal during static and dynamic conditions (36)) and the pressure 
head (J) at the Pitot static probe (i.e. the impaction pressure rela-
tive to pleural pressure) (23). 
In frictionless flow where pfr is zero, there is a unique relation-
ship between the maximum flow static recoil (lvIFSR) curve, 
5 
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describing maximal expiratory flow (V'max) as a function of Pel, 
and curves describing A as a function of Ptm at the flow limiting 
site. If one of the two is known the other can be calculated 
(20-22). Therefore the MFSR curve, that can easily be obtained 
in humans, can be transformed into a compliance curve (i.e. a 
tube law or AJPtm curve) for the flow limiting segment of the air-
way. However, if the FLS moves between airways with different 
tube laws this curve will have a composite appearance reflecting 
the elastic behavior of the different flow limiting segments. It has 
also to be taken into account that the validity of this curve 
depends on the assumptions that peripheral friction loss is negli-
gible and that well defined tube laws exist. Two findings, how-
ever, support that frictional losses under certain circumstances 
may not be very important in this context. Firstly, calculation of 
AlPtl11 curves from MFSR curves in dogs provided curves that 
were comparable to AJPtm curves for the bronchial system that 
could experimentally be obtained by use of the Pitot static probe 
method mentioned above (23). Secondly, a change in gas physical 
properties that diminishes viscous frictional losses in the peri~ 
pheral airways, did not change the compliance curve calculated 
from the MFSR curve in normal subjects to a great extent (22). 
Large epidemiological studies of the configuration of the MEFV 
curve (14;24;25) showed that a plateau knee configuration is 
most common in young non-smokers. Age, smoking and disease 
lead to disappearance of the knee, most likely due to peripheral 
displacement of the FLS. This indicates that changes in the air-
way mechanical properties do occur as the result of a chronic 
stimulus as e.g. chronic asthmatic inflammation. The configura-
tion of the MEFV curve is certainly modified by environmental 
factors, possibly as early as in childhood (16). 
We do know that childhood asthma continues into adulthood 
(9). The questions arise whether in some or maybe in all young 
patients with asthma (e.g. puberty or adolescence) a change in 
airway elastic properties does exist, whether this change is 
reversible by (a change in) therapy or whether it can be used as a 
prognostic feature of asthma. 
Chapter 1 
PURPOSE OF THE STUDIES 
In the studies in this thesis (patho-) physiology of expiratory flow 
limitation in man ill vivo w~lS investigated. The lnain goal was to 
study both 'directly in vivo measurecP and 'indirectly calculated' 
airway mechanics during forced expiration in non-smoking 
young adults, and, furthermore, to extend onr physiological 
knowledge of the end result of asthmatic inflammation. 
Therefore, both healthy controls and patients with long-lasting 
mild to n10derate asthma were studied in order to test the 
hypothesis that structural remodeling caused by chronic inflam-
mation of the airway wall, results in altered mechanical proper-
ties of the airway. 
We applied simultaneously an intra bronchially placed Pitot static 
probe and an esophageal balloon in order to measure local air-
way compliance, and to determine the occurrence of flow limita-
tion. Airway parameters calculated from :Nlaximal Flow Static 
Recoil curves were compared with the in vivo Pitot static probe 
results. 
According to this approach we tried to answer the following 
questions: 
Does airway compliance, as a measure of (retllodeled) airway 
structure, differ between healthy controls and patients with 
asthma? 
(Chapter 4) 
Where does flow limitation, based on the wave speed concept, 
occur ;11 vivo in human airways? 
(Chapter 5) 
Does chronic airway inflammation (and possible airway wall 
remodeling) lead to a change in the site of flow limitation in 
patients with asthma? 
(Chapter 5) 
Can airway elastic behavior be meaningfully described by air-
way compliance curves derived fro111 MFSR curves? 
(Chapter 6) 
Is Peak Expiratory Flow only determined by effort or by flow 
limitation as well? 
(Chapter 7). 
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GENERAL DESCRIPTION 
Asthma has been discllssed in medical literature for over 2000 
years by its Greek term 'O:C5't~to:\ meaning panting, as a special, 
clinical discriminative disorder occurring in people with difficult 
breathing. The most common symptoms are episodic wheezing, 
dyspnoe, chest tightness and cough. Bronchial hyperresponsive-
ness to non specific triggers and irritants like cold air, exercise, 
cigarette smoke and fog is generally present and is regarded as a 
hallmark of asthma. Early morning and nocturnal symptoms are 
characteristic and are related to bronchial hyperresponsiveness 
(4;76). Most patients with asthma are allergic to airborne aller-
gens and show an early bronchial reaction caused by the direct 
effects of mediators and a late allergic reaction related to an 
inflammation of the bronchial mucosa. In most patients with 
asthma the family history for atopy is positive. The genetic 
prevalence for non specific bronchial responsiveness and allergy 
seems to increase with the number of parents or siblings with an 
atopic disorder (54). Although a genetic predisposition for atopy 
and possibly for asthma, with assignment of gene loci for allergy 
to different chromosomes, becomes clearer (87;98), asthma is 
still considered as a multifactorial disease. Psychological (emo-
tional) and environmental factors, such as allergic, aspecific stim-
uli and (viral) respiratory infections determine the character and 
severity of symptoms as well (100). 
Asthma is one of the most common chronic disorders in the 
Netherlands as well as in other countries with a \V'estern lifestyle, 
affecting approximately 10-20% of the population (54;62;90). 
~lost asthmatic subjects show a l11ild presentation and course of 
the disease. Its natural history, with respect to outcome, is not 
well described despite its large prevalence (18). Asthma is partic-
ularly a disease of the young; it starts generally at a young age 
(67;116) and persists in two thirds of asthmatic children into 
adulthood (95); more than half of asthmatic adults still have 
asthma after 25 years (81). There are strong indications that the 
prevalence of asthma increases worldwide in children (5;16;17; 
84;109) and in adults (106), in spite of the introduction of better 
medical treatment and preventive measures. 
Chapter 2 
In spite of real progress in understanding the nature of asthma 
and its possible causes in the second half of the last century, the 
exact pathogenesis remains unclear. This also explains why we 
still lack a precise, universally accepted definition of asthma, 
although every experienced clinician immediately recognizes the 
clinical presentation in childhood as well as in adulthood. 
ASTHMA, BRONCHIAL OBSTRUCTION AND 
BRONCHIAL HYPERRESPONSIVENESS 
For many decades, asthma was mainly considered as a disease 
with varying and reversible bronchial obstruction due to episodic 
bronchospasm. Therefore the therapeutic approach was focused 
on symptomatic relief and control and consisted of a bron-
chodilator, even as maintenance treatment, to regulate smooth 
muscle contraction. The inaccessibility of airway tissue for fur-
ther study explains the long lasting lack of understanding the 
basic mechanism of asthma, and the emphasis on physiological 
methods to assess airway obstruction in asthma (43). Spirometry 
and flow volume measurements (65) in the clinical setting and, 
later, peak flow measurements in the clinic and at home, howev-
er, taught physicians to regard asthma more as a chronic disorder 
with often a disagreement between clinical symptoms and objec-
tive measures of airway obstruction (97). 
The introduction of pulmonary function tests provided also a 
tool to assess bronchial hyperresponsiveness objectively. The con-
cept of specific and/or non specific bronchial hyperresponsive-
ness explained plausibly the paroxysmal symptoms of asthma 
and gave a link to exogenous triggers, causing exacerbation of 
bronchial obstruction. Activators of asthma can be divided into 
two general classes: 'inducers' (cause) and 'provokers' (exacerba-
tion) (75). 'Inducers' are not only considered to increase the 
intensity of asthma or its severity but also the underlying 
bronchial inflammation. As such, allergens (14;22), viral respira-
tory infections (19;20;26;64) and occupational agents (66) 
increase the severity of asthma and their effects persist long after 
initial exposure (21). 'Provokers' such as exercise (6;49), expo-
sure to irritants such as fog or cold dry air (78), and emotional 
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factors induce hronchoconstriction and influence airway obstruc-
tion in an acute manner but do not necessarily cause or enhance 
existing bronchial inflammation. 
Bronchial hyperresponsiveness, Ineasured with triggers as hista-
mine or methacholine acting directly on the airway, broadly indi-
cates the severity of the underlying asthma (52). However, 
repeated measurements over longer periods fail to do so (51). 
Indirectly acting agonists, such as exercise, cold ail; hypotonic or 
hypertonic saline, adenosine or sodium metabisulphite indicate 
involvement of nerves and inflammation in bronchial hyperre-
sponsiveness in asthma but correlate only marginally with hista-
mine or methacholine tests. Although tests on bronchial hyperre-
sponsiveness increased insight in to the mechanisms of episodic 
bronchial obstruction, they did not explain why asthmatic air-
ways show an exaggerated response to many different stimuli, 
occurring in normal life as well. However, they lead to redirec-
tion of aims in asthma therapy, nowadays described in 'global 
guidelines' (77), with elimination of known andlor suspected 
triggers and the use of 'reactivity modifying' drugs as (inhaled) 
corticosteroids. 
IRREVERSIBILITY OF AIRWAY OBSTRUCTION 
Smooth muscle contraction, hypersecretion of mucus and airway 
wall edema are the main pathophysiologic alterations in asthma 
responsible for airway obstruction and are potentially reversible. 
However, all clinicians are familiar with asthmatic patients with 
a significant degree of airway obstruction persisting in spite of 
aggressive anti-asthma treatment. Furthermore, some degree of 
airway hyperresponsiveness persists in most patients with asthma 
despite prolonged treatment with an (inhaled) corticosteroid. 
That an irreversible component of bronchial obstruction devel-
ops during long existing asthma was confirmed in earlier studies 
(15;85). More recent studies, that looked into the decline of lung 
function (63) and into preventive effects of anti-inflammatory 
asthma therapy (3;40;41;55;80;99), reconfirmed this finding. 
Lange and coworkers reported that patients with asthma experi-
ence a greater decline in FEV1 when compared to control sub-
Chapter 2 
jects (38 versus 22 ml/yr) (63). Haahtela et al. (40) reported in a 
longitudinal study comparing an inhaled corticosteroid (budes-
onide) and a short acting p-2-agonist (terbutaline), that the 
potential to restore airway obstruction and to decrease bronchial 
hyperresponsiveness is impaired in patients in wh01n anti-inflam-
matory treatment has been postponed. Agertoft and Pedersen (3) 
found that the annual increase in FEVI was greatest in children 
with the shortest duration of asthma at the start of steroid treat-
ment. These findings indicate that postponing the start of anti-
inflammatory treatment may cause loss of functional reversibili-
ty. This may be explained by the fact that structural changes, 
which occur in chronic asthma, may be prevented by the use of 
inhaled corticosteroids. Probably, it is more difficult to reverse 
these structural changes once they have occurred, than it is to 
prevent with anti-inflammatory treatment (88). This was also 
shown by two related Dutch studies by respectively Kerstjens and 
coworkers and Overbeek and colleagues (55;80). The pathogene-
sis of these clinical findings is poody understood but is increas-
ingly related to airway remodeling in the asthmatic airway (31). 
On the other hand, the clinician can witness that not all patients 
with long-lasting asthma show a marked loss in reversibility of 
airway obstruction. Additionally, Merkus et al. showed that 
growth of airways relative to volume was not significantly differ-
ent in symptomatic (i.e. respiratory symptoms) and asympto-
matic subjects, in spite of persisting lower expiratory flows for a 
given lung volume in the symptomatic subjects (71). It may there-
fore be concluded that the intensity and prognosis of 'scar for-
mation' and remodeling in the airways is unpredictable and 
varies greatly between patients (39). We do not know the risk 
factors that are responsible for the occurrence of airway remodel-
ing andlor the resulting deterioration of lung function (39). 
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INFLAMMATION AS THE BASIS OF ASTHMA 
The first reports of the pathophysiological features of asthma 
were based on autopsy findings in patients who had died from 
asthma. Osler (79) was the first who referred to asthma as 'a spe-
cial form of inflammation of the smaller bronchi: bronchiolitis 
exudative', in his first edition of the Principles and Practice of 
Medicine (1892). In this way he differentiated airway inflamma-
tion from 'spasm of the bronchial muscles'. Several other authors 
described the pathology of asthma from autopsy studies as well 
(32;35). It took, however, till the 1960's before Dunnill described 
extensively the cellular components of the airways in asthma 
deaths compared to other airway disorders (29;30). Gradually a 
better explanation of the process resulting in asthma death 
became clear. One recognized increasingly the presence of excess 
luminal secretion, hypertrophy and hyperplasia of submucosal 
glands and goblet cells, edema, epithelial damage, thickening of 
the epithelial basement membrane region, and infiltration of the 
airway wall with mononuclear cells and granulocytes (mainly 
eosinophils) in asthma (7;48). Although the presence of airway 
inflammation was interpreted as characteristic of severe, fatal 
asthma, the occurrence and recognition of these findings during 
asthma excacerbations and the association of asthma with other 
atopic diseases indicated that asthma was more than only airway 
smooth muscle dysfunction. 
The development and use of fiberoptic bronchoscopy with 
bronchial alveolar lavage and biopsy was the breakthrough in 
the study of the pathogenesis of asthma (1). Histologic evalua-
tion of the airways of asthmatics showed that chronic inflamma-
tion of the airway wall (28) is a common feature of asthma, pres-
ent in severe asthma in a varying degree (7;60), as well as in 
moderate or even in mild asthma (8;34;48). Asthma inflanuna-
tion appeared to be multicellular in nature (28;48), with mast 
cells (53;108), neutrophils, eosinophils (107), macrophages, 
basophils, lymphocytes, and epithelial cells all present as active 
participants. Each different cell type showed its own characteris-
tic and important contribution to the development and presenta-
tion of ainvay inflammation. Mast cells and granulocytes are 
capable of releasing different mediators and proteins which may 
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affect (the regulation of) airway caliber and lead to changes in 
bronchial responsiveness. 
Ultimately, above findings led to a more extensive definition of 
asthma (76) as 'a chronic inflammatory disorder of the airways' 
in which many cells play a role, including mast cells and 
eosinophils. In susceptible individuals this inflammation causes 
symptoms that are usually associated with widespread but vari-
able airway obstruction that is often reversible either sponta-
neously or following bronchodilator treatment, and causes an 
associated increase in airway responsiveness to a variety of stim-
uli' (76). As such, two characteristic features define asthma: 
intennittent reversible airway obstruction and ainvay hyperre-
sponsiveness due to airway inflammation. 
The main focus of much recent asthma research has been on 
establishing a direct link on the one hand between pulmonary 
function as measure of airway obstruction and (hyper-)respon-
siveness and on the other hand the profusion and activation state 
of inflammatory cells. If this link is present, than functional 
changes could be used as a surrogate for airway inflammation 
and therefore as an effect marker of anti-inflammatory treat-
ment. However, it is unlikely that this will be possible because 
inflammatory cells modify airway responses in at least two differ-
ent wa),s (42). Firstly, cell released chemical mediators as hista-
mine, leukotrienes, platelet activating factor and various proteas-
es (mediators with a very short half-life) can mediate direct 
changes in airway patency and airway responsiveness. These fac-
tors could explain reasonably well a correlation between airway 
inflammation and functional changes. HCJ\vever, a second way in 
which inflammatory cells can modify airway patency and respon-
siveness is through release of cytokines and chemokines, mole-
cules with intense and long-lasting biologic effects as well in the 
direct environment of their release as at distant sites (50;94). 
Cytokines and chemokines cause recruitment of additional 
inflammatory cells, modification of epithelial cells, mast cells and 
smooth muscle cells and result in changes in the non cellular 
components of the airway wall (42). An example is eosinophilic 
cationic protein that can stimulate fibroblasts, causing among 
other things, modifications in the pl'Oteogl)'can metabolism (104) 
which ma), result in thickening of the airwa), wall (92). At the 
time the effects of cytokines are apparent, it is quite possible that 
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the original inciting cells mal' no longer be present, as described 
in a study by Crimi et al. (24). They found no correlation 
between methacholine hyperresponsiveness and the number of 
inflammatory cells. If one assumes that airway hyperresponsive-
ness is an expression of the pathobiologic process in asthma, then 
it may be accompanied by cellular infiltration, like e.g. a late 
phase asthmatic reaction (2;27;47;96). However, bronchial 
hyperresponsiveness may also be solely associated with chronic 
thickening of the airway wall (46;110). 
In other words: asthma can be regarded as an inflammatory dis-
order, but the relationship between the number of inflammatory 
cells in the airway wall and measures of airway function is not 
very strong and may vary. This indicates that other factors, e.g. 
airway remodeling, are related to airway patency as well (42). 
REMODELING 
The concept of asthma as a chronic inflammatory disorder was 
widell' accepted in the last decade. At the same time, however, 
careful histologic and morphometric studies showed structural 
changes to be present throughout the airway wall (56) even in 
patients with mild, intermittent asthma (105). These structural 
changes are grouped under the heading 'airway remodeling' and 
include airway wall thickening, subepithelial fibrosis, mucous 
metaplasia, l11yofibroblast hyperplasia, myocyte hyperplasia and 
hypertrophy, and vascular abnormalities as its most important 
features (31) . 
.NIany elements, including an increase in airway smooth muscle, 
edema, infiltration with inflammatory cells, glandular hypertro-
phy, and connective tissue deposition, contribute to thickening of 
all components of the airway wall. Models of airway behavior 
showed that thickening of the airway wall reduces the smooth 
muscle shortening required for airway closure. These models 
showed also that the magnitude of airway wall thickening is suf-
ficiently great to explain part of the airway hyper responsiveness 
in asthma (46;111). Others suggest that wall thickening hampers 
the control of airway caliber, causing airway collapse (36). 
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Electron microscopic studies demonstrated that, in contrast with 
earlier conclusions from postmortem studies (45), the basement 
membrane itsetf was probably not thickened in asthmatic air-
ways. Howevel; an enhanced deposition of collagen I, III and V, 
fibronectin and tenascin in the reticular layer beneath the true 
basement membrane (48;58;59;69;92;93;102;113) was found. 
The significance of subepithelial fibrosis ('scarring') and other 
aspects of airway remodeling remain unknown (88). Although 
the number of myofibroblasts seems to correlate with the dura-
tion of asthma (13), there is no clear correlation between the 
thickness of the subepithelial layer, measured in the large 
bronchi, and clinical or physiological indicators of asthma severi-
ty (92). An injury repair process driven by inflammation is 
thought to be responsible for the structural changes in the airway 
wall as seen in airway wall remodeling. These changes are sup-
posed to result not only in partially irreversible airway obstruc-
tion but also to contribute to the development and/or persistance 
of bronchial hyperresponsiveness (33). 
PATHOPHYSIOLOGIC CONSEQUENCES OF 
INFLAMMATION AND REMODELING OF THE AIRWAY 
IN RELATION TO FLOW LIMITATION IN ASTHMA 
Enhanced tone of bronchial smooth muscle, inflammation and 
edema of the airway wall, increased endothelial and epithelial 
pernleability and hypersecretion are the main characteristics of 
asthmatic airway obstruction. They may all affect the three main, 
interrelated determinants of maximal attainable airflow: lung 
elastic recoil pressure, upstream pressure loss, and airway tube 
law determined by the relationship between airway distending 
pressure and airway cross sectional area. As snch, these factors 
contribute directly or indirectly to a decrease in expiratory flow 
in asthma. 
LUllg elastic recoil: Several studies have focussed on the elastic 
properties of the lung parenchyma and reported a reduction of 
lung elastic recoil pressure in asthma (38;70;115). Mauad and 
coworkers suggest that dis rupture of fiber attachments at the 
basement membrane in the superficial layer could impair the 
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mechanism of airway recoil in asthmatic patients (68). Although, 
a case control study by Merkus et a!. (72) showed larger lungs 
after childhood asthma, it did not support a mechanism with 
progressive loss of elastic recoil of the lung (72). Artifacts may 
partly explain a reduced lung elastic recoil pressure in asthma: in 
case of airway obstruction or even airway closure alveolar pres-
sure is not reflected by mouth pressure. Lung elastic recoil pres-
sure may then be underestimated (57;86). Maximal bronchodila-
tion relieves airway constriction but relaxes contractile elements 
that contribute to the overall elasticity of the lung, as well (44). 
This may reduce lung elastic recoil pressure as well. 
If indeed lung elastic recoil is decreased in long lasting asthma, 
this will directly result in a reduced expiratory flow because lung 
elastic recoil is the main driving pressure for maximal expiratory 
flow. This may explain partly the apparent irreversibility of air-
flow in some patients with asthma (11;15;89). 
Cross sectiollal area: An increased airway wall thickness reduces 
airway cross sectional area and may effect baseline airway resist-
ance (37). Elaborate computer models show that airway wall 
thickening dramatically affects changes in airway caliber and 
provide a potential explanation for bronchial hyperresponsive-
ness (46;74;112). A decrease in local cross sectional area reduces 
directly the local wave speed and therefore the local maximal 
attainable expiratory flow (chapter 3). Furthermore, it causes an 
increase in pressure loss due to friction and therefore an 
upstream shift of the flow limiting segment which usually leads 
to a decrease in maximal flow as well. 
Airway compliance: Asthmatic airway inflammation is associated 
with airway wall thickening and subepithelial fibrosis with possi-
ble thickening of the basement membrane (13;25;92). The 
mechanical consequences of subepithelial fibrosis as part of the 
remodeling process will depend on the chemistry of the different 
collagen types involved ancl on the architecture of the collagen 
deposits. Therefore, it is unclear what the effect will be on e.g. 
airway compliance. 
One can imagine that thickening of all components of the airway 
wall, as the result of 'scarring' (91) with increased subepithelial 
deposition of densely packed collagen, will increase the tensile 
stiffness of the airway wall and resistance to airway deformation 
(82;83;91). Wilson and coworkers (114) and Colebatch and 
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associates (23) support this hypothesis. They concluded that the 
distensibility uf- asthmatic airways was decreased i1l lIiuo. 
Furthermore, Mitchell and colleagues concluded that lung 
inflammation increased airway wall stiffness from a model of 
sensitized pig bronchi (73). On the other hand, the process of 
chronic destruction, healing and repair in asthmatic airways will 
involve degradation of matrix components, as described by 
Bousquet and coworkers (9;10). They demonstrated that an 
abnormal, fragmented, superficial network of elastic fibers as 
well as patchy, tangled and thickened elastic fibers in the deeper 
layers, were present in the airways of most asthmatic patients. 
Electron microscopy studies suggested severe elastolysis with 
fragmented elastin fibers in the larger airways of asthmatic sub-
jects. This indicates elastic fiber degradation and may explain an 
increased compressibility of the larger airways, coinciding with a 
decreased elastic retraction in the lung. Consequently, elastic 
fiber degradation could lead to an increase in compressibility of 
the airways coinciding with a decrease in elastic recoil of the 
lung. Both effects may result in more narrow airways and, possi-
bly, to earlier airway closure during forced expiration in asthmat-
ic subjects. This hypothesis was supported by an ill /litl'D study by 
Bramley and coworkers. They sho\ved that a single asthmatic air-
way preparation showed less passive tension and a threefold 
greater shortening than six non asthmatic airway preparations 
(12). Tiddens and coworkers studied ill /litra isolated peripheral 
airways from smokers with different degrees of COPD. They 
concluded that smooth muscle area and smooth muscle tone, but 
not total airway wall area are the main determinants for compli-
ance, hysteresis, and collapsibility. Reduction in smooth muscle 
tone made these peripheral isolated airways more compliant and 
collapsible (103). An increased local airway compliance will 
decrease the local wave speed and therefore maximal expiratory 
flow (chapter 3). This decrease in flow will be augmented by a 
decrease in elastic recoil as driving expiratory force. 
On the other hand, increased collagen fibril density and thick-
ened subepithelial matrix may also increase the tensile stiffness 
and resistance to deformation of the airway wall (82;83;91). This 
may have a protective effect hecause it imposes a greater load on 
bronchial smooth muscle during bronchoconstriction and possi-
bly prevents excessive airway narrowing (61). However, thicken-
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ing of the airway wall may contribute to excessive airway nar-
rowing (46). 
Whether and to what extent possible changes in airway compli-
ance, related to asthmatic remodeling, will affect expiratory flow 
limitation is subject of study in this thesis (chapter 5). 
CONCLUSION 
The main focus of current research is on the understanding of the 
cellular and molecular abnormalities in asthmatic inflammation. 
Eventually this may lead to clarification of its pathogenesis and 
to preventive strategies. The concept of airway remodeling as the 
result of chronic airway inflammation and its role in irreversible 
airway obstruction is widely accepted. However it is still a con-
cept. Attempts to unravel the physiological consequences of the 
numerous specific histopathologic abnormalities related to air-
way remodeling are at an early stage of development (33). To 
learn more about and to be able to influence the prognosis of 
asthma, knowledge of the mechanisms determining the severity 
of airway obstruction is necessary (101). Studies, combining 
physiology, morphology and the molecular basis of asthma are 
needed to help identify who is at risk of the physiologic conse-
quences of remodeling and to develop new rational therapeutic 
intervention (101). 
The studies in this thesis try to reveal a piece of the puzzle of 
asthma. They focus on the functional consequences of long last-
ing asthma with regard to airway mechanics that may not be 
detected by conventional pulmonary function techniques. 
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INTRODUCTION 
Maximal Expiratory Flow Volume measurement (MEFV) is the 
cornerstone of modern lung function assessment. Because, above 
a certain expiratory effort, the expiratory flow is independent of 
the pleural pressure, MEFV curves are highly reproducible within 
one person. The pleural pressure is the result of the expiratory 
effort and is transferred through the chest wall to the lungs. The 
effort independence of the maximal expiratory flow together 
with its volume dependency strongly suggcsts a flow limiting 
mechanism within the lung and the airways (4). In this chapter 
the evolution of our understanding of expiratory flow limitation 
is described, with special emphasis on the aspects forming the 
theoretical basis for the experiments described in the chapters 4-
7. 
It was already recognized in the 19th century that increased expi-
ratory airway resistance could be very disabling to patients with 
severe obstructive airway disease, since increased effort in 
breathing resulted in a limited increase in ventilation. 
Hutchinson (15) was in 1846 the first to report that airway 
obstruction could be derived from forced expiration, but he did 
not understand the mechanism. 
DESCRIPTIVE APPROACH TO FLOW LIMITATION 
In 1892, Einthoven (6) hypothesized intuitively, based on lung 
function experiments with dogs, that during forced expiration 
compression of intrathoracic airways results in expiratory flow 
limitation. He related the peribronchial pressure (Ppb) over the 
airways with the different segmcnts of the bronchial tree: from 
the alveoli via small, medium and large bronchi to the trachea 
(Fig. 1). During breathholding, when alveolar pressure equals the 
pressure in the airways, pressure in the pleural space, and hence 
in the peribronchial space, is lower Cncgative') than pressure in 
the alveoli by an amount equal to Pel, the elastic recoil pressure 
of the lung. Einthoven was aware of the fact that this pressure 
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gradient distends the airways, and that this distending pressure 
increased during inspiration both because Pel increases with lung 
volume and drops more than bronchial pressure (curves C and 
D). During expiration alveolar pressure rises; so does intra-
bronchial pressure, being highest near the alveoli, and dropping 
gradually towards the mouth. During quiet expiration the trans-
bronchial pressure gradient still distends the airway (curve E). 
During a forced expiration, however, the distending pressure may 
drop to zero at some point in the intrathoracic airways (G)(this 
was later called the Equal Pressure Point (EPP)). Einthoven 
hypothesized that, downstream from this point, the airways will 
be compressed and narrowed. This will result in a hampered, and 
prolonged expiration, and in increased work of breathing and 
hyperinflation; i.e. the symptoms of obstructive airway disease. 
Einthoven found proof of his hypothesis of airway compression 
and/or collapse in the recruitment of accessory respiratory mus-
cles during an asthma exacerbation and in the closing valve 
sound his dogs produced when coughing or barking. He suggest-
ed that quiet expiration to be of benefit for asthma patients. 
Nowadays pursed lip breathing is supposed to decrease the expi-
ratory effort patients with chronic airway obstruction. Einthoven's 
pioneer work was purely descriptive. His suggestions were con-
Figure 1 
Eiuthovell's theoretic.tl 
model of drllamic air-
way compression (from 
reference 6). Ppb = 
peribrollchi,ll pressure 
relative to mouth pres-
sure. 
(further explanation: 
see text). 
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firmed by DaYll1an (5) who described that the intrathoracic air-
ways behaved as check valves and stressed the importance of the 
elastic recoil of the lung for the occurrence of maximal expirato-
ry flow. 
ISOVOLUME PRESSURE FLOW ANALYSIS (lVPF) 
In 1954, Fry and Hyatt showed and quantified actual expiratory 
flow limitation with their crucial observations (11;12). They 
obtained inspiratory and expiratory flows at the same lung vol-
ume (isovolume) during maneuvers carried out with varying res-
piratory effort. The effort was estimated from transpllimonary 
pressure, i.e. the pressure difference between pressure in the pleu-
ra (obtained with an esophageal balioon catheter) and pressure 
in the mouth. Using the flow results at different isovolumes and 
at different intrathoracic (pleural) pressures, they constructed iso 
volume pressure flow curves (IVPF curves). Using these curves, 
Figure 2 
Right: flow - volume plot for a normal subject. Expimtory flow (V'max, lis) ",litles are 
plotted against their corresponding \'olume ilt A, B, .md C and define the MEFV curye 
(solid line). Left: three ism'olume pressure flow curves from same object. Cun'es A, B, 
and C were measured at volumes of 0.8, 2.3 and 3.0 liters from tot,ll lung capadtr 
(TLC), respectively. Tmnspulmomry pressure (cm H20) is the difference between 
pleural (estimated by an esoph<lge.ll balloon) ;lnd mouth pressures. (figure modified 
from reference 17) 
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Ff)' and coworkers were able to show that the expiratory £low 
reached a maximum at moderately positive transpuimonary pres-
sures (12). From a family of multiple isovolume pressure maxi-
mal flow relations a maximal expiratory flow volume (i\IIEFV) 
curve could be constructed (9;12). This demonstrated that maxi-
mal expiratory flow (V'max) is limited over a large range of the 
forced vital capacity. This method allowed the analysis of a 
forced expiratory maneuver in terms of volU111e, pressure and 
£low. Fig. 2 shows the IVPF results from measurements in a body 
plethysmograph recording breathing maneuvers while increasing 
effort. Flow and transpulmonary pressure values were obtained 
at specific lung volumes and used to construct the IVPF curves 
(18;20) and thereby indirectly a J\'IEFV curve. Two important 
aspects could be deducted from these IVPF curves: I) at a high 
level of lung inflation (± TLC) flow increased with increasing pos-
itive pressure without a clear limit. This indicated that the effort 
by subjects, i.e. the force velocity behavior of respiratory mus-
cles, is the limiting factor for maximum expiratory flow (V'max) 
at high lung volume (curve A). 2) After exhaling ±20% of the 
forced vital capacity (FVC) the IVPF curves exhibited flow 
plateaus, indicating that the expiratory £low became effort inde-
pendent and a flow limiting mechanism occurred in the airways. 
When lung volume decreased the V'max decreased (curve Band 
C). Based on experimental data from a rubber model of a 
bronchial segment, Fry presented evidence that the elastic prop-
erties of the intrathoracic pulmonary system and the physical 
characteristics of the exhaled gas determined the flow at the 
plateau on the IVPF curves (9;12). 
During forced expiration V'max values were highly reproducible 
when the expiratory pressures exceeded the pressure value at 
which maximum expiratory flow was reached (12;16;18). 
Therefore lvlEFV curves could be constructed from V'max and 
volume measured simultaneously, without measuring transpul-
monary pressure as was demonstrated by Hyatt, Schilder and Fry 
(20). Because V'max depends on lung volume, it is essential to 
specify the volume at which V'max is reached. Close to residual 
volume V'max was considered to become effort dependent because 
the outward acting elastic recoil of the chest wall antagonizes the 
driving pressure generated by respiratory muscles contracting at a 
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disadvantageous length tension relationship at low lung volume. 
The above described analysis of pressure and flow in relation to 
volume was the breakthrough in the concept of expiratory flow 
limitation in the lung during (forced) expiration, 62 years after 
the first description by Einthoven. Although such flow limitation 
had previously been noticed in variolls vascular beds, an expla-
nation of the underlying mechanisms had never been available 
and the analysis had only been descriptive. 
Fry (9;12) extended his theories by using a mathematical model 
of flow along an elastic (bronchial) segment, in which the caliber 
of a compliant tube segment varied with the transmural pressure. 
By relating the pressure gradient at a certain locus in the tube to 
the density and viscosity of the gas, the flow and the local area, 
Fry was able to show that expiratory flow limitation could occur 
at this particular point. He also predicted that a change in resist-
ance downstream from this point (e.g in vivo: upper airway 
resistance) would only have a slight effect or no effect at all on 
the local maximal flow. Only after many years some investigators 
were able to prove the rightness of his predictions. Further elabo-
ration of the work by Fry et al. was hampered because detailed 
data on the anatomy, geometry and dimensions of the airways, 
the mechanical properties of the airways and/or the flow regimes 
in the (human) lung were missing (17). In 1958, Martin and 
Proctor (31) first described in detail the elastic behavior of dog 
bronchi. In his classic work from 1963, Weibel gave eventually 
data that were suitable for modeling the geometry of the human 
lung (53). 
That it was important to correct for gas compression in the eval-
uation of maximal expiratory flow was recognized by Mead (32) 
and documented by Ingram and Schilder (22) after the introduc-
tion of the volume displacement body box by 1\'!ead in 1960 (33). 
Macklem and coworkers (28;29) measured directly the intra-
bronchial pressure during forced expiration. They provided as 
such the first estimates of the dimensions of the airways during 
forced expiration and of the location of flow limiting points in 
the airways. 
Chapter 3 
EQUAL PRESSURE POINT (EPP) 
In 1967 Mead et al. (35) introduced the descriptive approach to 
flow limitation during forced expiration in terL)1s of the 'Equal 
Pressure Point' (EPP) concept. By stating that the alveolar pres-
sure (Palv) is the driving pressure causing gas to flow from alve-
oli to the mouth, Palv can be regarded as the Slllll of pleural pres-
sure (Ppl) and the elastic recoil pressure of the lungs (Pel): 
Palv = Ppl + Pel 
During rapid and forced expiration Ppl is positive in sign in rela-
tion to the mouth pressure (atmospheric pressure). During sl(n\' 
expiration and during inspiration Ppl is negative. There is a drop 
in pleural pressure to perialveolar and peribronchial pressures 
during forced expiration, caused by tissue friction. However, this 
drop in pleural pressure is minimal when compared to the pres-
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sure drop caused by frictional resistance to gas flow in the air-
way (30). Mead showed indeed that tissue resistance could be 
neglected (32). 
During expiration the intra bronchial pressure falls due to fric-
tional resistance (pfr) and due to the energy needed to accelerate 
the air in the convergent bronchial system, i.e. the pressure drop 
due to convective acceleration (Pea) (35). As Palv represents the 
total fall in pressure between alveoli and mouth, then at some 
point in the conducting airways this fall in pressure equals Pel. At 
this particular point the intra bronchial pressure (Pbr) equals the 
peribronchial intrathoracic pressure which can be regarded to be 
similar to Ppl (at least in the extra pulmonary intrathoracic air-
ways). The point where Pbr equals Ppl is called the EPP (Fig. 3). 
Crucial in the analysis by Mead is that Pel is considered to be the 
driving pressure in the airways upstream fro111 EPP (alveoli -> 
EPP) and that Ppl is the remaining driving pressure from EPP to 
the mouth. A positive transmural pressure Pt1l1 distends the air-
,vays upstream from EPP: 
Ptm = Pbr - Ppl 
The airways downstream from EPP will be compressed increas-
ingly as the intra bronchial pressure decreases towards the mouth 
(Ptm becomes more negative). Indirect measurements via neigh-
boring blood vessels suggest that the pressure outside the intra-
pulmonary airways are negative with respect to Ppl (14;46). 
Therefore, actual Ptm will remain positive immediately down-
stream from EPP until a point is reached where the ongoing 
intra bronchial pressure drop overcomes the difference between 
Ppl and the peribronchial pressure. 
Compression of airways during forced expiration can only take 
place downstream from the point where Ptm is zero. However, 
airway narrowing is not a binary phenomenon. The change in 
airway cross sectional area with changing Ptm is a continuous 
one and takes place over a wide range of positive as well as nega-
tive transmural pressures. The EPP approach divides the 
bronchial system into two differently behaving parts. When expi-
ratory flow (V') is limited (V' equals maximal flow (V'max)) the 
bronchial system can be considered as an elastic element empty-
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ing through a fixed upstream resistance (RllS) at a given volume: 
Rus = Pei / V'max 
in series with a variable resistance in the downstream airways 
(Rds). 
THE LOCATION OF EPP 
In the intrathoracic airways, no EPP can exist with a subatmos~ 
pheric Ppl. With gradually increasing Ppl, the EPP will firstly 
occur at the thorax aperture when Ppl equals the intratracheal 
pressure at that site. The EPP will proceed upstream with a fur-
ther increase in Ppl. In isovolume circumstances the elastic recoil 
pressure, as driving force, is unchanged. Therefore flow can only 
increase by a decrease in resistance upstream from EPP (Rus), 
which is possible by a shortening of the upstream segment (i.e. 
upstream movement of EPP). The IVPF curves by Fry (5;6;11) 
demonstrate a plateau indicating a maximal attainable flow 
(V'max). With both flow and volume (and therefore Pel) fixed, 
Rus must be fixed at a given volume and thus the geometr>' of the 
lung upstream from the fixed location of EPP. J\'lead explained 
the phenomenon of reaching a V'max by the lengthening of the 
downstream segment during this process, causing a greater 
degree of compression and an increase in resistance downstream 
of EPP (35) thereby preventing a further increase in expiratory 
flow and fixation of EPP. According to ?\1ead, the increase in 
downstream resistance counterbalanced the increase in Ppl with 
regard to the effect on flow. This phenomenon was observed and 
proven in experiments with living dogs by Martin (31). 
Experiments with ill llillO intra bronchial measurements of total 
and lateral airway pressures during forced expiration in man and 
in dogs by Macklem et al. (28;29) showed that at high lung vol-
umes EPP indeed existed and was located in the large extrapul-
monary airways. Airway compression occurred between the seg~ 
mental bronchi and the glottis at lung volumes between 75% and 
25% vital capacity (VC) and was the main factor in limiting 
expiratory flow. Tracheal resistance varied little with lung vol~ 
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ume but considerably with pleural pressure in contrast with the 
upstream resistance between alveoli and segmental bronchi, that 
was largely influenced by lung volume but far less by pleural 
pressure. At low lung volumes EPP moved beyond the reach of 
the intra bronchial catheters with a marked decrease in pressure 
(Pca) required to accelerate air from alveoli to EPP and an 
increase in pressure loss due to friction (pfr). Macklem concluded 
that in normal lungs: "the cross sectional area (A) at EPP (to 
which Pca is inversely related) and lung elastic recoil are the most 
important determinants of V' max at high lung volume. At low 
lung volume V'max is determined mainly by lung elastic recoil 
and the frictional resistance of airways upstream from EPP" (29). 
THE CRITICAL TRANSMURAL PRESSURE (Ptm') 
The concept by Mead, which divided the airways in two seg-
ments separated by the EPP, was extended by Pride et a!. (47) 
using another descriptive approach to flow limitation. Pride 
introduced the mechanical elastic properties of the airway wall as 
determinants of flow limitation and stated that the bronchial col-
lapsibility of the airways downstream from EPP determines at 
which critical Ptm value (Ptm') instability, compression or col-
lapse of an airway segment occurs. According to the so called 
'waterfall' or 'Starling resistor' rnodel by Pride et al., all events 
downstream from the dynamically compressed airway segment 
Ppl collapsible 
"---__ ---'s::;e:,,9ment 
P~v Pmo 
......-seg s .. ..._seg d -lI>-
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(with clastic properties characterized by Ptm') are irrelevant with 
regard to flow limitation (Fig. 4). Pride's model separates there-
fore the location of EPP and Ptm'. According to Pride et aI., the 
Ptm' locus is the waterfall locus, where actual flow limitation 
takes place. They concluded from the work by Macklem and 
Wilson (29) that this waterfall locus had to be located between 
the segmental bronchi and the trachea in normal subjects and 
therefore downstream from EPP (47). In this model, both the 
peripheral and central airways are thought to be a system of col-
lapsible tubes surrounded by pleural pressure and divided in two 
parts by a collapsible segment with an abrupt narrowing caused 
by an exceeded Pun'. Rs (i.e. Rus + something more if Ptm' < 0) 
and Rd represent subsequently the airway resistance upstream 
and downstream from those airways where a 'waterfall' with 
regard to pressure drop occurs during forced expiration. Ptm' 
quantifies the collapsibility of the airways at the locus of the 
'waterfaW. In extra pulmonary airways, Ptm' is determined by 
the airway wall characteristics: elasticity, smooth muscle tone 
and surface forces; in the intrapulmonary airways effects of sur-
rounding lung tissue as radial traction and/or compression are 
added as determinants of Ptm'. The compressed locus in the air-
ways with the waterfall was called the Flow Limiting Segment 
(FLS). III vitro experiments with tracheobronchial trees of dogs 
(40) supported the theoretical separation of EPP and FLS as 
assumed from the model. A decrease in lung volume resulted in a 
shift of EPP towards the periphery whereas the FLS stayed in the 
central airways over a large volume range. \,lork by Macklem 
and Wilson showed that with a fixed volume and expiratory flow 
the EPP remained fixed somewhere between segmental and lobar 
bronchi and did not shift with increasing expiratory effort (29). 
An FLS at the EPP would mean that Ptm', by definition, is zero. 
According to the Pride model this can only occur in very thin 
walled airways as is not the case i1l uiuo. Therefore a 'waterfall 
locus' (FLS) occurring at the EPP is unlikely. Macklem and 
Wilson (29) showed that in normal subjects at the isovolume 
plateau flow, with increasing expiratory effort, the transmural 
pressure of the intrathoracic trachea became more negative. This 
implies that the trachea is downstream from the "waterfall H. 
Therefore the "waterfall locus" had to be located between the 
segmental bronchi and the trachea in normal subjects. 
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In summary Based on the above findings the basic mechanism of flow limita-
tion was the coupling of airway compression and a flow depend-
ent drop in intrabronchial pressure (54). On the one hand, the 
fall in pressure along the airways is essential for the generation of 
flow and the acceleration of air in a converging bronchial system 
with a decreasing total airway cross sectional area (Pca). On the 
other hand, the pressure drop along the airways is the result of 
laminar and turbulent energy dissipation in the airflow (PEr). The 
translllural bronchial pressure (Pun) in peripheral airways is pos-
itive and therefore distending during expiration. Ptm decreases 
downstream and becomes negative or compressive in more cen-
trally located airways. An increased driving pressure for flow is 
in balance with a decrease in ainvay area caused by the decrease 
in transmural pressure when flow limitation is present. 
MODELING FLOW LIMITATION; THE PHYSIOLOGICAL 
APPROACH 
The coincidence that an increase in Ppl as driving force for flow 
was in balance with a decrease in Ptm and airway area and there-
fore resulted in flow limitation was remarkable and thus far 
amazing. The fact that it occurred over a large range of lung vol-
tunes in health as well as in disease indicated that local explain-
ing flowlimiting mechanisrns had to exist. The qualitative 
approaches by Mead, Pride, Macklem and others gave some 
insight into the site of flow limitation and its behavior in various 
disease states. However, they did not really explain the mecha-
nism of flow limitation itself. Mead et al. and Pride et al. showed 
the importance of the elastic recoil pressure (Pel) and the trans-
mural pressure to be crucial determinants of maximal flow. Their 
approaches were, however, mainly based on pressure distribution 
in the airways and were very limited with regard to the orienta-
tion of flow limitation in the bronchial tree. Limitations of their 
approach were that Ptm' and the upstream and downstream 
resistance were regarded as relatively 'static', i.e. independent of 
lung volume. The influences of the properties of the airflow itself 
(speed, density, and viscosity) and their relation with ainvay wall 
properties were only partly taken into account. 
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The conducting airways in the human lung fonn a complex sys-
tem, composed of 23 generations of dichotomic branched elastic 
tubes, converging from alveoli to the trachea (53). The bronchial 
system can thus be regarded as a 'trumpet' or even as a 'thumb-
tack' model: a broad base of ±300 cm2, representing the total of 
the area of the respiratory bronchioles, connected with the mouth 
with a conical shaped airway with a minimum cross sectional area 
of ± 2 cm2 at lobar bronchi (53). The total cross sectional area of 
the conducting human airways decreases thus ± 150 fold from the 
alveoli to the mouth. The velocity of air at a given flow is negligi-
ble at the smallest conducting peripheral airways but accelerates 
by a factor of more than 100 because of the decrease in total cross 
sectional area (A) of the conducting airways. 
The pressure drop between the alveoli and the mouth results in 
an expiratory flow, provides the energy for the accelerating 
velocity of air and compensates for dissipative energy losses asso-
ciated with laminar andlor turbulent flow (friction). 
This intra bronchial pressure drop results in a drop in total pres-
sure (Ptot) by frictional losses as well as in a drop in laterally 
directed airway pressure (Plat). Focussing on convective accelera-
tion and neglecting unsteady and compressible effects on the 
exhaled gas, the Bernoulli equation can be used to relate the lat-
eral pressure Plat to the flow speed (v): 
Plat + Y,opov2 ~ C 
The Bernoulli constant C is the stagnation pressure which is 
equal to the intra bronchial pressure at any point in the flow 
when airspeed is zero and dissipative energy losses due to friction 
are neglected. In the most peripheral bronchioli at alveolar level 
airspeed is negligible and therefore the Bernoulli constant C 
equals the alveolar pressure (Palv). If flow has a blunt profile, v is 
uniform over a cross section (A) of the air"ways and can be 
defined as 
v ~ V'/A 
with V' identical to flow at the mouth. Gas compressibility, 
unsteady changes of volume of airways and frictional pressure 
losses are neglected in this approach. 
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The Bernoulli equation can, in this case, be written as (21): 
Plat = Pall' - y,.p. V,2/A2 
In other words: the laterally directed pressure (Plat) at a point in 
the airways is entirely determined by the local flow and the local 
cross sectional area (A) if the intra bronchial pressure drop is 
entirely due to convective acceleration. A local mechanism then 
determines V'max because V'max is totally independent fr0111 the 
variations in A upstream from that point. (The effects of dissipa-
tion of energy due to friction and the intrinsic mechanical prop-
erties of airways will be discussed elsewhere). 
Fry (9; 11) in 1968 restudied the problem of flow limitation by a 
formal mathematical operational approach. He combined one 
equation describing the mechanics of airway deformation: the 
cross sectional area (A) of an airway as a function (g) of 
trans pulmonary pressure P and the position (x) along the 
bronchial tree (A = g(P,x)), with another equation describing the 
pressure gradient (dP/dx) in the airways as a function of area, 
position and flow: (dPldx = g(A,x,V') ). Fry pointed out that the 
coupled set of equations would have to be solved simultaneously, 
going stepwise from the periphery to the central airways, in order 
to obtain a solution of local airway properties that could explain 
a local maximal flow. In other words: for some airway pressure 
area curves, there is a maximum value of expiratory flow for 
which a solution for both equations is present. 
A graphic example of the mathematical approach by Fry is given 
in Fig.5 that can be explained as follows: 
The follmving conditions are assumed: a) the bronchial tree is a 
symmetric binary branching network with a known cross sec-
tional area (A) for each generation, b) the elastic properties 
(dAldPtm) of the airways of all generations are known (A as 
function of Ptm is represented as the partial curves labeled with a 
generation number in Fig. 5, with the generation 3 curve shown 
as the minimum are a) and c) the only pressure drop in the sys-
tem is due to convective acceleration: Pca = V2opo V'2/A2. 
At a given static lung volume with a static recoil pressure Pel 
shown on the abscissa, all intrathoracic airway generations have 
an A given by the intersection of the AlPtm curves with the verti-
cal Pel line in the absence of flow. For a given flow V'l or V'2 
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(V'l < V'2) the transmural (distending) airway lumen pressure 
Ptm is reduced by Pca = y,.p.V,2fA2 (Ptl11 = Pel - Pca). Theoreti-
cal curves of A of a local airway segment as a function of PUn for 
a given V'l or V'2 (V'1 < V'2) are given by the two dashed lines. 
The actual area and distending pressure Ptm of an airway genera~ 
tion for a given flow are given by the intersections of the genera-
tions AlPtrn curves (solid) and the theoretical NPtm curves 
(dashed). Point 'a' gives the minimal actual airway area for a giv-
en flow V'l which happens in generation 3, whereas the actual 
area's of generation I and 2 are given by the vertical line above 
'a'. Because at flow V'l two intersections ('a' and' a' ') occur 
with e.g. the generation 3 compliance curve, no stable solution 
resulting in one unique flow value originates. 
With increasing flow (V' 1-> V'2) the pressure drop between alve-
oli and generation 3 is large enough that the curve of A versus 
Ptm is tangent to one of the airway area curves. In Fig. 5 this 
happens at the tangency point 'b' in generation 3, the correspon-
ding curve is the one shown for flow V'2. Flows larger than V'2 
are not possible because the flow pressure area will then not 
intersect the airway area curve of generation 3: no simultaneolls 
solution would exist for the flow and the airway mechanics at 
that point in the bronchial tree. In other words airway generation 
3 allows no larger flow than flow V'2 and can be regarded as the 
A --Tube laws :V'2 'V' 
....... convective acceleration .: ,1 
.... , .. 
................... 
Ptm 
.... 
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Figure 5 
Graphic solution to the 
limitation of expiratory 
flow. (exp!anation: see 
text) 
Curws 1-5: Cross sec-
tional area (A) - dis-
tending (tmnsmuml) 
airway pressure (Ptm) 
curves of 5 different 
airwar generations, V': 
expir.ltorr flow, Pc!: 
lung elastic recoil pres-
sure, PC,l: pressnre drop 
due to convecth'e accel-
eratiun. 
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flow limiting segment for a flow with a V'2 value. At high lung 
volumes (at large Pel) and at large flows flow limitation will start 
in the first generation (e.g. the intrathoracic part of the trachea). 
\Vith decreasing Pel, decreasing l11aximal flows and/or increasing 
upstream pressure drops, the tangency points will occur in the 
AlPtm curves of more peripheral airway generations with a high-
er number and minimal A. At the points of tangency at common 
values of A and pressure Ptlll, a simultaneous solution (the com-
mon curve slope) exists for the two equations describing the two 
curves. 
Solving equation Ptm = Palv - Y,opo V'2/A2 for V', gives: 
V'max = Ao[AI(podAldPtm)]O.5 (19) 
(This is the same equation, Dawson and Elliott described later 
for flow limitation at wave speed (4;7;8)). 
This theoretical graphical analysis predicts a maximal flow 
(V'max) for pressures greater than necessary to obtain V'max. At 
maximal flow, curves of area against pressures are tangent to 
curves of actual airway area versus pressure. Nlaximal flow is 
entirely determined by the properties of the airway generation 
with minimal area. The value of maximal flow and the pressure 
difference required to achieve maximal flow both depend on Pel 
and therefore on lung volume. 
Although this graphical approach was a major simplification, it 
proved to be successful in Penrose tubing (25) and in the larger 
extra parenchymal airways in excised dog lungs as a method of 
predicting flow (23). The simplification being that pressure losses 
because of friction and turbulence and effects of surrounding 
lung tissue and disease were not taken into account. However, 
Fry extended the understanding of flow limitation and made it 
likely that local airway characteristics playa major role in deter-
mining the maximal flow for the total bronchial system. 
Unfortunately no sufficiently precise data existed about actual 
flow or airway elastic properties to apply Fry's approach with 
trustworthy results. The occurrence of flow plateaus on the iso 
volume pressure flow curves was not explained either. 
Subsequently, simplified models were proposed for localized 
mechanisms that could explain flow limitation. Pardaens et a1. 
(41), Lambert and Wilson (26) and Pedersen et a1. (45) all stated 
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that pressure drop due to convective acceleration (Pea) takes 
place mainly in the central airways and that frictional pressure is 
lost mainly in peripheral airways. These qualitative mechanisms 
can be expressed by a common equation: 
Plat ~ Palv - PEr - Pea ~ Palv - Nr - "apa V'2/A2 
Experiments by Hyatt et a!. (21) showed indeed that combining 
actual measures of Pfr with central airway pressure area plots 
from excised human lungs resulted in a graphical solution of 
V'max that agreed with measured maximal flows at high and 
middle lung volumes. However, at low lung volume this agree-
ment was poor, suggesting that other flowlimiting mechanisms 
were dominant. 
It was likely that two basic mechanisms were responsible for 
flow limitation: 
1) The coupling of airway compliance with pressure drop due to 
convective acceleration, occurring at high and middle lung 
volumes and mostly in central airways (later called the 'wave 
speed mechanism') and 
2) A mechanism related to viscosity dependent pressure loss 
playing its role mainly at low lung volumes and in the more 
peripheral airways. 
Both mechanisms are summarized in the equation: 
Plat ~ Pel - Pfr - ;;'01'0 V,2/A2 
WAVE SPEED FLOW LIMITATION 
Airways of the lung are compliant meaning that their caliber, i.e. 
cross sectional area (A), depends on the transmural pressure Ptm. 
1>tm is the difference between the pressure inside the airways and 
the peribronchial pressure which approximates the pleural pres-
sure. In case of flow the intra bronchial pressure distribution is 
determined by lung volume, gas properties, flow and airway cal-
iber. Therefore airway and flowmechanics are coupled by the 
concept of airway compression. Fry (9-12) and Hyatt (16) under-
In summary 
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stood in a qualitative way that this coupling could lead to flow 
limitation. Dawson and Elliott (4;5;7;8) provided, however, the 
most important breakthrough in the understanding of flow limi-
tation and its quantitative modeling. They understood that gas 
filled airways in the lung behave identical to fluid filled compli-
ant tubes with regard to flow limitation. The wave speed theory 
of flow limitation states; elastic tubes can not carry fluid at a 
mean velocity greater than the speed at which a pressure distur-
bance propagates along the tube. The speed at which a pressure 
disturbance travels through a fluid filled compliant tube was 
called wave speed. Not in lung mechanics but during micturation 
in males, Griffiths et al. (13) explained steady flow by the wave 
speed mechanism. In the arteries the propagation speed of the 
pulse is equal to the wave speed. Mathematics in fluid and gas 
mechanics are the same, only the physical entities differ. 
Dawson and Elliott applied the wave speed concept to the 
bronchial tree and stated that the maximal possible airflow 
through (compliant) airways is reached when the local air veloci-
ty becomes equal to or exceeds the local wave speed at any point 
in the tube. This point is called the choke point (CP). 
Given a compliant tube with a cross sectional area A, a trans-
mural pressure Ptm, a tube wall compliance dPtmJdA and filled 
with a fluid (or gas) with a density p, the wave speed (c) is given 
by: 
c = [(A/p).(dPtmldA)]o.5 
Because maximal flow V'max is equal to: A.c, it follows that 
V'max = A.[(Alp).(dPtmldA)] 0.5 
As previously described, the same equations can be derived math-
ematically from the simultaneous solution of the PtmJA curve 
and the V'2 curve at their point of tangency at point 'b' in Fig. 5 
in the graphical approach of flow limitation. 
It is important to realize that every elastic tube can always be 
characterized by a wave speed, even if the flow is zero. \\lave 
speed should not be confused with the velocity of the gas. The 
less dense the fluid or gas is, the stiffer the tube (airway) is, 
and/or the larger its cross section (the area) is, the higher the 
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wave speed will be (4;43). Using the wave speed approach, Jones 
et al. (23) were able to calculate V'max from the A-Ptm-relation-
ship of the flow limiting segments in dog lungs. Hyatt (21) and 
Mink (39;40) demonstrated graphically the maximal flows in 
dogs and in man are consistent with wave speed flow at middle 
and high Inng volumes. 
In isovolume conditions the wave speed is high when there is no 
flow or only a low flow. The explanation is that the airways area 
is large in absence of relevant compression and that the airways 
are stiff because they are on the upper part of their sigmoid pres-
sure area characteristic, so their dAJdPtm is low. In case of low 
expiratory flow, the downstream directed gas velocity will only 
slightly diminish the upstream transmission of a pressure change 
at the outlet (e.g. the mouth). However, the upstream transmis-
sion speed of a downstream located pressure change will fall 
\'1hen expiratory flow increases. This is the result of an increase 
in opposing airflow velocity and a decrease in wave speed. 
The drop in wave speed c is the result of a decrease in transmural 
pressure Ptm causing a decrease in area A and possibly in airway 
wall compliance as well. Airway compliance (Caw) may both 
increase or decrease with decreasing PUn, according to the shape 
of AlPtm curves (Fig. 9). When the upstream velocity of pressure 
disruption (the wave speed predicted by the wave speed equa-
tion) no longer exceeds the actual downstreanl flow velocity, 
downstream pressure changes can not move upstream nor affect 
the flow anymore. Flow has then become independent of down-
stream events. \Vhen this phenomenon happens, flow limitation 
is a fact and the point in the airways at which it occurs is called 
the choke point. In this situation the speed index (SI = vic), as 
indicator for the occurrence of flow limitation, is equal or larger 
than one. 
The airway area A diminishes during expiration because the teth-
ering force of the lung parenchyma diminishes with decreasing 
volume and Plat decreases with increasing flow because of the 
Bernoul1i effect, causing more compressive force on the compli-
ant airway walls. At high lung volume the total cross sectional 
area of the peripheral airways is very large compared to the nar-
row central airways, explaining the inevitable acceleration of the 
gas in the converging bronchial system. The large increase in gas 
velocity due to acceleration when reaching the relative narro\'1 
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central airways, leads to further airway narrowing, and therefore 
to further acceleration up to the point where gas velocity 
becomes equal to a local wave speed. This also explains that a 
choke point will occur first where the wave speed flow is mini-
mal, i.e. where airway area cubed divided by airway compliance 
is minimal. As A is the stronger determinant of the two, the 
choke point is likely to occur at the narrowest airway segment, 
being the outlet of the s),stem as was shown b)' Macklem (28). 
\'(1hen lung volume and therefore lung static recoil decrease dur-
ing expiration, the peripheral total airway area A decreases dra-
matically, resulting in a net drop in peripheral wave speed. If 
peripheral wave speed is less than central wave speed, this will 
result in an upstream movement of the choke point. This can be 
compared with a shift of the point of tangenc), in Fig. 5 to area 
pressure curves of more peripheral airways. 
The wave speed concept represents the theoretical approach of 
the assumption described b)' Pride (47) that a "waterfall" (or 
Starling resistor) could occur in an)' collapsible tube at a critical 
transmural pressure Pun'. When the velocit)' of gas at a (choke) 
point in the airwa), is equal to or exceeds the speed of upstream 
pressure propagation, events (e.g. an outflow pressure drop) 
downstream from this choke point can no longer influence what 
will happen at or upstream from this point. This is also the case 
in a real waterfall: the flow of the lVaterfall itself is determined 
by upstream events and independent of changes in the down-
stream water level up to a certain level. Translated to the lung: an 
increase in effort (i.e. in pleural pressure) results in a decrease in 
transmural pressure Ptm. Ptm is the analog of the downstream 
water level: when Ptm becomes equal to or more negative than a 
critical Ptm value (Ptm'), Ptm itself can no longer determine the 
local flow and flow limitation will occur. One can compute 
V'max for each airway segment from airway wall compliance at 
all Ptm values. H)'att et a!. (21) predicted accurate maximal expi-
ratory flows in excised human lungs using this quantitative theo-
retical approach. Mink (38) lVas able to show that the character-
istics of forced expirator), flows at high and middle lung volume 
in dog lungs agreed with the wave speed model using the same 
principle. 
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DETERMINANTS OF Ptm, THE PRESSURE WALK 
The wave speed concept explains that the maximal flow through 
a collapsible tube can be deducted from the product of the wave 
speed and the cross sectional area of the tube (4). Flow at wave 
speed (V'ws) is: 
V'ws = (lIp)o.5.(dPtmldA)o.s.A312 (34). 
Tube compliance (dAldPtm) and gas density as intrinsic factors 
and local transmural pressure (Pun) as an extrinsic one, deter-
mine the local wave speed flow. dPtmldA and A can be derived 
from the pressure area characteristic of the collapsible tube 
(Fig. 6). The tube characteristics in Fig.6 show stiffening of the 
tube at the two extremes, a phenomenon that corresponds to real 
ill vivo airway characteristics (31). dPtmldA and V'ws diminish 
over a wide range with decreasing A. However, with further 
decreasing of A, at a certain A the stiffness of the tube starts to 
increase again with an increase of V'ws at the end. Mead pointed 
out that the tube stiffness dPtmldA is a local intrinsic factor, 
mostly determined and/or influenced by local and neighboring 
conditions (e.g. its directly surrounding tissues) (34). However, 
Ptm Ptm 
+ 
o A V'ws 
(1/p )0.5.( dPtml dA)O.50A3/2 
Figure 6 
left: a typical tmllS-
muml pressure (Ptm) -
are.l (A) cll,uacteristic 
fOf an elastic tube: the 
'tube law', Right: COf-
responding wave speed 
flow (V'ws), based on 
the equation given in 
the figure; p is the fluid 
density, and dPtmJdA is 
the slope of the 'tube 
law' characteristic at a 
point, (from reference 
34) 
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Figure 7 
A 'map' of the 'pres-
sure walk' by J.l...Iead. 
(explanation: see text) 
fib: intr,lbronchial 
starting point, pb: peri-
bronchial point, alv: 
.llwolus) 
(from: reference 34) 
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Ptm is a complicated extrinsic factor determined by factors some 
of which originate far fro111 this local airway, These extrinsic fac-
tors can be illustrated by the "pressure walk" through the lung as 
pointed out by Mead (34) (Fig. 7). Wle start in the bronchus 
(point 'ib') and cross the airway wall into the peribronchial tissue 
('pb') further progressing into the alveolus ('alv'). From the alve-
olus we proceed towards the mouth through the bronchi to onr 
original bronchus ('ih'), Along this walk we encounter several 
pressures. The first is Ptlll (Ptm = Pib - Ppb), the second is the 
pressure difference between Pb and the alveolus (Ppb - Paly) and 
the third is the intra bronchial pressure difference between the 
alveolus and our starting point (Paly-Pib). 
The SUIll (Pib-Ppb)+(Ppb-Paly)+(Paly-Pib) ends up in zero (2nd 
Kirchoff's law). This 'walk' indicates that PUn is determined by 
two (extrinsic) factors: 
Pun = (Palv-Ppb) - (Palv-Pib) 
The first term (Palv-Ppb) equals the lung elastic recoil pressure 
(Pel) in a homogeneously expanded lung under static conditions 
(and probably during forced expiration as well (52)) because in 
such a lung the pcrialveolar andlol' peribronchial pressure is 
regarded to be similar to the pleural pressure (Ppl) 
Pel = Paly-Ppl 
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The greater the Pel is, the greater Ptm will be. The second term 
(Palv-Pib) is zero under static conditions resulting in Ptm equal to 
Pel and it explains a decrease in Ptm during expiration when Palv 
is greater than the bronchial pressure (Pib). 
During ~1EFV maneuvers> V\vs decreases over the larger range 
of the Ptm/A relation with decreasing Ptm (Fig. 6). This may 
result in V\vs becoming equal to expiratory flow, resulting in 
local flow imitation. 
Palv-Pib has dynamic characteristics during expiration and con-
tains the two components Pca and Pfr. Pca is the pressure drop 
due to convective acceleration solely determined by the local 
cross sectional area A at our specific point in the bronchi. Pfr is 
the pressure drop due to any friction of gas in the conducting air-
ways and is a more complicated ten11. Plr depends on: 1) the 
geometry> length, branching and area of the airways between the 
alveoli and the starting point of our pressure walk; 2) the density 
(p), 3) the viscosity (~l) and 4) the flow characteristics. For pure 
laminar flow (expected in peripheral airways) Pfr depends on vis-
cosity. In full turbulent flow, Pfr depends on the density. Between 
these extremes Pfr depends on both factors and the character of 
the flow. 
The transmural pressure Pt111 at a chosen point in the airways is 
determined by two main factors. 1) Lung elastic recoil (Pel) is a 
positively contributing static component and is positively corre-
lated to lung volume. Pel can be considered to be independent of 
flow, contributes to all intrathoracic airways to the same extent 
and results in positive transmural pressures, which increase with 
increasing lung volume. 2) The intra bronchial pressure drop is a 
negatively contributing dynamic component. It correlates with 
flow (Ptm becomes less with expiratory flow), increases with 
increasing distance between alveoli and the position in the 
bronchial tree and increases with decreasing cross sectional area 
A. This dynamic component changes therefore over the bronchial 
tree. 
\\lith increasing expiratory flow, the transmural pressure Ptm 
decreases from static elastic recoil level progressively along the 
bronchial tree from alveoli to the thoracic outlet (34). 
In summary 
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Figure 8 
Viscous flow limihltioll. 
A: pressure- area curve 
of a smaller airway. B: 
if the PoiseuiHe equa-
tion describes the pres-
sure gmdiem in the 
flow, then for a fixed 
pressure at the 
upstream end of a tube 
(PI), flow ,viii depend 
on the pressure ,It the 
downstream end of the 
tube (1'1). (From \,\'ilson 
and coworkers, refer-
ence 54). 
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A 
Pressure Pressure drop P1-P2 
VISCOUS FLOW LIMITATION 
The wave speed equation (c = [(AJp).(dPtmJdA)]O.5) makes wave 
speed (c), airway area (A) and airway compliance (dAJdPtm) 
functions of transmural pressure (Ptm). In other words: the later-
ally directed intra bronchial pressure Plat determines wave speed 
and therefore maximal flow. However, the intra bronchial pres-
sllre will be, apart from the pressure drop due to convective vol-
ume acceleration, also be determined by intra bronchial frictional 
or dissipative pressure losses. 
This is illustrated by the poor predictive capability of the wave 
speed theory at low lung volumes, where (apart from the relative-
ly larger influence of non homogeneity and airway closure) the 
density dependence of maximum flow is small and the viscosity 
dependence is large. The frictional loss is dependent on the flow 
regime being laminar or turbulent. Reynolds and Lee (48;49) 
described frictional pressure losses in studies of expiratory flow 
in models and bronchial casts. Plr, the dissipative gradient along 
an airway, was expressed by an equation comparable to the 
Rohrer's equation (50): 
plr = (a+b.Re).8.1l.~I. V'/A2 
(a and b are experimentally detennined parameters, ~ being vis-
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cosity; the coefficient SnpV'/A2 is the pressure loss pel' unit 
length in Poiseuille flow; Re is the local value of the Reynolds 
number (Re = lopo V'/~I.[(TC.A)o.sl ). 
Shapiro (51) used a compliant tube with a pressure area charac-
teristic as shown in Fig. 8 and described purely viscous flow limi~ 
tation in a compliant tube based on the coupling between the vis~ 
cous losses and the tube compliance. A viscous flow limit can be 
reached dependent on diameter and elastic properties of the tllbe 
wall, as indicated in Fig. 8b. 
The important result of the analysis, described in detail in the 
paper by Wilson et a!. (55) is that in larger central airways wave 
speed limitation dominates. In smaller peripheral airways the vis-
cous mechanism has already established effectively a limiting 
flow before the wave speed limit is reached. 
Flow passes many parallel paths in the periphery of the lung. The 
area and the flow through an individual airway in a generation 
with 'n' parallel airways are respectively Aln and V'/n. According 
to Weibel the Aln is minimal for the 8th through 12th genera-
tions (53). At high lung volume, the wave speed limit on flow in 
the central airways is less than the viscous limit in the peripheral 
airways, causing flow limitation to be located in the central air-
ways. At low lung volumes, the viscous limit to expiratory flow 
in the peripheral airways is lower than the wave speed limit in 
the central airways (54). Viscous flow limitation has thus become 
a fact. 
WHERE DOES FLOW LIMITATION OCCUR? 
The maximal possible flow through an elastic tube can be 
derived from the tubelaw, an intrinsic purely local feature of a 
tube, and the Ptm (an extrinsic determinant) according to the 
wave speed theory. Air is expired through thousands of elastic 
airways in the human lung. Each airway or airway segment has 
its own characteristic tubeia\" and therefore wave speed flow. 
Mead (34) gave a 'physiologists view' on the localization of flow 
limitation in this maze of airways: starting at the alveoli and after 
. passing a number of branches we arrive in parallel airways of 
similar size and presumably similar tllbe law. If the tube law of 
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Figure 9 
Airway cross sectional 
area A (expressed ,1S 
fraction of maximal A) 
versus transmural pres-
sure {Ptill (em H1O)) 
for each airway genef<1-
tion from trache.1 (z=O) 
through 10th genef<1-
tion. Generations 11-
15 lie between Z= I 0 
and z=I6. 
The pressure-area 
cUr\'es are ,l(cording a 
comput<ltional model 
for expirator}' flow by 
Lambert and cowork-
ers (see text) (from ref-
erence 27) 
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these comparable, parallel operating airways can be expected to 
be the same, the total tube wave speed flow for the SlUll of these 
airways at a specific Ptlll is the product of the local wave speed 
and the total sum of cross sectional areas. Different levels (gener-
ations) in the lung are thus characterized by their individual air-
way size and total wave speed flows. Lambert et al. (24;27) com-
posed pressure area curves ('tube la\"s') for the generations 0 
(trachea) till 16 (Fig. 9). They applied these tube laws in a com-
puter model in order to predict the pressure distribution in the 
airways, IVPF curves and, above all, maximal flow volume 
curves. Lambert's choice for basic measured data on human pres-
sure area curves was constrained to pressure area data obtained 
from central airways by Hyatt (21) and the data by Weibel on the 
maximal area for all generations (53). However, Lambert's com-
puter model was able to predict sufficiently accurately the aver-
age MEFV curves of five human lungs when introducing high 
compliance values for the peripheral airways. 
The wave speed flows of the different generations arc highest 
under static conditions, i.e. no flow. Three features (a, b and c) 
result in a progressive downstream decrease in wave speed flows 
and one (d) works opposite in the upstream direction during 
expiration. All these features are influenced by lung volume. 
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a) Ptm decreases progressively along the airways during expira-
tion. Therefore wave speed flows can be expected to be the low-
est near the farthest point: the thoracic outlet. b) Cross sectional 
area decreases from alveoli towards the mouth; thereby favoring 
low wave speed flow near the thoracic outlet. c) The intrapul-
monary airways may behave relatively more stiffly compared to 
the more centrally located extrapllimonary airways as a result of 
mechanical interdependence between intrapulmonary airways 
and the surrounding pulmonary parenchyma. This results in rela-
tively lower wave speed flows centrally. d) Airway compliance 
data from excised dog lungs by Martin (31) showed that excised 
trachea's have a substantially larger intrinsic stiffness than 
excised 5 mm airways which, in turn, are stiffer than 2 nun air-
ways. This factor alone would result in a decreasing gradient of 
tube wave speeds running opposite (upstream) to the gradient of 
the cross sectional areas. 
The localization of developing choke points depends on the (lung 
volume dependent) contribution of each of these factors. In 
healthy subjects, at high lung volumes the first three are expected 
to locate the FLS in the neighborhood of the main carina. 
Indirect evidence for this claim can be found in the experience 
that, at high lung volume, only the configuration of the upper 
part of the MEFV curve will be influenced by stretching and 
thereby increasing the stiffness of the trachea and carina by neck 
extension (36). At lower lung volumes, neck extension has no 
effect indicating that the choke point(s) has (have) moved to 
nlore peripheral generations. This was confirmed by intra-
bronchial pressure measurements in a model and in dogs by 
Pedersen et al. (2;3;42;44;45). In many subjects the shape of the 
MEFV curve is irregular with reproducible abrupt changes in 
MEFV configuration. This can be explained by sudden shifts of 
flow limitation to other airway levels during expiration. III VitlO, 
the proposed lumping of the airways with a comparable size is 
probably not justified with regard to the prediction of the local-
ization of wave speed flow. Apart from possible intrinsic differ-
ences between airways, systematic extrinsic differences can be 
expected (34). An example is the gravity induced expansion of 
the upper lobes, resulting in higher local wave speed flows than 
in comparable airways in the lower lobes. Following this reason-
ing, it may be expected that multiple choke points may exist 
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simultaneously. This remains undetected as long as for instance a 
central choke point still limits the total flow. When the rest of the 
peripheral airways parallel to one or more already "choking" 
airways choke as well, the overaJi flow limitation moves to that 
level with a different V'max and subsequently a more or less 
abrupt change in MEFV shape results. In general: the airway lev-
el with the lowest V'ws will detennine the V'max for the whole 
lung. 
Intrinsic airway characteristics (e.g. A and tubelaw, modified by 
mechanical interaction with surrounding lung tissue) and extrin-
sic factors (e.g. Pel and Ptlll, influenced by complicated features 
of airway flow resistance) are distributed along the bronchial tree 
and change differently with lung volume. These factors collabo-
rate and/or compete with regard to the process and the localiza-
tion of expiratory flow imitation in the complex bronchial 
branching system. To predict where flow limitation will occur is 
therefore difficult. 
Chapter 3 
CONCLUSION 
Many different individual and interdependent factors contribute 
to the determination of expiratory flow. The wave speed concept 
of flow limitation explains that the coupling between geometry, 
size and compliance of the airways, in combination with pressure 
distribution and flow results in flow limitation (Fig. 10). 
Although it is an all embracing concept, the phenomenon of 
expiratory flow limitation has still not been solved completely. 
As described by Hyatt: 'We are still confused but at a much high· 
er level'(17). 
In the studies as described in this thesis, we applied the wave 
speed concept in combination with intrabronchial measurements 
in order to obtain more insight in the qualitative and quantitative 
effects of abnormalities of airway mechanics present in asthma. 
These abnormalities may be the result of airway remodeling 
caused by chronic inflammation. 
Wave speed flow: [(1/p)O.5.(dPtmldA)O.5.A3/2] 
physlcal properlles 
of the gas area (A) 
tube elastance Ptm (Plb- Ppl) 
physical properties 
01 airway wall 
(and interdependence loss) 
site 01 flow 
limftatlon 
1 
elastlc recall 
of the tung 
1- .... 1 . l 
Palv-Pib (resistive 
pressure) 
physical properties degree of lung 
of the lung Inflation 
convective acceleration losses 
geometry 
1 
I 
area of alveolus 
geometry 
area of site of flow 
limitation 
frictional pressure 
··T--rJ--1 
flow' density viscosity 
Figure to 
Factors determining 
W,lVe speed flmv limita-
tion 
PpJ: pleuml pressure, 
Fib: intmbrochial pres-
sure, {ltm tmIlsmuml 
pressure. Pal\': 'llveolar 
pressure. 'f: Flow: lami-
nar to fully develuped 
turbulent flow. 
(Modified from !:leck 
Wahl (1), with permis-
sioIl from PJF11 
J..·lcrkus (37)). 
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ABSTRACT 
Chronic inflammation and extracellular remodeling of the air~ 
way wall characterize asthma. The purpose of this study was to 
examine whether these features cause a change in airway 
mechanical properties. 
We examined 14 healthy and 10 young adults with long-lasting 
asthma, the latter treated with inhaled bronchodilators and corti-
costeroids. To obtain area-versus-transmural pressure (A-Ptm) 
curves during forced expiration (Pedersen O.E et al. l.Appl. 
Physiol. 1982; 52: 357-369), we used an esophageal balloon and 
a Pitot static probe positioned at five locations between the right 
lower lobe and midtrachea. Cross sectional area (A), airway 
compliance (Caw = dNdPtm) and specific airway compliance 
(sCaw = Caw/A) were obtained from the A-Ptm curves. 
Results showed that: 1) A was larger in males than in females, 
2) Caw and sCaw decreased with a more downstream position 
and 3) Caw and sCaw were significantly lower in the patients 
with asthma, with the differences between the asthmatic patients 
and the healthy subjects becoming smaller toward the trachea. 
The lower Caw and sCaw in the patients with long-lasting asth-
ma support the concept that chronic inflammation and remodel-
ing of the airway wall may result in stiffer dynamic elastic prop-
erties of the asthmatic airway 
Chapter 4 
INTRODUCTION 
Chronic airway inflammation plays a central role in the patho-
physiology of asthma. Mucosal biopsies show that in adult 
patients with different grades of asthma (2;10), even after 10 yr 
of treatment with inhaled corticosteroids (20), inflammatory 
changes are present in the airways. Studies of asthmatic children 
indicate that airway inflammation is present in childhood as well 
(9;16). 
Simultaneously with these effects, extracellular remodeling asso-
ciated with fibrosis and elastolysis takes place in the airway wall 
(3), probably as a result of a repair process following acute aller-
gic inflammation and driven by mediator release after chronic 
allergic inflammation (31). Extensive thickening of the basement 
membrane, due to subepithelial fibrosis, is commonly observed 
even in stable asthma (9;15;17) at an early stage (7; 17), as well 
as in childhood asthma (9). The deposition of collagen in the 
subepithelial matrix is increased (36), and the lamina propria is 
thickened as a result of iucreased microvascular permeability and 
plasma exudation in combination with an increase in the number 
of blood vessels (19). The entire airway wall is thickened (28), 
and the percentage cross sectional area (A) of the airway occu-
pied by airway wall tissue is increased by 1.5- to 2- fold (14). 
One may expect that these extracellular structural changes with-
in the airway wall alter the mechanical properties of the airways 
in asthma through geometric effects (31), by changes in tissue 
biomechanics (36), and a change in the interaction between air-
ways and the surrounding lung parenchyma (30). However, the 
net airway mechanical effect of these changes remains unclear. 
Both increased thickening of the airway wall and increased colla-
gen fibril density are important determinants of airway collapsi-
bility, and may stiffen the subepithelial matrix (36) and increase 
the ability of the airways to withstand bronchoconstriction (18). 
On the other hand, reorganization and degradation of elastin 
and cartilage could result in a decrease in airway wall stiffness 
(4), thereby decreasing the load on airway smooth muscle (31). 
The present study was done to test the hypothesis that structural 
remodeling, together with chronic inflammation of the airway 
wall, results in altered mechanical airway properties in long-last-
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ing asthma. It is the first ill vivo study comparing differences in 
airway compliance in asthmatic patients and healthy controls. 
METHODS 
Subjects The study was done with 24 non-smoking young adults, consist-
ing of eight healthy female and six healthy male subjects and 
three female and seven male patients with asthma meeting 
American Thoracic Society (ATS) criteria (1). The subjects' mean 
ages and anthropometric data are given in Table 1. 
The patients had a history of moderate to severe asthma (27) 
beginning in early childhood, and had used maintenance treat-
ment with inhaled corticosteroids for at least 3 yr. They exhibited 
bronchial hyperresponsiveness (BHR) and were atopic, as 
defined by total IgE > 100 IU/ml and a positive radioallergosor-
bent test for at least one inhaled allergen. All of the asthma 
patients were in stahle clinical condition. If an exacerbation or a 
respiratory tract infection had occurred within I 1110 before 
scheduled measurements, the measurements were postponed 
until at least 2 wk after recovery. In an attempt to minimize 
bronchial obstruction caused by edema or hypersecretion at the 
time of measurements, all of the asthma patients were pretreated 
with a lO-d tapering course of prednisolone in addition to their 
regular treatment (45 mg on day 1, 25 mg on study day 7). 
Within 1.5 h before the Pitot static probe (PS) experiment, all of 
Anthropometric data and spirometry results for healthy and asthmatic subjects. 
N Ago HeIght nc RV / TlC fVC FEVI FEVUFVC PEF 
y, Cm %pred" %pred" %pred" %pred" 
Healthy 14 26.1 ± 5.1 179 ± 9 104±9 0.26 ± 0.05 111 ±8 107 ± 11 0.83 ± 0.07 114 ± 13 
Asthma* 10 22.2 ± 3.9 177 ± 10 101 ± 16 0.27 ± 0.05 97 ± 16 85 ± 7 0.76 ± 0.09 90± 14 
p-vaille 0.06 0.56 0.50 0.89 0,01 <0.001 0.05 <0.001 
PEF = peak expiratory flow . 
• Asthmatics: values alter bronchodi!atation and antiinflammatory treatment "Mean, ± sd expressed as percent predicted according to the European 
Community for Coal and Steel standard (21) 
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the asthmatic subjects inhaled the dose of terbutaline (generally 1 
mg) that had resulted in maximal bronchodilation during record-
ing of a dose-response curve 1 wk before the prednisolone 
course. The healthy subjects obtained no pretrea tment with a ~-
2-agonist, since they showed no significant change from baseline 
after inhalation of Img terbutaline. 
The medical ethics committee of the University Hospital 
Rotterdam approved the study, Informed written consent was 
obtained from all subjects. 
Baseline lung function tests consisted of maximal expiratory flow 
volume (MEFV) maneuvers, whole body plethysmography, and 
quasistatic pressure-volume (PV) measurements (Table 1). MEFV 
curves were generated with a pneumotachometer (JaegeJ~ 
Wiirzburg, Germany) with" heated Lilly head. Both the pneu-
motachometer and the volume constant plethysmograph were 
part of a Jaeger Masterlab system. 
lVlaximal bronchodilatation was determined during generation of 
a dose response curve with terbutaline, the need of which was 
considered if an extra dose of 500 fIg of terbutaline resulted in 
less than a 5% increase in FEY 1, expressed as a percent of base-
line. 
PY measurements were made according to the method of 
Zapletal and colleagues (43) and the European Community for 
Coal and Steel Standard (34). A latex balloon 8.5 em long and 
with a 2-cl11 perimeter (International Nledical Products bv., 
Zutphen, the Netherlands) was introduced into the esophagus in 
such a way that the length of the catheter from the nares to the 
balloon tip was one-fifth of the subject's body height (in cm) plus 
9 cm (43). At the corresponding esophageal location, the pres-
sure proved to be most negative during maximal inspiration. The 
balloon was filled with 1.5 1111 of ail; remained ill situ throughout 
the subsequent PS probe experiment, and was subsequently 
checked for leakage. 
For a detailed description of the equipment used to measure air-
way pressures, we refer to the studies by Pedersen and colleagues 
based on similar PS probe experiments (32;33). The PS probe 
was a device comparable to the one used by Macklem and Mead 
(21) (Figure 1). The tubes connected to the PS probe for measure-
Lung Function 
Equipment 
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Figure 1 
Pitot static probe 
0.0. == 3mm; hole at 
tip to record Ptot; 1.3 
em from tip: six lateral 
holes with 0.5 mm 
diameter to record Plat. 
(from refcrcnce 22, 
with permission) 
Experimental 
procedure 
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Ptot r Plat ___ _ 
l.( ;:0J -: : : :: ::::::::: : -----------------:---------------- -- : : : : : : : : -
- - - - - - - - -. ----- - - - - - -- - - - - - _A ________________ _ 
1 em 
ment of end hole pressure (Ptot) and lateral pressure (Plat), and 
the tube attached to the esophageal balloon for indirect measure-
ment of pleural pressure (Ppl), were connected to three identical 
pressure transducers (EMT34; Elema Schiinander, Stockholm, 
Sweden) and via EIVIT 311 amplifiers to an electronic subtractor. 
Thus, both the pressure loss due to convective acceleration (Pea) 
(= Ptot - Plat) and the transmural pressure (Pun) (= Plat - Ppl) 
were calculated on line. 
Nlouth flow (V'm) was measured with a non heated Fleisch no. 
3.5 pneumotachograph (Fleisch, Lausanne, Switzerland). IVlouth 
flow and the pressure signals for Pea, Ptm, and Pplwere visible 
on line. The electronic subtractor, flow amplifier, and PS probe 
were fabricated for this purpose at the University of Aarhus. The 
method used for tuning of the catheters among themselves and in 
combination with the pneumotachometer, and for testing of the 
PS probe, is described elsewhere (32). During ill lIitro tests, the 
accuracy of measurement of the A of different rigid tubes was in 
the range of ± 10% with Pea> 0.5 kPa, except for values of A > 
2 cm2 (32). 
All subjects were premedicated with 0.5 mg atropine intramuscu-
larly at 0.5 hour before introduction of the PS probe. The mouth, 
pharynx, vocal cords, and bronchial tree were anesthetized with 
topical anesthetic. A cuffless endotracheal tube (Err) was passed 
between the vocal cords into the trachea after introduction of the 
bronchoscope. The bronchoscope was pulled back, and, after 
placing the PS probe with its two catheters into the trachea 
through the ETT, the tube was removed. Through use of the rein-
troduced bronchoscope, the tip of the PS probe was positioned 
just above the entrance of the right lower lobe (in one subject the 
left lower lobe). This was the most peripheral position (Position 
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0) used for measurements. The PS probe was then pulled back 
under bronchoscopic view until the four other intended locations 
were reached. These were, respectively, the entrance to the mid-
dle lobe (Position 1), the middle of the main stem bronchus 
(Position 2), 1. cm above the main carina (Position 3) and midtra-
chea (Position 4) (Figure 2). In the following text, the term 'posi-
tion' indicates the intra bronchial position of the PS probe unless 
used in another context. The distance between two intended 
intra bronchial locations was determined individually by measur-
ing at the subject's mouth the distance across which the catheter 
was pulled back between these locations. Next, the PS probe was 
repositioned at Position 0, the bronchoscope was carefully with-
drawn, and the two catheters were pushed through and secured 
in two tightly fitting sideholes in a specially designed mouth-
piece. The free ends of the PS probe catheters and the esophageal 
balloon catheter were then connected to the pressure transducers, 
and the mouthpiece was connected to the pneumotachograph. 
For all measurements subjects were in the sitting position in a 
chair, and were wearing a nose clip. Before each individual forced 
expiratory maneuver, the Ptot and Plat catheters were flushed 
forcefully with air to remove secretions from the end and side 
holes in the PS probe. If the on line visible pressure signals indi-
cated plugging or blockage of the endhole or sideholes, flushing 
was repeated andlor the PS probe was carefully turned or moved 
upstream and downstream for a maximum of 1 em. All subjects 
were asked to perform several NIEFV maneuvers with the PS 
Figure 2 
Positions of the Pitot 
static probe in the 
bronchial tree. 
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probe at each position, starting at Position O. In addition, most 
of the subjects were asked to produce sigh and huff maneuvers, 
for the purpose of another study (21). At each position the proce-
dure was repeated until acceptable results were obtained or four 
or five maneuvers had been performed. A total up to 30 MEFV 
maneuvers was performed. A complete 1'S probe experiment 
took about 1 to 1.5 h. 
Data selection Initial assessment of the quality of the experimental maneuvers 
and analysis was done by eye, using the on line visible curves on the computer 
screen. The V'm, Pea, Ptm and Ppl signals from accepted maneu-
vers were saved digitally for su bsequent calculations. Curves 
with obvious errors (non maximal effort or blockage of the end-
hole or lateral sideholes in the 1'5 probe) were discarded. Asyst 
software (Asyst Software Technologies Inc., Rochester, N.Y.) and 
the Statistical Package for Social Sciences (SPSS Inc. Chicago, IL) 
were applied for data acquisition and calculation of additional 
variables. Initially, the results of V'm, 1'1'1, Pea, and Ptm, and 
their derived variables at 13 different 'levels' of each MEFV 
maneuver with the pS probe, were selected for further analysis. 
Each level was characterized by a lung volume equal to 80, 70, 
60,50,40% TLC, or 75, 50, 25% FVC, or by a V'm equal to 
100, 80, 60, 40, or 20% of peak expiratory flow (pEF). Each of 
these volume or flow levels coun ted as one 'case' in the su bse-
quent analysis. Ideally, a complete data set from a single PS probe 
MEFV maneuver therefore consisted of 13 'cases'. Subsequently, 
cases with a lung volume within 20% to 0% of FVC and cases 
with Ppl, Pea, airway compliance (Caw) or upstream pressure 
loss (pfr) values of zero or less were discarded. 
Calculations 
In order to reduce problems of differences in the number of 
measurements andlor missing values among subjects andlor 
between positions, all data per variable per position from a single 
subject were later pooled within the following four lung volume 
ranges: 100% to 80% , 79% to 60%, 59% to 40% and 39% to 
20% of FVC. 
During each individual MEFV maneuver, with the PS probe ill 
situJ data on V'm, PpJ, Pca and Ptm were collected simultaneous-
ly. The curves for these variables served as the basis for the calcu-
lation of additional parameters. Figure 3 gives an overview of the 
+V' Ptot Ptr ~I ~~~===;j"';:;2?;;::J, .' ... e-----------'---'-'-- • P alv 
Probe Plat <ill Pca 
Ptm 
Figure 3 
• Ppl 
Pel 
Pressures and pressure differences measured in .1I1 airway during expimtion. 
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V' == expiratory flow, Pal" = alveobr pressure, Ppl =; pleural pressure, Ptot = impaction 
pressure, Plat = Jatem[ pressure, Pel '" lung elastic recoil pressure, rtm =; tmnsrnural 
pressure, Pfr = upstream pressure loss, Pca =; pressure 105s due to convective accelera-
tion, J =; pressure he.ld. (from reference 23, with permission) 
different intra' and peribronchial pressures during forced expira-
tion in terms of a 'pressure walk' along the airway, as suggested 
by Mead (24). 
Using the Bernoul1i equation, and assuming a blunt velocity pro-
file and an incompressible medium gives: 
Pca = Ptot - Plat = 100. P .V'2! (2. A2) 
where p is the density in g/cm3, A is cross sectional area in cm2 , 
P is pressure in kPa, and V' is flow in lis. 
A at the PS probe can be calculated if Pca and V' at the PS probe 
(V'ps) are known. The change in A with change in Ptm is a meas-
ure of Caw at the PS probe (Caw = dNdPtm). 
For the calculations of V'ps and of other parameters used in the 
study and for the correction of exhaled volume for intrathoracic 
pressure (V!'pl) we refer to the article by Pedersen and coworkers 
(32). A values calculated fr0111 Pea values below 0.5 kPa were 
disregarded in the subsequent analysis, since they proved to be 
less reliable during testing of the PS probe in rigid tubes (32). 
V'm was not corrected to body tcmperature- pressure-saturation 
conditions, and no attempt was made to correct for the differ-
ence in composition of air and alveolar gas. This will introduce a 
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Figure 4a 
l' .... lEFV maneuycr in a 
he,llthy subject; local 
flows <lIld pressures 
with the Pitot st<ltic 
prohe at the lower end 
of the trachea, 
V'ps = local flow (lIs), 
VPpl = exhaled volume 
(I), Ptm = tmnsmuml 
pressure, Pca = pres-
suredrop due to cun-
vective acceleration, J = 
pressure head at tip of 
the probe, Ppl = pleural 
pre~sure (pressures in 
kP,,). 
Figure 4b 
On line c"kulatcd 
curve of cross sectional 
<He,l A (cm2) versus 
PtIll (kP<l) (solid line) 
<lOd fitted polynomial 
(dashed line) 
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small but systematic error in both the asthmatic and the healthy 
subjects, which we considered to be of no significance in the 
present study (35). 
Figure 4A shows an example of an l"IEFV maneuver by a healthy 
subject with the PS probe at the lower end of the trachea 
(Position 3). V'ps and different pressures at the PS probe was 
plotted against the change in VPpl. For each individual PS probe 
experiment, A at the PS probe was plotted against local PUn. 
This generally resulted in a curve with a regular and irregular 
region (Figut'e 4B). A 2nd- to 5th-degree polynomial was fitted 
through the regular part of the A-versus-Ptm curve, and its agree-
ment with the actual curve was assessed visually. The polynomial 
was saved for subsequent calculation of Caw values (provided by 
the first order differentiation of the polynomial), together with 
the lower and upper Ptm values of the fitted part of the A-Ptm 
curve. For further analysis, A and Caw derived from the polyno-
mial were used. Specific airway compliance (sCa'w) was calculat-
ed as Caw/A. 
Lung [unction results for asthmatic and healthy subjects were 
compared through a two sample (-test. All initial values for A, 
Ptm, Caw and sCaw were logarithmically transformed. 
\Xlhen two or more values for a variable from a particular subject 
and specific position within a single volume range were available, 
the values were averaged. The aim was to ensure that for each 
subject, all 20 combinations of the five PS probe positions and 
four volume ranges used in the study contained a single mean 
logarithmic value of Caw, A, sCaw and Ptlll. Nevertheless, values 
for some positions and/or volume ranges were still missing for 
some subjects. 
The outcome variables A, Caw, sCaw and Ptm were then ana-
lyzed, using release 7 of the BNlDP software system, module 5V 
(BMDP Statistical Software Inc., Los Angeles, CAl, by applying 
analysis of variance (rmANOVA). 
In this analysis, the following independent factors were used: 
1) two intersubject factors, each with two levels: sex (male/ 
female) and asthma (yes/no); and 2) two intrasubject factors: vol-
ume (four ordinal levels) and position (five ordinal levels [pas]). 
The assumed variance or covariance structure of the residuals 
was compound symmetry. The analysis began with a full model 
Statistics 
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containing the four explanatory factors just described (volume 
and position as categorical factors) and all of their first order 
interactions. 
The initially used full model was as follows: predicted variable = 
dis + sex + pos + volume + dis. sex + dis.pos + dis. volume + 
sex.pos + sex. volume + pos.volume, with dis = disease and pos 
= airway position. 
A backward elimination method was then applied, using likeli-
hood ratio tests (embedding tests), in which in each step the fac-
tor with the highest p value above 0.05 was eliminated, in hierar-
chical fashion starting with the first order interaction (i.e., main 
effects were not eliminated as long as they had a significant inter~ 
action with one of the other factors). If the restricted model thus 
selected still contained at least one of the categorical (ordinal) 
factors of volume andlor position, then these categorical factors 
were replaced (one at a time) b)' their continuous (numeric) ver~ 
sions in order to test whether an embedded model with a linear 
trend gave a better goodness of fit, considering the lesser number 
of degrees of freedom required for the further restricted model. 
As a consequence of the logaritlullic transformation, model pre~ 
dictions were back transformed to geometric means, and effects 
must be interpreted in a multiplicative wa)'. 
\'\1hen in the following text A, Ptm, Caw or sCaw are discussed, 
their predicted values according to the final model are meant. 
Otherwise the suffix 'measured' is used. A two sided level of sig~ 
nificance of p < 0.05 was used. 
RESULTS 
Data Because of the invasive nature of the measurements, no complete 
13-case data set from each MEVF maneuver with the PS probe 
could be obtained for each subject at each airway position. For 
the healthy subjects, an average of 2.9 volume ranges and for the 
asthmatic subjects an average of three volume ranges with data 
from each position per subject could be obtained. A data set with 
1,477 cases from a total of 218 accepted MEFV maneuvers with 
the PS probe was used for final analysis of A, Ptm, Caw and 
sCaw. 
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Table 2. 
Healthy subjects, measured values of cross sectional area of the airway, transmural pressure, airway 
compliance, and specific airway compliance 
Healthy 100-80%FVC 79·60% FVC 59-<l0%FVC 39-20%fVC 
Pas a A 1.31 (0.69/2.27) 1.17 (0.80/1.88) 0.72 (0.44/1.02) 0.65 (0.37/1.17) 
Ptm ·0.67 (·0.18/·2.10) ·1.04 (·0.15/ ·2.66) -1.80 (-0.43/-7.16) -2.72 (-0.96/-8.05) 
Caw 0.71 (0,20/1.82) 0.60(0.2111.41) 0.40 (0.11/0.88) 0.26 (0.10 ( 0.51) 
sCaw 0.54 (0.21 11.34) 0.51 (0.19/1.32) 0.55 (0.21/1.19) 0.41 (0.1311.07 
n 9 10 9 
Pos 1 A 1.42 (0.87 12.27) 1.18(0.66/1.75) 0.87 (0.4711.44) 0.64 (0.08 11.40) 
Ptm -0.87 (-0.41/-1.51)* ·0.95 (·0.081·3.90) ·1.83 (·0.36 1-5.71) ·2.35 (·0.93 1·8.08) 
Caw 0.47 (0.1813.84) 0.39 (0.17 12.28) 0.3 1 (0.08 11.49) 0.23 (0.04/0.84) 
sCaw 0.33(0.16/1.02) 0.33 (0.16/1.36) 0.35 (0.0811.49) 0.36 (0.07 ( 1.26) 
n 10 12 13 11 
Pas 2 A 1.22 (0.59 12.41) 1.07 (0.5811.69) 0.85 (0.52/1.37) 0.85 (0.53 11.32) 
Plm ·1.37(-0.821A.41) ·1.61 (·0.40 J.J.40) -2.63 (-0.94/-5.28) -2,83 (-1.671-4.80) 
Caw 0.22 (0.03 11.14) 0.27 (0.09/0.82) 0.19 (0.04 I 0.59) 0.23 (0.061 0.44) 
sCaw 0.18 (0.051 0.64) 0,25 (0.08/0.57) 0,22 (0,07 1 0,43) 0.27 (0,11/0.50) 
n 10 8 8 
Pos 3 A 1.05 (0.61 11.771 0,84 (0,40 12,04) 0.72 (0.33 11.29) 0.80 (0.3411.40) 
Ptm ·2.15 (·0.51/·5.60) -2.82 (-0.55 I -11.53) ·3,26 (·1.04 J.1I.17) ·2.58 (·1.17 J.7.35) 
Caw 0.24 (0.081 0.64) 0,12 (0.02 I 0,40) 0.12 (O.Oll 0.81) 0.11 (0.021 0.34) 
sCaw 0.23 (0.12/0.59) 0,15 (0.03/0,45) 0.16 (0.05 I 0.60) 0.14 (0.051 0.38) 
n 9 13 12 11 
Pas 4 A 0.98 (0.4111.79) 0.90 (0.30 11.58) 0.86 (0.42 11.67) 1.02 (0.53 11.78) 
Plm -2,69 (-0.90 1-5,77) ·3.62 (·1.01/·10.18) ·4.34 (·1.681 ·10.10) ·2.43 (·1.03 1·3.96) 
Caw 0.14 (0.041 0.68) 0.12(0.0111.41) 0.15 (0.0411.36) 0.15 (0.06/0.49) 
sCaw 0,14 (0,04 { 0,69 0.13 (0.021 0.89) 0.17 (0.07 I 0.81) 0,15 (0.04 ( 0,55) 
n 10 13 10 10 
A", cross sectional area of airivay (cm l ); Caw = airi"lay compliance (cm 2/kPa); Ptm = transmural pressure (kPa); seaw:=: specific airivay 
compliance (lIkPa); Pas = Pitot static probe position: 0 = at lower lobe, 1 = at middle lobe, 2 = middle of main stem bronchus, 3 = end 
trachea, 4 = mid trachea; • = calculated in eight subjects. Values are expressed as group geometric means (minimum! maximum value) of 
measured values in n subjects. 
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Tahle 3 
Asthmatic subjects, measured values of cross sectional area of the airway, transmural pressure, airway 
compliance, and specific airway compliance 
Asthma 100·80'~b FVC 79-60% FVC 59-40% FVC 39-20%FVC 
Pos 0 A 0.78 (0.21 I 1.49) 0.63 (0,20/1.44) 0.82 (0.57 11.32) 0.97 (0.50/1.84) 
Ptm -2.08 (-1.22/-2.62) -3.33 (-0.56/-8.77) -2.14 (-0.22 I -7.18)· -2.53 (-1.17/-'1.38) 
Caw 0.11 (0.04 I 0.22) 0.17 (0.07 I 0.85) 0.21 (0.11 I 0.33) 0.16 (0.04 I 0.28) 
sCaw 0.15 (0.04 I 0.43) 0.27 (0.09 I 1.48) 0.25(0.1110.41) 0.16 (0.04 I 0.35) 
" 
6 8 8 
Pas I A 1.38 (0.67 I 2.84) 1.04 (0.54 I 2.41) 1.06 (0.46 fl.62) 1.14 (0.69 I 2.42) 
P1m -1.36(.0.11 1-523) -2.68 (-0.51 1-6.96) ·2.96 (-1.12 I ·8.40) -2.09 (·0.85 I -5.25) 
Caw 0.19(0.1110.28) 0.22 (0.07 I 0.57) 0,27(0.15/0.77) 0.21 (0.07/0.43) 
sCaw 0.14 (0.D4 I 0.33) 0.21 (0.06/0.66) 0.26 (0.081 0.74) 0.19 (0.08/0.39) 
" 
9 8 6 
Pos 2 A 1.41 (0.88 I 2.45) 1.22 (0.62/2.58) 1.22 (0.74/2.32) 1.37 (0.83/3.26) 
Plm -1.51 (-0.47 I ·2.94) -2.05 (-0.43/-4.77) -2.21 (-0.47/-5.79) -2.48 (-0.73/-7.23) 
Caw 0.20 (0.04 11.03) 0.15 (0.06/0.24) 0.12 (0.051 0.27) 0.14 (0.02 I 0.43) 
sCaw 0.14 (0.03 I 0.42) 0.13(0.09/0.31) 0.10 (0.03/0.15) 0.10(0.0110.17) 
9 8 
Pos 3 A 1.02 (0.86/1.41) 1.01 (0.63/2.13) 0.98 (0.67 11.89) 0.97 (0.671 1.87) 
Ptm -1.89 (-0.53/-4.65) -3.14 (-1.43 I -7.38) -3.39 (-1.39 I -7.99) -3.11 (-1.291-7.43) 
Caw 0.15 (0.10/0.30) 0.14 (0.07 I 024) 0.10(0.0710.17) 0.12 (0.07 10.18) 
sCaw 0.14 (0.09/0.35 )0.14 (0.08 I 0.22) 0.11 (0.06 I 0.211 0.13(0.071020) 
" 
6 8 8 
Pos 4 A 1.13 (0.83/1.34) 0.91 (0.43 I 1.35) 0.93 (0.70 11.52) 1.1 0 (0.86 I 1.57) 
Ptm -3.52 H.41/-7.03) -4.35 (·0.75 I -12.86) ·4.17 (·0.72 I -12.36) -3.41 (-0.89/-9.54) 
Caw 0.17 (0.08 I 0.72 0.10 (0.04 I 0.26) 0.10 (0.05 I 0.22) 0.12 (0.071 0.34) 
sCaw 0.15 (0.071 0.60) 0.11 (0.0510.19) 0.11 (0.07 I 0,20) 0.11 (0.06/0.22) 
" 
8 8 8 
A = cross sectional area of airway (em'); Caw = air.vay compliance (cm'/kPa); Ptm = transmural pressure (kPa); sCaw = specific air.'1ay 
compliance (lIkPa); Pas = Pilot static probe position: 0 = at lower lobe, 1 = at middle lobe, 2 = middle of main stem bronchus, 3 = end 
trachea, 4 = mid trachea; • = calculated in seven subjects. Values are expressed as group geometric means (minimuml maximum value) of 
measured values in n subjects. 
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Table 4 
Factors explaining the logarithmic values of cross sectional area of the airway, transmural pressure, airway 
compliance, and specific airway compliance according to the final statistical model 
p values 
'"A 
D'lsease 0.793 
Sex 0.002 
Position (categorical) < 0.001 
Position (continuous) 
Volume (categolical) < 0.001 
Volume (continuous) 
Dis· Position 0.002 
Dis· Volume < 0.001 
Sex· Position 
Sex· Volume 0.019 
In -Plrn 
0.654 
0.003 
< 0.001 
< 0.001 
0.025 
< 0.001 
0.039 
0.017 
In Caw 
< 0.001 
< 0.001 
< 0.001 
< 0.001 
In sCaw 
< 0.001 
0.Q18 
< 0.001 
0.003 
0.013 
Dis:=: disease; In A = logarithm of airway cross sectional area; In Caw = logarithm of airway (ompliaflce; In -Ptm :=: logarithm of negative 
transmural pressure; In sCaw = logarithm of specific airway compliance; Position = Pilot static probe position; Volume = lung volume 
range. p-values according to Wald tests of significance of fixed effects and covariates. 
Tables 2 and 3 give the geometric means of the values of meas-
ured A, Ptm, Caw and sCaw for the healthy and the asthmatic 
subjects, respectively. 
A was significantly determined by sex, airway position, volume, 
the interactions of disease with airway position, and volume lev-
el, and of sex with volume (Table 4). In general, A became small-
er with decreasing volume, with the greatest decline in A occur-
ring between the volume ranges of 100% to 80% and 79{Yo to 
60% FVC. A was smaller in the female subjects at all volume 
ranges: at 1000/0 to 80o/t) FVC, Afelll<lle was 6YYo of Amale 
(1'<0.001); at 79% to 60% FVC it was 63% of Am,le (p<O.OOl); 
at 59% to 40% FVC it was 77% of Amalc (p<0.05); and at 39% 
to 20% FVC it was 83% of Am,l, (p>O.l). The difference in A 
between males and females did not depend on the healthy or 
asthmatic status of the subjects or on the position of the PS 
probe. 
Results for A 
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Results for Ptm Ptm became more negative with decreasing volume during forced 
expiration in the individual subjects. Overall, disease status did 
not contribute significantly to Ptlll. However, there was a signifi-
cant interaction between disease status and airway position and 
volume range that contributes in a non-log-linear way to Ptm. In 
the asthmatic subjects, Ptm was on average more negative in the 
upstream positions at comparable high lung volumes. 
Results for Caw Caw was log-linearly related to disease status, airway position, 
and volume level, and to the interaction of disease and airway 
position. Caw at the entrance of the lower lobe ( Position 0) in 
the asthmatic subjects was 0.52 of local compliance in the 
healthy subjects. This difference decreased toward the trachea 
and became minimal at the trachea. In both the asthmatic and 
the healthy subjects, Caw was lower at a more central position of 
the PS probe (from Position 0 to Position 4). With each down-
stream step in position, Caw decreased in the healthy subjects by 
29.5 % and in the asthmatic subjects by 10.5 %. In the healthy 
subjects, Caw at the lower lobe (Position 0) was 4.04 times larger 
than at the mid trachea (Position 4), whereas in the asthmatic 
subjects this factor was 1.56. 
Results for sCaw Disease status, sex, airway position, and the interaction of air-
way position with sex and disease contributed to sCaw in a log-
linear way. seaw was significantly lower in the asthmatic than in 
the normal subjects (Figure 5: measured sCaw). In contrast to 
Caw, sCaw was not significantly determined by volume. As could 
be expected from the dependence of A on sex, sCaw was also 
determined by sex and was smaller in the male subjects for a giv-
en disease status (Table 5). The difference in sCaw between males 
and females became smaller with a more downstream position. 
There was no interaction between sex and disease status. With 
each subsequent downstream position, sCaw decreased by 33 % 
in the healthy females, 24% in the healthy males, 23% in the 
asthmatic females and 130/0 in the asthmatic males. 
In summary the foregoing results show that: 1) Central airways 
of asthmatic subjects behave more stiffly during forced expira-
tion than those of healthy subjects. The difference between 
healthy and asthmatic subjects became smaller at the level of the 
trachea. 2) Caw and sCaw decrease with a more downstream 
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Table 5 
Ralio of specific airway compliance in asthmatic versus healthy subjects and in males versus 
females, 
At lower lobe 
At middle lobe 
Mid·mainstem bronchus 
End trachea 
Midtrachea 
sCawasthmatlc: 
Healthy subjects 
0.55 
0.62 
0.72 
0.84 
0.96 
sCaw male: female 
0.70 
0.78 
0.88 
0.99 
1.12 
Definition of abbreviaUon', s(aw ",-spedflc a'f'I'/ilY compliance 
0.60 
0,50 
0.40 
, 
8 0.30 , 
0.20 
0,10 
specific Airway CompUance within 79·60 % FVC 
-B-heallhy 
- ..... -asthma 
II •• 
'. 
• __ .. , - - - - -11-1':--:-: .. :-:-.-:--_ 
., ........ 
O.ooL-----------------------
lower fobe middle lobe mid main stem 
bronchus 
Pliot Sialic Probe Position 
endlrachea mid trachea 
position in the tracheobronchial tree. 3) A in the central airways 
is larger in males than in females. The difference between the sex-
es became smaller with decreasing lung volume. 4) seaw is vol-
ume independent. 
Figure 5 
Geometric mean values 
of measured specific 
airway complhmce 
(sCa\\', lIkPa) versus 
Pitot Shltic Probe posi~ 
tion for lung volume 
mnge of 79% to 60% 
FVC in healthy and 
asthmatic subjects. 
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DISCUSSION 
This is the first in uiuo study in long~lasting asthma of functional 
airway change as a possible result of chronic inflammation and 
structural remodeling of the airway wall. The main purpose of 
the study was to examine the cOll1pliance of central airways dur-
ing forced expiration in young adult subjects with long-lasting 
asthma. The results indicate that central airways behave more 
stiffly in asthma patients than in healthy subjects. 
With regard to the technical aspects of the study and their limita-
tions, we refer to rcIa ted studies by Pedersen and colleagues 
(32;33) done with the same method and calculations. 
The invasive nature and the time consuming complexity of the 
experiments conducted in the study limited the inclusion of more 
volunteers. A complete matching of the two groups could there~ 
fore not be obtained (Table 1). I-:lowever, because we found no 
significant differences in TLC or tlleasures of airway patency, we 
assumed that differences between the two groups in lung volume 
changes caused by air compression could be neglected. 
For ethical reasons, only the asthmatic subjects were pretreated 
with systemic corticosteroids and a ~-2-agonist. The p-2-agonist 
may have reduced bronchial tone and therefore increased Caw in 
the asthmatics as compared with the healthy subjects (29). The 
difference found in sCaw may therefore have been even larger 
before bronchodilatator treatment. 
Despite instructions and encouragement, not all subjects could 
repeatedly exhale across the full range of FVC with the PS probe 
il1 situ. Typical problems were fits of coughing during the experi-
ment, increased mucus production with a need to swallow, and a 
premature cessation of local anesthetic effect. At some PS probe 
positions in some subjects, no reliable data could be obtained 
because of wedging of the probe, especially at low lung volumes, 
or because of temporary mucus obstruction of one or more holes 
in the probe. 
Accepted maneuvers could still have contained artifacts over cer-
tain volume ranges. These ranges were omitted in the final analy~ 
sis. Although FVC was lower in the asthmatic subjects, FYC was 
chosen as the basis for distribution of data over volume ranges 
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because both FVC and 1'5 probe data were obtained during com-
parable forced expiratory maneuvers. It was expected that the 
mechanism(s) responsible for a reduced FVC in the asthmatic 
subjects also occurred during NIEVF maneuvers with the PS 
probe in these subjects. 
For each individual PS probe measurement, only the volume 
range corresponding specifically to the Ptm range for which the 
polynomial through the A-Ptm curve was fitted, could be used 
for analysis. Because this volume range was generally smaller 
than FVC, this often resulted in less than the intended total of 13 
cases per measurement. 
These factors explain why almost all subjects had volume ranges 
with missing data for A, PUn, Caw and SC~lW. However, no clear 
pattern was noticeable in the distribution of these 'empty' vol-
ume ranges among the 10 asthmatic and 14 healthy subjects that 
could have significantly influenced the results of the multiple 
regression modeling. 
With regard to the differences in A, In A, Ptm, In Ptm, Caw, In 
Caw, sCaw and In sCaw between the healthy and the asthmatic 
subjects, there were no statistically significant differences 
between the data set used for final analysis and the data set con-
taining the finally excluded cases. This was analyzed for the 
pooled data of all five PS probe positions and all four volume 
ranges. Therefore, no bias with regard to the differences found 
for asthmatic versus healthy subjects and caused by the exclusion 
of these cases is likely to have occurred. Because data from only 
24 subjects were analyzed, we assumed a compound symmetry 
structure for the variance and covariance matrices of the residu-
als in the statistical model used in the study, in order to reduce 
the number of estimated parameters. 
The choice for the logarithmic transformation was based on the 
theory that the physically defined relationships between the vari-
ous outcome measures (A, Ptm, Caw, and sCa\\') imply that val-
ues for these variables are generated by multiplicative rather than 
by additive processes. 
The values of A found in our study are comparable to those 
described by lvlacklem and Wilson (22), who used the same 
method that we used. Brooks using the acoustic reflection tech-
nique, found a mean tracheal area of 1.87 ± 0.1 cm2 in II ado-
Results for A 
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lescent subjects (6). This is somewhat larger than our results at 
mid trachea. However, our findings were obtained during forced 
expiration with a compressive negative transmural pressure. The 
value of A throughout the central airways was significantly 
smalier in the females in our study at all volume ranges, inde-
pendent of whether they had asthma or not. This is consistent 
with the difference in A between sexes as found by Martin and 
colleagues with the acoustic reflection technique during tidal 
breathing (23). 
The decrease in A during forced expiration can be explained by 
dynamic compression causing a decrease in the dilating effect of 
Ptm. As shown in our study, Ptl11 decreases with volume. A may 
also decrease in direct relation to volume because of a reduction 
in axial tension and possibly because of a decrease in tethering by 
surrounding tissue. This is in agreement with findings by others. 
Hoffstein and associates found that the area of tracheal and 
bronchial segments increases with an increase in lung volume 
and transpulmonar)' pressure (11). Hughes and coworkers found 
decreasing airway diameters with a history of volume deflation 
(12). 
Results for Plm At all positions we found that on average, measured Ptm (= Plat-
Ppl) became more negative during forced expiration with 
decreasing lung volume. This can predominantly be explained as 
follows: Ppl and therefore peribronchial pressure are maintained 
during an MEFV maneuver. In contrast, elastic recoil pressure 
and therefore outward acting intra bronchial pressure (Plat) 
decrease progressively when lung volume becomes smaller. The 
end result is a negative Ptm, compressing the airway. 
Narrowing of the airways may increase the pressure loss caused 
by friction and (possibly) by convective acceleration during 
forced expiration. This leads to a further reduction of intra-
bronchial pressure and therefore of A. Extra narrowing of the 
airways stretches the airway-parenchyma attachments and 
increases parenchymal support. This may lead to a decrease in 
dynamic airway compliance (Cdyn) (13;38;40). 
At comparable (high) lung volumes, Ptm was on average, more 
negative at the more peripheral positions in the asthmatic sub-
jects. A more leftward (negative) position on the A-PUll curve of 
an airway will coincide with a lower A and with a less steep 
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slope. A more negative Ptm at comparable lung volume may 
therefore (partly) explain lower Caw values in our study, and 
lnay hamper comparison of data on compliance for the asthmatic 
as compared with the healthy subjects for evaluation of differ-
ences in the two groups' airway structures. 
The (non-linear) A-Ptm relationship was volume dependent, 
mainly at high lung volumes, with Ptm becoming more negative 
and A and Caw decreasing with decreasing lung volume. This 
was also concluded from similar PS probe experiments in 
humans during repetitive huff maneuvers by Pedersen and associ-
ates (32). This means that the volume at which Caw is measured 
has to be taken into account when comparing compliance data. 
The decrease in Caw with decreasing volume may be caused by 
cartilage rings moving toward each other when length tension is 
reduced during exhalation, resulting in stiffer central airways, as 
reported for calves' tracheas by Suki and coworkers(39). This is 
in agreement with findings by Olsen and colleagues (29). They 
observe that muscular constriction of central air"ways may lead to 
a decrease in compressibility by covering the soft parts of the air-
ways with sleeves of fibrocartilage (29). 
The larger Caw at more upstream airways in both groups of sub-
jects in our study is in agreement with findings in dogs (26) and 
humans (11). 
The dependency of Caw on volume and Ptm complicates the 
interpretation of differences in Caw in healthy and asthmatic 
subjects. When Caw was corrected for A (Caw/A = sCaw), the 
volume dependency of Caw disappeared. This indicates that the 
decrease in Caw with decreasing lung volume is mainly related to 
a decrease in A. \\Te also made this finding during maximal effort 
huff maneuvers in our study of the speed index at peak flow (32). 
\\Then correlated with the dependence of A on sex, sCaw was sex 
dependent: a lower sCaw was found in the central bronchi for 
male subjects. The difference between males and females in sCaw 
did not depend on disease status, and became smailer toward the 
trachea. 
Sasaki and colleagues (38), Takishima and coworkers (40) and 
Nakamura and coworkers (26) deducted from experiments with 
excised dog lungs that sCaw is independent of Pt1l1 (see appen-
dix). The use of sCaw as a measure of airway elastic properties 
Results for Caw 
and sCaw 
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therefore circumvents the problem of differences in Ptm between 
asthmatic and healthy subjects at comparable lung volumes. In 
the studies just cited, the slope of the change in bronchial volume 
plotted against the change in the bronchial pressure (dlogVbr 
IdPbr) became steeper with a lower distending pressure at a low~ 
er elastic recoil. These findings indicate that comparison of elas-
tic behavior of bronchi should preferably be made with sCaw as 
the most relevant parameter, and at fixed elastic recoil values. 
This latter condition was met in our study because seaw was 
determined over equal ranges of lung volume with comparable 
elastic recoil values. 
In OUf study, seaw was significantly lower in the asthmatic than 
in the healthy subjects, especially at the more peripheral posi-
tions in the airway. This strengthens the conclusion that in asth-
matic individuals the airway wall behaves more stiffly during 
forced expiration. 
The decrease in Sea\V found in our asthmatic subjects may be 
due to structural remodeling in a chronically inflamed airway 
lVall. However, the net effect on airway mechanics of each of the 
many different structural changes that occur in the asthmatic air-
way wall is unclear. 
A number of arguments favor the hypothesis that inflammatory 
remodeling results in a decrease in Caw. Thus, all layers of the 
airway wall have been found to thicken as a result of extensive 
formation of granulation tissue (36). The end result may be scar-
like tissue with an increased deposition of densely packed subep-
ithelial collagen below an essentially normal epithelial basal lam-
ina (37), with fragments of elastic fibers and with inactive 
appearing fibroblasts. The mechanical consequences of this prob-
ably depend on the chemistry of the different collagen types 
involved and on the architecture of the collagen deposits. It can 
be imagined that an increased collagen fibril density and thick-
ened subepithelial matrix will increase the tensile stiffness and 
resistance to deformation of the airway wall (30;31;36). Indeed, 
Wilson and colleagues found a reduced increase of airway dead 
space volume during inspiration in asthmatic as compared with 
control subjects (42). They suggested that the addition of scar 
type collagen to the airway wall contributes to a reduction in air-
way distensibility without reducing airway lumen. \,lork by 
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Colebatch and associates supports the notion that airways of 
asthmatic individuals are less distensible than those of normals 
(8). However, one may question whether distensibility can be 
compared with compressibility of airways as a Ineasure of Caw. 
Mitchell and coworkers conclude, on the basis of a recent model 
study of sensitized pig bronchi, that lung inflammation increases 
airway stiffness and, by implication, airway wall load on the 
smooth muscle (25). 
Despite factors that may decrease Caw, airway remodeling in 
chronic asthma will involve degradation of matrix components 
as a result of the chronic destruction, healing, and repair that 
occur in the disease. Bousquet and colleagues reported that an 
abnormal, fragmented, superficial network of elastic fibers was 
present in most asthmatic subjects, together with patchy, tangled 
and thickened elastic fibers of the deeper layers of the airway 
wall (3;4). Electron microscopy studies suggested a severe elastol-
ysis with fragmented elastin fibers in the asthmatic subjects' large 
airways, possibly as a consequence of chronic inflammation, 
and/or mechanical stretching caused by hyperinflation or airway 
edema in asthma or both (3;4). An intact network of elastic 
fibers is crucial for the maintenance of structure and mechanical 
properties of the lung. A consequence of elastic fiber degradation 
could be an increased compressibility of central airways in long-
lasting asthma, coinciding with decreased elastic retraction in the 
lung. This was supported by the finding of Bramley and associ-
ates that a single asthmatic airway preparation showed less pas-
sive tension and a threefold greater shortening than did six 
nonasthmatic lobar airway preparations, without any difference 
in the amount of smooth muscle in the two types of preparation 
(5). Bramley and associates suggested that the release of protease 
enzymes (such as elastases and/or collagenases) from inflamma-
tory or resident cells degrades elements of the extracellular 
matrix and reduces airway tissue elastance. 
It remains unclear whether these pathophysiologic findings ill vit-
ro may be extrapolated to the iu vivo situation, in which many 
other different factors interact and determine the finalmechani-
cal behavior of the airways. Pare and coworkers reported carti-
lage proteoglycan degradation and cartilage remodeling in each 
of six fatal cases of asthma, changes that may decrease the force 
needed to deform the airwa)'s (31;36). Recent computational 
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modeling by Lambert and associates (18) predicted that the Ptm 
resulting in airway narrowing or collapse depends on the number 
of folds in the airway mucosa. The degree of mucosal huckling is, 
according to the computational model studies by Wiggs and col-
leagues, mainly determined by the compressive stiffness of the 
airway wall (41). The SlUn of the elastic moduli of the different 
layers in the airway wall is therefore an important determinant of 
airway compressibility. 
Main conclusion \Ve found stiffer airway behavior during forced expiration in sta-
and implications ble asthmatic patients than in healthy subjects. This supports the 
hypothesis that chronic airway inflammation andlor remodeling 
in asthmatic individuals may lead to a decreased Cdyn of the air-
ways. Since our observations were limited to the central airways, 
we can not predict whether a decreased compliance can also be 
found in the more peripheral, intrapulnl0nary airways. It is 
unclear how chronic inflammation with subsequent remodeling 
of the airway wall changes the mechanical properties of the air-
ways. The only way to obtain more insight into this process 
seems to be by means of ill vivo measurements, However, the 
exact role of airway inflammation as a factor contributing to 
decreased airway compliance can only be assessed when subep-
ithelial structural changes (e.g. collagen) deposition and airway 
mechanical properties are studied simultaneously. 
Increased stiffness of the airway wall will impose a greater load 
on bronchial smooth muscle during bl'onchoconstriction, and 
therefore has, to a certain degree, a protective effect. However, it 
does not rule -out the appearance of excessive bronchoconstric-
tion related to BHR, because many factors causing thickened air-
ways also contribute to excessive airway narrowing (14). 
The finding in relatively young asthmatic subjects of functional 
abnormalities of the airways as a possible result of long lasting 
inflammation stresses the importance of preventing and treating 
the airway inflammation in asthma as early and optimally as pos-
sible. It has to be kept in mind, however, that the possible long-
term effects of these functional abnormalities remain unkno\vn. 
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APPENDIX 
Sasaki and colleagues (38), Takishima and coworkers (40) and 
Nakamura and coworkers (26) describe a linear relationship 
between the logarithm of bronchial volume (Vbr), expressed as a 
percent of Vbr at zero bronchial pressure (Pbr), and bronchial 
pressure Pbr at fixed elastic recoil values. This was true except 
for the range of 100 to 80% of initial Vbr. 
The following equation can be applied to the linear relationship 
between log Vbr and Pbr: slope = dlogVbrldPbr. 
Using Ptm instead of Pbr produces a shift only along the abscissa, 
and Vbr can be expressed by: LbroA, where Lbr= length of the 
bronchus. Therefore: 
dlogVbrldPbr = dlogVbrldPtm 
= [dlogVbrldAJ • [dAJdPtml 
= constant. [dlogAJdA] • [dAJdPtmj 
= constant. llA • dAJdPtm 
;:; constant. Caw/A 
::: constant. seaw 
As the slope is linear, sCaw is a measure of airway elastic proper-
ties independent of PUn. 
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ABSTRACT 
The occurrence and behavior of flow limitation during forced 
expiration was studied ill vivo in 14 healthy and 10 asthmatic 
subjects. Using an esophageal balloon and a Pitot static probe at 
5 positions between right lower lobe and mid trachea, we 
obtained dynamic cross sectional area transmural pressure 
(A/Ptm) curves (Pedersen O.P. et al. J. Appl. Physiol. 52: 357-
369, 1982). From the AIPUl1 curves we obtained airway compli-
ance (Caw=dAldPtm), flow at wave speed (V'ws 
A.[lOAI(Cawep)]O.5 (p is density) and the speed index (51 = 
V'N'ws) within 80-40% FVC. 51 values ~ 1, indicative for a 
local chokepoint (CP), were found at all 5 positions in the 
healthy subjects and only at the two most upstream positions in 
the asthmatics. Conclusion: wave speed is reached throughout all 
central airways in the healthy subjects and only around the lower 
lobe in the asthmatics. The difference in CP distribution may be 
explained by changed local airway wall properties related to 
asthmatic remodeling. It can not be excluded that wave speed is 
also reached in more peripheral airways and that the most 
upstream points with flow limitation are located more peripher-
ally. 
INTRODUCTION 
The various aspects of flow limitation during forced expiration 
have been subject of study for many years. Fry et al. were the 
first to point out that, above a certain expiratory effort, expirato-
ry flow is independent of the pleural pressure (6). The effort 
independence of maximal expiratory flow, together with volume 
dependency, strongly suggested a flow limiting mechanism within 
the conducting airways (3) and indicated that Maximal 
Expiratory Flow Volume measurements (MEFV) could be 
regarded as the blue print of the mechanical properties of the 
lung parenchyma and airways. This was supported by the high 
reproducibility within one subject of concavities, convexities and 
sudden decreases in flows ('knee's') in the MEFV curve (22,35). 
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Several mechanisms are believed to determine the shape of the 
MEFV curve. One of these is the change in site of flow limitation 
within the airways during forced expiration, as demonstrated e.g. 
in studies in a mechanical model (24) and in dogs (28). Studies 
by Mink et a!., Smaldone et a!. and others indicated that the site 
of flow limitation during forced expiration is located in the cen-
tral airways of living dogs (20,33) as well as in excised dog and 
human lungs (7,19,32). Macklem and coworkers showed during 
i1I vivo studies in humans that the lobar and segmental bronchi 
were flow limiting in both normal and obstructed subjects over 
large ranges of volume (13,16). Smaldone and Smith showed that 
even near residual volume the dynamic airway compression, as 
defined by the flow limiting site, occurs in the central airways 
and did not move beyond subsegmental bronchi (34). 
The explanation of flow limitation can be based on the 'wave 
speed' concept by Dawson and Elliott (3-5). They described that 
flow is limited at that point in the airway where the velocity of 
expired air reaches the local speed of wave propagation ('wave 
speed'). This point is called the choke point (CP) in mechanical 
terms. The wave speed is a characteristic of an airway ( segment) 
and is determined by its local cross sectional area (A), its compli-
ance and the density (p) of the expired gas. Airflow can normally 
not exceed the local maximal flow, called 'wave speed flow' 
(V'ws). The airway with the lowest maximal flow determines the 
maximal flow for the whole lung (3,26) (the weakest link con-
cept) and is called the flow limiting segment (FLS). This is, in 
general, the most upstream site where local flow equals wave 
speed flow. The wave speed concept explains that maximal 
attainable flow during forced expiration is basically determined 
by the interaction between elastic recoil pressure (Pel), intra-
bronchial pressure loss upstream to CP (Ph) and the tube law at 
CPo The latter is the relationship between the distending trans-
mural pressure (Ptm) and the cross sectional area (A). The slope 
of this curve represents the airway compliance (Caw). 
No in vivo results with regard to the location of flow limitation, 
based on the wave speed concept, have been published for living 
humans, except at peak expiratory flow (23). Furthermore the 
effects of (possible) remodeling of the airway wall, due to chronic 
asthmatic inflammation, on the mechanism of flow limitation 
and therefore on the shape of the MEFV curve are unknown. 
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We applied an ill villa method, using an intra bronchial Pitot stat-
ic probe (PS probe), to measure intra bronchia I pressure, trans-
mural pressure, airway compliance and the velocity of flow in 
relation to calculated local wave speed in order to study ill vivo the 
occurrence and behavior of choke points and flow limiting seg-
ments in central airways during forced expiration. Both healthy 
subjects and patients with long lasting asthma were studied. 
SUBJECTS AND METHODS 
The mean age and anthropometric data of the participating 14 
healthy and 10 asthmatic non-smoking young adults are given in 
Table 1. The patients had a history of moderate to severe asthma 
(21), according to ATS criteria (1), since early childhood and 
used maintenance treatment with inhaled corticosteroids for at 
Anthropometric and spirometry data of healthy and asthmatic subjects. 
". heIght TlC RV / fVC fEV! fEVl/ PEf 
Y' ,m %pred TLC %pred okpred fVC %pred 
8 healthy f 25.8±3.9 173±4 104±9 0.28±0.O5 108±9 106±14 0.85±0.06 109±13 
6 healthy m 26.S±6.9 187±8 10S±11 0.22±0.03 114±7 108±7 0.79±0.08 121±10 
healthy f+m 26.1±S.1 179±9 104±9 0.26±0.OS 111±8 107±11 0.ShO.07 114±13 
3 asthma f 24.9±4,3 166±4 112±2S 0.31±0.03 104±30 86±9 0.7S±0.16 87±7 
7 asthma m 21.1±3.4 182±8 96±10 0.2S±O.05 94.3±8 85±7 O.76±O.O4 91±17 
asthma f+m 22.2±3.9 177±1O 101±16 0.27±0.O5 97±16 85±7 0.76±0.09 90±14 
p{f+m) 0.06 0.56 0.50 0.89 0.01 <0.001 0.05 <0.001 
f:::female,m:::male. asthmatics: values after bronchodilation and anti-inflammatory treatment, values: means ± sd, p: p·value according to 
a two sample Hest comparing healthy and asthmatic subjects 
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least the last three years. They were atopic for at least one 
inhaled allergen and demonstrated bronchial hyperresponsive-
ness. Although they were in a clinical stable condition, all asth-
matics were pretreated with a tapering course of prednisolone 
(45 mg on day 1, 25 mg on study day 7) in addition to their regu-
lar maintenance treatment, in order to minimize possible persist-
ent airway wall edema and hypersecretion due to chronic 
bronchial inflammation. Measurements were postponed for at 
least two weeks after recovery in case of a respiratory infection 
or an exacerbation within one month before scheduled measure-
ments. 
One week prior to the prednisolone course all subjects performed 
a dose response curve with an inhaled bronchodilator. The dose 
of the p-2-agonist terbutaline that resulted in maximal bron-
chodilatation (mostly 1mg) was inhaled by all asthmatics within 
1.5 h before the Pitot static probe (PS probe) experiment. 
Because the healthy subjects showed no significant change from 
baseline lung function after inhalation of 1 mg terbutaline, they 
obtained no p-2-agonist prior to the PS probe experiments. 
The medical ethics committee of the University Hospital 
Rotterdam approved the study. It was conducted in conformity 
with the principles embodied in the Declaration of Helsinki. 
\\fritten informed consent was obtained from all subjects. 
Baseline pulmonary function tests (Table 1) consisted of: maxi-
mal expiratory flow volume (MEFV) maneuvres with measure-
ment of FVC, FEVl and peak expiratory f101V (PEF); body 
plethysmography with determination of total lung capacity 
(TLC) and residual volume (RV) and quasi static pressure-vol-
ume (PV) measurements. A 'Jaeger lvIasterlab' system (Jaegel, 
Wiirzburg, Germany) provided the used volume constant 
plethysmograph and the pneuma tachometer with a heated Lilly 
head. Calibration of lung function equipment was based on stan-
dardized procedures (29). Lung function results are expressed as 
percentage of the predicted values according to the summary 
equations of the European Coal and Steel Community (ECCS) 
(29). 
lvIaximal bronchodilation was considered to be reached if less 
than 5% increase in FEV1, expressed as % baseline, was 
obtained by an extra dose of 500 microgram inhaled terbutaline. 
Pulmonary 
function 
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Figure 1 
Pitot st,Hie probe outer 
diameter: 3mm, hole at 
the tip to record Ptot. 
1.3 em from tip; 6lat-
em! holes with 0,5 mm 
di,lmeter to record Plat. 
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Quasi static Pressure Volume (PV) measurements were performed 
according to the ECCS (29) and Zapletal et al. (37). A latex bal-
loon (8.5 em long, 2 em perimeter, International :Nledical 
Products) was introduced, via one nostril into the esophagus, in 
such a way that the length of the catheter from the nares to the 
balloon tip was one-fifth of body height (in cm) plus 9 cm (37). 
At the corresponding esophageal location the pressure proved to 
be most negative during maximal inspiration. The balloon stayed 
ill situ throughout the subsequent PS probe experiment and the 
filling with 1.5 ml air was checked afterwards. Because of the 
large positive esophageal pressures, occurring during the forced 
expiratory maneuvers a somewhat larger volume of air in the 
balloon was chosen than is customary (29) 
The PV data were obtained prior to the forced maneuvres. After 
maximal inspiration till TLC level a slow expiration followed till 
RV level, the expiratory flow being such that alveolar pressure 
was negligible. Three technically satisfactory PV curves were 
matched at TLC and pressures were averaged at 2 % TLC levels. 
Volume dependent esophageal pressures were considered to be 
elastic recoil pressures (Pel) and used as such in the subsequent 
analyses. During the experimental forced expirations the 
esophageal pressure was considered to be the representative of 
pleural pressllre. 
For a detailed description we refer to the related studies by 
Pedersen et al. and by Brackel et aI., based on similar experi-
ments (23,28,2). A PS probe (Fig. 1) was used to measure 
impaction pressure (Ptot) and lateral airway pressure (Plat). It 
was comparable to the one used by Macklem and Mead (15). 
The Ptot and Plat tube of the PS probe and the tube attached to 
Ptot 1 Plat ........ . 
l.(:::::::::::::::::::::::::::::::t.:::::::::::::=::d§: ~ 
1cm 
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the esophageal balloon for indirect meaSUl'ement of pleural pres-
sure (Ppl), were connected to three identical pressure transducers 
(EMT34, Elema Schonander, Stockholm) and via EM3l! ampli-
fiers to an electronic subtractor. The transmural pressure Ptm (::: 
Plat - Ppl) and the pressure drop due to convective acceleration 
Pca (= Ptot - Plat) were calculated on line in this way. A non 
heated Fleisch no. 3.5 pneumotachograph was used to measure 
mouth flow (V'm). The pressure signals Pea, PUll, Ppl and V'm 
were visible on line. 
Calibration of the equipment, tuning of the catheters among 
themselves and in combination with the pneumotachometel; and 
testing of the PS probe is described by Pedersen (23). The accura-
cy of measurement of the CfOSS sectional area of rigid Plexiglas's 
tubes was in the range of ± 10% with Pca > 0.5 kPa, except for 
cross sectional areas> 2 cm2 (23). 
In order to minimize muclls production and prevent a vasovagal 
reaction, all subjects were premedicated with 0.5 mg atropine 
intramuscularly 0.5 hour before the introduction of the 1'5 probe. 
The oropharynx, larynx were anaesthesized topicall)' with xylo-
caine 10% puffs or lidocaine spray 4%. Further local anesthesia 
was given to the vocal cords and bronchial tree with maximally 
20 ml novesine 0.5% or lidocaine '1 % solution. A cuffless endo-
tracheal (ET) tube was passed into the trachea over an intro-
duced flexible bronchoscope. The bronchoscope was pulled back 
and, after placing the P5 probe with its two Polystan catheters 
into the trachea through the ET tube, the ET tube was removed. 
The tip of the PS probe was positioned just above the entrance of 
the right lower lobe (pos.O) (in one subject the left lower lobe) 
under visual control by the re-introduced bronchoscope. Pos.O 
was the most peripheral position that could be reached in all sub-
jects without visible plugging of the airway by the P5 probe. 
Subsequently the P5 probe was carefully pulled back under bron-
choscopic view and the distance between the subsequent intend-
ed intra bronchial positions was measured at the mouth by the 
catheter length (pos.l: above the entrance of the middle lobe 
(truncus intermedius), pos.2: mid main stem bronchus, pos.3: 1 
cm above the main carina and pos.4: mid trachea (Fig. 2). In the 
following text, 'position' means the intra bronchial position of 
the P5 probe if not used in another context. Subsequently the P5 
Experimental 
procedure 
101 
102 
Figure 2 
Positions of the Pitot 
static probe in the 
bronchial tree. 
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Position 4 
mid tracllea~ 
-4 
Position 3~ 
lcm above the carina 3 
probe was repositioned at pos.O and its two catheters were 
pushed through and secured in two tightly fitting side holes in a 
specially designed mouthpiece. The free ends of the PS probe 
catheters and the esophageal baUoon catheter were connected to 
the pressure transducers and the mouthpiece was connected to 
the pneumotachograph. The Ptot and Plat catheter were flushed 
forcefully with at least 2 x 50 ml of air before each individual 
forced expiratory maneuver to remove secretions from the end 
and side holes in the PS probe. 
Flushing was repeated andlor the PS probe was carefully turned 
or moved upstream and downstream for maximally 1 cm if the 
pressure signals indicated (persistent) blockage of the end or side-
holes. 
Subjects wore a nose clip and were sitting straight up in a chair 
during the measurements. AU subjects were asked to perform sev-
eral MEFV maneuvres with the PS probe at each position. In 
addition the healthy subjects were asked to produce sigh and huff 
maneuvers as well for another study purpose (23). Each proce-
dure was repeated at each position until acceptable results were 
obtained or a maximum of about 5 maneuvres was reached. A 
complete PS probe experiment took 1 to 1,5 hours with on aver-
age 30 ~1EFV maneuvres. In some subjects the nleasurements had 
to be stopped prematurely due to no long~r effective local anes-
thesia resulting in uncontrollable coughing and/or hypersecretion. 
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DATA SELECTION AND ANALYSIS 
Initial assessment of the quality of the on line visible V'm, Ppl, Pca 
and Ptm curves was done by eye. Curves with obvious errors (non 
maximal effort or non maximal in or exhalation, blockage of 
holes in the PS probe) were discarded. Asyst software (Asyst 
Software Technologies Inc., Rochester, N.Y.) and SPSS (Statistical 
Package for Social Sciences, SPSS Inc. Chicago, Illinois) were 
applied for saving the accepted maneuvers and calculation of 
additional variables. Thirteen different 'levels' of each MEFV 
maneuvre with the PS probe (characterized by a lung volume 
equal to: 80, 70, 60, 50, 40% TLC or 75, 50, 25% PVC or by 
V'm ~ 100, 80, 60, 40, 20% PEF) were used for further analysis. 
Ideally a complete dataset of one single PS probe MEFV maneu-
vre consisted thus of 13 'cases', each with the values of V'm, Ppl, 
Pca, Pun and their derived variables. Since only a few of the sub-
jects were able to reach an exhaled volume larger than 80% FVC 
with the PS probe in situ these 'cases' (n~72) were excluded. Also 
'cases' with values less or equal to zero for Ppl (n=11), Pca (n=30), 
Caw (n=24) or Pfr (pfr = Ppl + Pel- Ptot, n=24) were discarded 
for further analysis as these were considered to be not in agree-
ment with forced expiration or physiologically unlikely to occur. 
Figure 3 
Pressures iwd pressure djfferences 'measured' in an ainvay during forced expiration, 
V': expiratory flow, Paly: alYeo!ar -, PpJ: pleur.,1 -, Ptot: impaction -, Plat: lateral -, Pel: 
elastic recoil -, Ptm: tnmsmural pressure, Pfr: upstream pressureloss, Pca: pressureloss 
due to con\'ecth'e acceleration, J: preSStlre head. 
{from: Pedersen et al. J. App!. Physioi. 1997; 83(5): 1721-32, with permission) 
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Pca 
Ptm 
Palv 
Ph 
Caw 
Pflal 
V'ps 
VPpl 
A 
V'ws 
51 
Calculations 
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In accordance with the 'pressure walk' by Mead (17), Fig. 3 
shows a schematic bronchoalveolar unit with different intra- and 
peribronchial pressures along with flow (V'). Pca (~ Ptot - Plat) is 
the pressure drop due to convective acceleration of air molecules 
when passing the bronchial cwss sectional area (A) and is related 
to the kinetic energy of the passing air. Using the Bernoulli equa-
tion, assuming a blunt velocity profile and incompressible medi-
um gives: Pca ~ 50.p.V,2/A2 (p:density in g/cm3, A: C1112, P: kPa, 
V': flow lis). A at the PS probe can be calculated if Pca and V' at 
the PS probe (V'ps) are known. 
Table 2 gives an overview of the variable definitions and their 
equations used in the present study. Gas density p was calculated, 
using the weighted density at 37"C of expired gas from data pre-
sented by Radford (31) and Boyle's law, to be 0.00113 g/cm3• 
Bronchial flow at the PS probe level (V'ps) was similarly calculat-
ed by use of Boyle's law. In order to correct for the effect of gas 
compression (8) the expired volume from TLC level was correct-
ed for the compressive influence of pleural pressure Ppl. This rep-
Variable definitions and equations 
Oefinition EquaUon Unit 
Pressure for convective acceleration Plot· Plat kPa 
Transmural pressure Plat + Ppl kPa 
Alveolar pressure PpJ + Pel kPa 
Upstream presSure loss Palv - Ptot kPa 
Pressure head Plot - PpJ = Pca + Plm =: Pel - pfr kPa 
Air-Nay compliance dAI dP"" cm1lkPa 
Gas density at the probe PPb(Pb+Plat)lPb glcm3 
Flow at the PS probe V'moPbJ(Pb+Plat) II, 
Thoracic gasvolume change from HC (PbJvmGdt+TlCoPpl)/(Pb + Ppl) 
Airway cross sectional area V'pso(SOoPPlal IPea) ° 5 em2 
Wave speed flow A{10oN(PPIJl oCaw)] 0.5 II, 
Speed index V'psN'ws = (2oPeaoCaw/A) 05 
Ptot: impaction pressure, Plat: lateral airway pressure, Ppl: pieural pressure, pPb: weighted density 01 eXJlired gas at37'( bl' use of Boyle's law, pb: barometric 
pressure, Pm: pressure at the mouth, V'm: flow at the mouth. 
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resented the largest part of Palv that ideally should have been 
used in the correction. A values calculated from Pca values less 
than 0.5 kPa were disregarded as these proved to be less reliable 
during testing of the PS probe in rigid tubes (23). Mouth flow 
(V'm) was not corrected to BTPS conditions and no attempt was 
made to correct for the difference in composition of air and alve-
olar gas. This will introduce a small, but systematic error in both 
the asthmatic and the healthy subjects, considered to be of no 
significance in the present study (30). 
\Ve assumed that the pressure surrounding the airway is equal to 
the pleural pressure (Ppl). The upstream intra bronchial pressure 
loss (pfr) from the alveoli to the endhole of the PS probe can be 
expressed by: pfr = Palv - Ptot = Pel - Ptm + Pca. The term PUn + 
Pca is, in fluid mechanical terms, the pressure head J at the tip of 
the PS probe relative to Ppl (3). Rfr is calculated as PfrN'ps. 
Bronchial cross sectional area (A) plotted versus PUn resulted 
mostly in a curve with a regular and irregular part. The agree-
ment of a 2nd to 5th polynomial fitted through the regular part 
was assessed by eye. For further analysis only Caw values (calcu-
lated as first order differentiation of the polynomial) and A val-
ues from the part of the polynomial corresponding to the regular 
part of the actual AlPttn curve were used. 
In accordance with Dawson and Elliott (3), local maximal flow 
(V'WSO) at a certain point in the airways with a given tubelaw 
CawO and cross sectional area AO, can be calculated as: V'WSO = 
AO.[(lOoAo.dPtm°)/(p.dAono.5 (the notation w, indicates values 
at a 10calmaxiIl1um) (25,28). When V' equals V'ws, air speed (v) 
is supposed to be the speed of wave propagation (Le. wave speed 
c = V'ws/A) through the local airway (3) and the speed index (SI 
= vic = V'N'ws) will he equal to one. 
Fig. 4a illustrates the relation of expiratory flow (V') and speed 
index (SI) with volume (V) during an MEFV maneuver with the 
PS probe at one central and a more peripheral position. Fig. 4b 
the A/Ptlll curves obtained at these two different PS probe posi-
tions. 
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Figure 4a 
l\,lEFV curves and their 
related speed index 
CUfyeS (SI) with the 
Pirat static probe in the 
truncus intermedius 
(I ;=: pos.l) and ,1t mid-
trachea (4 :::: posA) in 
one healthy female sub-
ject. V': ~xpirator}' 
flow (Us), V: yolume (I), 
SI: Speed Index 
Figure 4b 
Corresponding AlPtm 
curves at the truncus 
intermedius (1:::: pos.l) 
and at mid-trachea 
(4", posA). A: cross 
scctional area (ClU2), 
Ptm: transmural pres-
sure (kPa). Note: the 
steeper slope of AJPtm 
curve 1, indicating a 
more compliant airway 
at the truncus inter-
medius compared to 
. mid trachea. 
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STATISTICS 
A two sample T-test was used for comparison of lung function 
results between asthmatics and normals. 
All initial values for Caw, A, pf,; Rfr, SI and PtIll were logarith-
mically transformed. 
Within one subject all data per variable pel' position were pooled 
according to their VPpl within the following 4 volume ranges: 
VPpl ~ 100-80%, 79-60%, 59-40% and 39-20% FVC. The aim 
was to reduce the problems in analysis due to differences in the 
number of measurements and/or missing values between subjects 
and/or bet\veen positions. Two or more values for a varia ble 
from one subject per position within one volume range were 
averaged. The aim was that for each subject, all 20 combinations 
of the 5 positions and 4 volume ranges contained a single mean 
logarithmic value of Caw, A, Pfr, Rfr, SI and Ptlll. Nevertheless 
missing values at some positions and/or volume ranges were still 
present in some subjects. 
Therefore we applied rmANOVA using BMDP module 5V 
(BMDP Statistical Software Inc., release 7, 1992, Los Angeles) to 
analyze the geometric mean values of the outcome variables Caw, 
A, Pfr, Rfr, SI and Ptm per combination of position and volume 
range for each subject, in order to compensate for missing values. 
As only 24 subjects were analyzed, the assumed (co-)variance 
structure of the residuals was compound symmetry in order to 
reduce the number of estimated parameters. 
In this analysis the following independent factors were used: 
two between subject factors with two levels: sex (malelfemale) 
and disease (healthy or asthma), 
two within subject factors: volume ('20%-FVC' ranges: 2 or 4 
ordinal levels) and position (5 ordinal levels). 
A full model with the above described four explanatory factors 
(volume and position as categorical factors) and all their first 
order interactions formed the basis of the analysis. This initially 
used full model was as follows: 
'Predicted' variable ~ 
disease + sex + position + volume + disease.sex + 
disease. position + disease. volume + sex.position + 
sex. volume + position.volume. 
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Subsequently a backward elimination method was applied using 
likelihood ratio tests (embedding tests), where in each step the 
factor with the highest p-value larger than 0.05 was eliminated, 
starting with the first order interaction in hierarchical fashion 
(i.e. main effects were not eliminated as long as they had a signif-
icant interaction with one of the other factors). If the restricted 
model thus selected still contained at least one of the categorical 
(ordinal) factors volume and/or position, then these categorical 
factors were replaced (one at a tirne) by their continuous (numer-
ic) versions in order to test if an embedded model with a linear 
trend gave a better goodness of fit considering the lesser number 
of degrees of freedom required for the further restricted model. 
~Ilodel predictions were back transformed to geometric means. 
Effects need to be interpreted in a rnultiplicative way because of 
logaritlul1ic transformation. 
When discussing the different variables in the following text, we 
discuss the predicted values according to the final model. 
Otherwise the suffix 'measured' is used. A level of significance of 
p < 0.05 two sided was used. 
RESULTS 
Data collection, The average number of replicate MEFV measurements pel' sub-
selection and ject for each PS probe position was 1.35 (range 0-3) for the 
analysis healthy subjects and 2.46 (range 0-5) for the asthmatics. From 
each individual PS probe measurement only the volume range, 
corresponding to the Ptlll range for which the polynomial 
through the NPt11l curve was fitted, could be used for analysis. 
As this volume range was mostly less than the FVC range, this 
often resulted in less than the aimed 13 'cases' per measurement. 
A small number of 'cases' with negative Pca, Ppl, Pfr, and Caw 
values was excluded for reasons stated earlier. Volume ranges 
with missing data occurred therefore in almost all subjects. There 
was no clear pattern noticeable in the distribution of these 'emp-
ty' volume ranges within the 10 + 14 subjects that could have 
influenced the results of the multiple regression modelling signifi-
cantly. Between the healthy and the asthmatic subjects there were 
no statistical differences for the pooled data of ailS positions and 
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4 volume ranges between the dataset used for final analysis and 
the dataset containing the excluded 'cases'. Therefore a bias with 
regard to the found differences between asthmatic and healthy 
subjects due to exclusion of these 'cases' is unlikely. 
A dataset with 1477 'cases' from in total 218 accepted PS probe 
.wlEFV maneuvers, resulting in 352 position - volume - range 
combinations with data, was used for final analysis. Tables 3a 
and 3b give the geometric means of the values of 'measured' Pfr, 
Rfr, 51, A and Caw values for the healthy and the asthmatic sub-
jects. 
The main factors and their interaction terms, contributing to the 
multivariate regression models finally fitted by the maximum 
likelihood method for In(Pfr), In(Rfr) and In(SI) are given with p-
values in Table 4. For these three variables no lineal' trend could 
be found with regard to volume and/or position. 
Disease, position, volume and the interactions: disease with posi-
tion, disease with volume and sex with volume contributed all 
significantly to SI (Table 4). Due to these interactions it was not 
possible to express differences in 51 between healthy or asthmat-
ics independent of the factors volume, position or sex. \Vithin the 
healthy subjects 5I values were near one at all 5 positions within 
the volume ranges 79-60% and 59-40% FVC. In the asthmatics 
this was only true at pos.O and pos.l within 79-60% and at 
pos.O within 59-40% FVC whereas low 51 values (51 < 0.8) were 
found at the other PS probe positions (Fig. Sa and 5b). 
A position - volume - range combination with an individual geo-
metric mean 'measured' 5I value> 1.2 (indicating supercritical 
flow) was found at pos.O: 11, at pos.l: 9, at pos.2: 1, at pos.3: 4 
and at pos.4: 5 times in 10 healthy subjects and 12 times (at 
pos.O: 8 and at pos.l: 4 times) in 9 asthmatics. 
Pfr was predicted by disease, sex, position, volume and the inter-
action of disease with position and sex with position (Table 4). 
At the most peripheral position (pos.O) Pfr was higher in the 
healthy subjects c01npared to the asthmatics within a given sex. 
At the more downstream positions, Pfr in the healthy subjects 
was lower compared to the asthmatics. At pos.4 the difference 
disappeared (Table 5). Nr increased significantly with decreasing 
volume and with a more do\vnstream position of the PS probe in 
Speed index (51) 
Pressure loss 
upstream from PS 
probe (Plr) 
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Table 3a Healthy subjects, 'measured' values of Pfr, Rfr, 51, A and Caw. 
Healthy 100·80% FVC 79·60% FVC 59-40%FVC 39·20~b FVC 
Pos..O Plr 0.57 (0.17 I 1.65) 0.71 (0.07 I 2.42) 0.76 (0.05 I 3.43) 1.03 (0.24 I 5.63) 
Rlr 0.10 (0.02 I 0,35) 0,15(0.02/1.01) 0.24 (0.02 I 0.78) 0.72 (0.16 13.31) 
51 1.04 (0.63 I 1.61) 0,95 (0.58/1.61) 1.13 (0.6711.72) 0.92 (0.34/1.55) 
A 1.31 (0.69 I 2.271 1.17 (0.80 I 1.88) 0.7' (0.44 I 1.02) 0.65 (0,37 I 1.17) 
Caw 0.71 (0.20 11.82) 0.60 (0.21 11.41) 0.40 (0.11 I 0.88) 0.26(0.1010.51) 
" 
9 10 9 
Pos.l Plr 0.33 (0.03/1.04) 0.44 (0.05 I 1.1 I) 0.86 (0.11 13.05) 1.21 (0.2316.15) 
Rlr 0.05 (0.011 0.14) 0.08 (0.02 10.22) 0.24 (0.02 I 1.03) 0.72 (0.09 I 11.48) 
51 0.83 (0.56/1.32) 0.89 (0.62 I 1.56) 0.84 (0,38 11.93) 0.74 (0,31 11.87) 
A 1.42 (0.87 I 2.27) 1.18 (0.66/1.75) 0.87 (0.47 I 1.44) 0.64 (0.08 I 1.40) 
Caw 0.47 (0.1813.84) 0.39 (0.17/2.28) 0.31 (0.08 I 1.49) 0.23 (0.04 I 0.84) 
" 
10 12 13 11 
Pos.2 Plr 0.65 (0.20/1.02) 0.68 (0.03 I 1.69) 1.23(0.41/2.62) 1.71 (1.0013.81) 
Rlr 0.10 (0.05/0.15) 0.13 (0.01 10.29) 0,32 (0.10 I 0.62) 0.84 (0,39 I 1.74) 
51 0.73(0.35/1.19) 0.82 (0,3 I I 1.12) 0.78 (0.54 I 1.37) 0.60 (0,361 0.97) 
A 1.22 (0.59/2.41) 1.07 (0.58 I 1.69) 0.85 (0.52 I 1.37) 0.85 (0.53 I 1.32) 
Caw 0.22 (0.03/1.14) 0.27 (0.091 0.82) 0.19 (0.04 I 0.59) 0.23 (0.06 I 0.44) 
10 8 8 
Pos.3 Plr 0.79(0.09 I 1.60) 0.78 (0.09 I 2.29) 0.83 (0.01 13.86) 1.47(0,30 I 5.04) 
Rlr 0.12 (0.02 I 0.25) 0.14 (0.021 0.41) 0.22 (0.00/0.79) 0.80 (0.20 I 2.88)' 
51 0.99 (0.88 I 1.12) 0.86(0,36 I lAI) 0.85 (0.39/1.44) 0.43 (0.22 I 0.68) 
A 1.05 (0.61/1.77) 0.84 (0.40 I 2.04) 0,]2 (0.3311.29) 0.80 (0,34 I 1.40) 
Cew 0.24 (0.08/0.64) 0.12 (0.02 10AO) 0,12(0,03/0.81) 0.11 (0.021 0,34) 
9 13 12 11 
Pos.4 Plr 1.28 (0.30 12.82) 1.60 (0,34 I 6.80) 2.59 (0.46/7.30) 1.70 (0,30 I 3.84) 
Rlr 0.21 (0.06 I 0.44) 029 (0.08 I 0.87) 0.65(0.17/1.21) 1.13 (0.24 I 4.03)' 
51 0.79 (0.40 11.26) 0.81 (0,38 11.82) 0,73 (0.36/1.67) 0,34 (0.16 I 0.70) 
A 0.98 (0.41/1.79) 0.90 (0,30 11.58) 0.86 (0.42 11.67) 1.02(0.53 I 1.78) 
Caw 0.14(0,04/0.68) 0.12(0.0111.41) 0.15 (0.04 I 1.36) 0.15 (0.06 IOA9) 
10 13 10 10 
Values as group geometric means (min I max. value). pfr: prEssure loss upstream from PS probe (kPa), Rlr: resistance upsueam from PS probe (kPa11Is}(#: calculated 
in 9 subjects), 51: speed ind~ (see tlOXtj,A: uoss sectional area (em2), Caw: airway compliance (cm2fkPaj, n: no, subjects. Pos: PS probe position: O=at lower lobe, 
l=at middle lobe, Z=mid main stem bronchus, 3=end trachea, 4= mid tramea, 
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Table 3b Asthmatic subjects, 'measured' values of Pfr, Rfr, 51, A and Caw. 
Asthma 100·80% FVC 79·60% FVC 59·40% FVC 39·20% FVC 
Pos,O pll 0.54 (0.09/1.65) OA6 (0.02/2.94) 0.32 (0.01 12.20) 1.24 (0.321323) 
RII 0.10 (0.011 0.60) 0.12 (0.01/1.01) 0.14 (0.01/1.23) 1.01 (0.17 I 5. 13)S 
51 0.74 (0.4511.59) 1.23 (0.62 11.83) 0.85 (0.45/1.71) 0.55 (0.39/0.88) 
A 0.78 (0.21 11.49) 0.63 (0.20/1.44) 0.82 (0.5711.32) 0.97 (0.50 (1.84) 
Caw 0.11 (0.04/0.22) 0.17 (0.071 0.85) 0.21 (0.11 10.33) 0.16 (0.041 0.28) 
6 8 8 7 
Pos.! pll 1.02 (0.1015.31) 1.22 (0.1015.29) 0.99 (0.0615.42) 1.23 (0.24/4.771 
RII 0.19(0.01/1.44) 0.27 (0.01 (2.44) 0.36 (0.03/1.771 1.14 (0.1214.25) 
51 0.51 (0.20/1.08) 0.81 (0.2711.71) 0.78 (0.25/1.71) 0.43 (0.221 0.82) 
A 1.38 (0.6712.84) 1.04 (0.541 2Al) 1.06 (0.4612.62) 1.1 4 (0.6912.42) 
c,w 0.19(0.11/0.28) 0.22 (0.07 I 0.57) 0.27 (0.151 0.77) 0.21 (0.07/0.43) 
n 9 8 6 
Pos,2 pll 1.31 (0.7612.86) 1.63 (0.381 4.44) 1.73 (0.14/4.98) 1.91 (0.6017.10) 
RII 0.22 (0.13 I 0.38) 0.32 (0.10/0.77) 0.59 (0.0812.63) 1.16 (0.41/3.64) 
51 0.55 (0.221 0.81) 0.51 (0.3310.74) 0.32 (0.17/0.61) 0.23 (0.04/0.82) 
A 1.41 (0.8812.45) 1.22 {0.62 12.58) 1.22 (0.7412.32) 1.37 (0.83/3.26) 
Caw 0.20 (0.04/1.03) 0.15 (0.061 0.24) 0.12 (0.051 0.27) 0.14 (0.021 0.43) 
9 8 
Pos.3 PlI 1.04 (0.2312.56) 1.99 (0.55/5.16) 2.26 (0.50 17.78) 2.51 (0.97/5.12) 
RII 0.18 (0.061 0.33) 0.41 (0.15/0.90) 0.93 (0.2212.68) 1.53 (0.65/3.67) 
51 0.71 (0.43/0.89) 0.65 (0.371 0.93) 0.42 (02311.17) 0.32 (0. I 21 0.96) 
A 1.02 (0.86/1.41) 1.01 (0.6312.13) 0.98 (0.6711.89) 0.97 (0.67 11.87) 
Caw 0.15 (0.10 I 0.30) 0.14 (0.071 0.24) 0.10 (0.0711.17) 0.12 (0.071 0.18) 
n 6 8 8 
PosA pll 2.13 (1.33/4.42) 2.53 (0.41/6.96) 3.00 (0.4219.91) 2.74 (0.68/8.66) 
RII 0.32 (0.24/0.45) 0.44 (0.11 I 1.1 I) 0.85 (0.2312.43) 1.59 (0.8514.73) 
51 0.78 (0.56/1.01) 0.75 (0.52/1.08) 0.55 (0.37 I 0.68) 0.33 (0.231 0.44) 
A 1.13 (0.83/1.34) 0.91 (0.43/1.35) 0.93 (0.70/1.52) 1.10 (0.86/1.57) 
Caw 0.17 (0.081 0.72) 0.10 (0.041 0.26) 0.10 (0.05 I 0.21) 0.12 (0.071 0.34) 
n 7 8 8 8 
V~lues as group geometric meartS (min I ma~. value). Plr: pressure 1055 upstream from PS probe (kPa), Rfr: resistance upstream lrom PS probe (kPallIs)(S: calculated 
in 6 subjects), SI: speed index (see text),A: (fOSS sectional area (eml), Cal'l: airway compliance (cm1/kPa), n: no. subjects. POI: PS probe position: O=at lower lobe, 
l=at middle lobe, 2=mid main stem bronchus, 3=end trachea, 4= mid trachea 
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Table 4 Factors explaining the logarithmIc value of Pfr, Rfr and SI according to the final 
statistical model based on the data In the volume ranges 79-60% and 59-40% FVC. 
p values In(Pfr) In(Rfr) In(SI) 
Disease 0.781 0.188 <0.001 
Sex 0.001 0.062 OJ13 
position (cat) <0.001 <0.001 <0.001 
volume (cat) 0.02 <0.001 <0.001 
dis· pos <0.001 <0.001 0.001 
dis "I 0.002 
sex· pos 0.006 0.005 
sex· vol 0.026 
Figures represent the p values according to Wald-tests of significance of fixE'd effE'cts and covariatE's. 
(cat: catE'gorical, dis: disease, pos: position, vol: volume range) 
Table 5 Pfr and Rfr: ratio healthy: asthma withIn a given sex and volume range 
Pfr healthy Rfr healthy 
PS probe posItion Plr asUlma Rfr asthma 
at lower lobe (pos.O) 3.54 2.54 
at middle lobe (pos.1) 0.57 OJ9 
mid main stem bronchus (pos.2) 0.59 0043 
end trachea (posJ) 0.53 0.15 
mid trachea (poso4) 1.00 0.86 
Plr: pressure loss upstream from the PS probe 
Rff: airway resistance upstream from PS probe 
both groups (Table 3a, 3b and 4). Pfr was significantly lower in 
the females compared to the males within equal disease status 
and volume range (Table 4). 
Rfr depended significantly on pos1l10n, volume range and the 
interaction between disease and position and sex and position 
(Table 4). Rfr increased, on average, with decreasing volume and 
with a more downstream PS probe position in all asthmatic and 
healthy subjects. Within equal volume range and sex, Rfr was 
higher in the healthy subjects at the most peripheral position 
(pos.O). At the more downstream positions 1, 2 and 3, Rfr was 
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Figure Sa 
Statistical predicted 
Speed index values 
(SI) at different PS 
probe positions at 
volume range 79-60% 
and 59-40% FVC for 
male and female 
healthy subjects. 
Pas 0: entrance right 
lower lobe, 1: 
entrance middle lobe, 
2: mid main stem 
bronchus, 3: end tra-
chea, 4: mid trachea. 
Figure Sb 
Statistical predicted 
Speed index vllilies 
(SI) at different PS 
prube positions at 
volume range 79-
60% and 59-40% 
FVC for m~lle and 
female asthmatic sub-
jects. 
Pas 0: entrance right 
lower lobe, I: 
entrance middle lobe, 
2: mid main stem 
bronchus, 3: end tra-
chea, 4: mid trachea. 
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significantly higher in the asthmatics and at mid tracheal level 
comparable between both groups (Table 5). Rfr was significantly 
lower in the females compared to the males within equal disease 
status and volume range (Table 4). 
At the most peripheral PS probe positIOn (pos.O) 'measured' 
cross sectional area A and airway compliance Caw were signifi-
cantly smaller, PUn significantly 1110re negative and local Pca sig-
nificantly larger in the asthmatics compared to the healthy sub-
jects. In contrast, local 'measured' V\vs was comparable between 
both groups (Table 6). At the more downstream PS probe posi-
tions 1, 2, 3 and 4 no significant differences for these 'measured' 
variables were found between asthmatic and healthy subjects. 
TABLE 6 Variables at lower lobe with condition 0.8< 'measured' SI <1.2 
Healthy Asthma p 
Pos.O n= 19 n=S 
A 1.20 (0.46) 0.88 (0.18) 0.02 
Caw 0.71 (0.37) 0.23 (0.08) <0.001 
V'ws 5.07 (2.31) 5.61 (2.69) 0.66 
Pea 1.03 (0.57) 2.01 (0.71) 0.004 
Ptm ·1.33 (0.96) ·2.45 (1.08) 0.034 
He,t comparison betwe.;n IlNlthy and asthmatic subjects of the geometric mean yalu~s pN subject at lower lobe (1'0\,0) 
of 'measured' A (cross·sectional area, unl), Caw (aif\'lay compliance, cm2/kPa), V'ws (calculated wavespeed flow, !Is), I'ca 
(pressure loss due to convective acceieration, kPa) and Ptm (trarl5mural pressure, kPill. Only 'cases' with a 'measured' 51 
(speed inde.'\) between O.S and 1,2 were selected, 3114 volume ranges \'JNe pooled, 
DISCUSSION 
The purpose of the present study was to examine, in vivo, the 
occurrence and behavior of choke points in central airways of 
healthy and asthmatic human subjects. Measurements and caleu-
lations were based on the wave speed concept and the method 
was previously applied in dogs (28) using a Pitot static probe as 
originally used by Macklem and Wilson in 1965 (16). 
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In this study we defined a choke point (CP) as an intra bronchial 
position where flow (V') reaches wave speed flow (V'ws). As 
such, we characterized an CP by an 51 value (51 = V'/ V'ws) 
between 0.8 and 1.2. The 51 results, based on the statistical mod-
el, describe the overall distribution of chokepoints within the two 
groups of subjects. These model 51 results indicate that, in 
humans during forced expiration, chokepoints do occur central 
airways and that the distribution and volume dependent behav-
ior of the chokepoints (CP) differ between healthy subjects and 
patients with asthma. In the healthy subjects CP's were distrib-
uted over all central airways and in the asthmatics limited to the 
most upstream intra bronchial position. The difference can possi-
bly be explained by differences in local airway properties as 
described in another paper (2), based on the same subjects and 
set of measurements, where we concluded that airway compli-
ance (Caw) and specific airway compliance (sCaw = Caw/A) 
were significantly lower in patients with asthma than in the nor-
mal controls. 
Using a Pitot static probe for this purpose is technically difficult 
as mentioned by Macklem and Wilson (16). Related papers by 
Pedersen et a!. (23) and Brackel et a!. (2) using the same method 
discuss most of the technical problems encountered. Crucial for 
the calculation of A and therefore of Caw, V'ws and 51 are the 
measurements of Pca (Ptot - Plat) with the PS probe and of Ptm 
(Plat - 1'1'1) by further use of an esophageal balloon. Measure-
ment of A was reasonably accurate even for small Pca values for 
A values up to 2 cm2 (23). In the present study only 3.6% of the 
original 1477 'measured' A values was> 2 cm2 . These A results 
may have been overestimated by ± 10-15% (23). Obstruction of 
1-4 sideholes of the 1'5 probe did not change the results of the ill 
vitro control experiments significantly. Howevel~ the conditions 
during the ill vivo measurements were far more complicated. 
Mucus could temporarily plug the endhole and one or more side-
holes of the 1'5 probe. This was checked by eye using the on line 
signals of V'm, Ptm, Pca and Ppl, as much as possible. 
Measurements were rejected and repeated if not reliable. A non 
axial position of the 1'5 probe may have altered the A results, 
although in a previous study an angle up to 20" changed 'meas-
ured' A less than 10% (28). Diverging airways in the flow direc-
Technical and 
analytical 
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tion may lead to underestimation or overestimation of A depend-
ing of the position of the PS probe in relation to the waIl (23,28). 
In the present study, however, tracheal A decreased, on average, 
with a more downstream PS probe position. 
The smaller number of MEFV measurements per subject in the 
healthy subjects can in part be explained by the fact that they 
were asked to produce other types of expiratory maneuvres as 
weIl in the time limited by the duration of the bronchial anaes-
thetic. Despite practical problems due to mucus impaction, the 
asthmatics produced, however, more useful results. 
Due to the invasive character of the experiments it was difficult 
and fatiguing for the subjects to perform adequate MEFV 
maneuvres repeatedly. Not all subjects were able to produce reli-
able results throughout the full FVC range and/or at all five posi-
tions. Typical problems were fits of coughing, increased mucus 
production with the need to swallow and premature running out 
of local anaesthetic. At some positions in some subjects no reli-
able data could be obtained due to wedging of the PS probe espe-
cially at low lung volumes. Accepted maneuvers could still con-
tain artifacts over a certain volume part. These parts were 
omitted in the final analysis. 
The asthmatics were pretreated with maximal bronchodilation 
and anti-inflammatory treatment and their pulmonary function 
testing did not differ significantly from that of the normal volun-
teers. Therefore, we assumed homogeneously emptying of the 
lung parts in both groups and used total expiratory flow, meas-
ured at the mouth and corrected for local Plat, for the calcula-
tions. The intra bronchial cross sectional areas (positions 0, 1 and 
2) are therefore in fact 'functional' cross sectional areas related to 
the total cross section at the corresponding levels, assuming that 
all airways at the same level behave like the 'PS probe airway'. 
Since choke points were identified in the trachea as well in the 
mainstem and lobar bronchi (i.e. the large airways) intralobar 
differences in emptying reflecting small regional variations have 
probably not affected the calculations (9). However, it is neces-
sary to assume that the airways of the same generation con-
tribute uniformly to flow. The Pitot static probe itself diminished 
the local cross sectional area and may have caused airflow 
obstruction or even collapse of an airway around the PS probe. 
Therefore the PS probe may have influenced intra bronchial pres-
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sures and may have artificially induced a chokepoint. This may 
partly explain the differences between the two MEFV curves in 
Fig. 4a. Since it is difficult to predict what Plat and local flow 
would have been without the 1>S probe ill situ, the 'measured' A 
values in the present study were not corrected for the cross sec~ 
tiona I area of the PS probe. The cross sectional area of the PS 
probe was 0.07 cm2 and the 'measured' A at the level of the most 
peripheral position was 0.7-1.2 cm2 in the healthy subjects and 
0.6-0.8 cm2 in the asthmatics (2). These A values are measured at 
the entrance of the lower lobe and represent the total functional 
cross sectional area of 4 airway branches at this level. The esti~ 
mated mean A, during forced expiration, of the individual air-
way containing the PS probe was therefore 0.15-0.3 cm2, and 
therefore still larger than the dimension of the PS probe. 
Expiration from TLC level to RV level caused the PS probe, 
being fixed by its catheters, to move upstream with shortening of 
the airways. Although the relative motion within the trachea was 
less than two cartilage rings, it meant that the 'nleasured' A did 
not reflect the A of a fixed airway site. 
At all positions the surrounding pressure of the airways was 
assumed to be the pleural pressure as discussed by Mead et al. 
(18). 
OUf analysis is based on concepts, related to wave speed deter-
mined flow limitation. Although the flow limiting process 
already starts at peak flow (23) the volume range 100-80 % FVC 
will incorporate an effort dependent part as well. In the tail of 
the 1vlEFV curve, at low flow and lung volume, non uniform air~ 
way closure and viscous flo\v limitation may be present and 
make the interpretation difficult. Model simulations based on the 
wave speed concept yielded most accurate predictions in the mid 
part of the MEFV curve (7,11). One may then expect that, dur-
ing forced expiration, study into wave speed flow limitation will 
be most fruitful throughout the lung volume ranges 79-60% and 
59-40% FVC. Therefore we focused mainly on the pooled data 
within these two ranges for statistical analysis of flow limitation 
within the two groups of subjects. 
In our study, all factors (except sex as main factor) included in 
the statistical model, contributed significantly to SI (Table 4). 
Although this influence was to be expected for volume and posi-
Interpretation of 
results 
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tion, we fonnd also a different behavior according to the between 
subjects factor 'disease'. Wave speed was almost reached at all PS 
probe positions in the healthy subjects whereas it was only 
reached at the most upstream position 0 (and position 1 for 79-
60 %FVC) in the asthmatics (Fig. 5a and 5b). These results sug-
gest that flow limitation occurred more upstream in the bronchi 
in the asthmatics than in the health), subjects. Downstream of a 
flow limiting segment the flow chokes or becomes supercritical, 
meaning that the velocity of expired air exceeds local wave 
speed. In the latter case the airway segment often becomes more 
narrow than the FLS and the flow will often decrease with SI 
increasing above one (28). In the current study, the distribution 
of positions with 'measured' SI > 1.2, indicative of local super-
critical flow and therefore of positions downstream of the FLS, 
support both the occurrence of flow limitation in central airways 
and the conclusion that the site of flow limitation is located more 
upstream in the asthmatic subjects compared to the healthy sub-
jects. 
The finding of wave speed flows ill vivo in human central air-
ways in the current study is in agreement with the location of 
FLS in central airways in intact dogs (10,20,28,33) and in 
humans (13,16) as well as in excised clog and human lungs 
(7,19,32). 
If one acids the lung volume ranges 100-80% FVC and 39-20% 
FVC to the anal)'sis, an upstream shift of the SI= I site with 
decreasing volume can be noticed (Table 3a,b): A representative 
example of this shift is shown in Fig. 4a and is related as well 
with an increase in airway compliance at a more upstream locat-
ed airway segment (Fig. 4b). At high inflation level (100-80% an 
79-60% FVC) mean 'measured' SI was between about 0.8 and 
1.2 at all positions in the healthy subjects. At 39-20% FVC this 
was only true for the most peripheral position O. On average, 
'measured' SI values in the central airways decreased with 
decreasing volume. The asthmatics showed the same pattern 
although less clear. An upstream shift of CP with decreasing vol-
ume is consistent with e.g. studies in dogs by Smaldone and 
Bergofsky (32), by Pedersen (28) and by Lambert, using a mathe-
matical model (11). 
In neither groups of subjects the PS probe could be placed in suf-
ficiently peripheral airways to measure SI significantly smaller 
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than one. The intrabronchial sites with SI ;-:::: 1 are indicative of 
local snpercriticai flow extending further downstream in the 
healthy subjects than in the asthmatics, but do not explain where 
the most upstream position with SI = 1 is located. Therefore, the 
SI results in our study can not inform us about the real intra-
bronchial position of FL5 at different lungvolumes in both 
groups nor can we conclude definitively that FLS is located more 
peripherally in the asthmatics. 
A related study by Pedersen et al. of flow limitation at peak flow 
(23) showed smaller maximum SI values in the central airwa}'s at 
peak flow in stable asthmatics than in the healthy subjects. They 
hypothesised but could not confirm that this was due to a lower 
local Caw in the asthmatics. 
Brackel et al. described, in the same groups of subjects as the cur-
rent study but irrespective of flow limitation, stiffer and more 
narrow airways in the asthmatics during forced expiration, espe-
cially at the most upstream central airway positions (2). They 
suggested that these differences from the healthy subjects may be 
related to airway remodeling caused by chronic asthmatic airway 
inflammation (2). A lower airway compliance and smaller A may 
explain the difference in distribution of sites with 51 = 1 (CP's) 
between the two groups. Analysis of the 'cases' with 0.8 ::; 'meas-
nred' 51 ~ 1.2 showed indeed significantly lower 'measured' A 
and Caw values at position 0 in the asthmatics, compared to the 
normals, without a difference in local V'ws (Table 6). This indi-
cates that a lower local Caw, resulting in a higher V\vs, counter-
balances a lower A, causing a lower V'ws. The differences in 
overall pulmonary function between healthy and asthmatic sub-
jects (Table 1) are therefore likely to be due to properties of more 
peripheral airways than those 'measured' with the PS probe. 
The position of the FLS is determined by the local properties of 
the airway (A and Caw) and the upstream resistance. Therefore 
we also examined the loss of pressure (pfr = Palv-Ptot) and the 
resistance (Rfr = PfrN'PS) upstream from the PS probe over vol-
ume range 79-60% and 59-40% FVC. To interpretate Pfr well it 
is important to realize that Pfr includes viscosity dependent pres-
snre loss in the peripheral airways as well as density dependent 
pressnre losses upstream from the PS probe. Macklem found low 
values for peripheral flow resistance compared to total pul-
monary flow resistance at high and mid lung volumes in dogs 
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(14). Pedersen showed that viscosity dependent losses may not be 
very important in healthy subjects (27). Wagner et aL showed 
that peripheral airway resistance was 7 times higher in asthmat-
ics compared to normals, although it contributed little to total 
airway resistance (36). Therefore pfr and Rfr may playa role in 
the asthmatics in spite of pretreatment. \Vie constructed maximal 
flow static recoil curves (MFSR curves) from the MEFV and the 
PeW curves \vithin each subject and compared these between the 
healthy and asthmatic subjects (unpublished results). Pel was 
slightly but not significantly lower in the asthmatics whereas 
lung compliance was comparable. In the volume range 79-40% 
FVC, the slope of the mean MFSR curve within each group was 
comparable between the groups of healthy and asthmatics sub-
jects. This suggested that airway conductance upstream from the 
FLS and therefore viscosity dependent pressure losses in the 
periphery were on average comparable in both groups although 
the model on which the MFSR analysis is based (12) can be con-
sidered as a simplification of the mechanics of a forced expira-
tion. 
The total pressure loss upstremll fro111 position 0 was, on aver-
age, higher in the healthy subjects. This finding may be related to 
the fact that the healthy subjects received no pretreatment with 
systemic corticosteroids 01' maximal bronchodilation. Another 
explanation could be that in the group of healthy subjects more 
CP's or the actual FLS existed upstream from position 0 and that 
in the asthmatics these were mainly located around the lower 
lobe. This could, however, not be confirmed in the current study. 
In both groups Pfr and Rfr were relatively low at position 0 com-
pared to more central positions. At mid trachea (posA) pfr was 
equal and Rfr almost equal between the healthy and asthmatic 
subjects. This indicates that, during forced expiration, the largest 
pressure drop occurs in the central airways. 
Within equal disease status and volume range, Pfr and Rfr were 
significantly lower in the females compared to the males at all PS 
probe positions (Table 4). As there was no indication for a 
decreased airway patency according to the routine lung function 
parameters (FEV1, FEV1NC) in the female subjects, this sug-
gests that in the females the main pressure drop occurred in the 
central airways. This is in agreement with a lower A in the cen-
tral airways in the females, as described by Brackel et aL (2). 
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If peripheral (viscosity dependent) pressure losses are comparable 
between the healthy and asthmatic group of subjects, the Pfr and 
Rfr findings, in combination with the SI results, suggest that in the 
healthy subjects positions with SI = 1 are located throughout the 
central airways and probably even upstream from position 0 during 
forced expiration. We do not know where in the periphery CP's 
originate or where actual FLS is located. In the astlllnatics positions 
with SI = 1 are only found in the airway segment near Pos.O one 
(and Pos.l at high lung volume). The effect of a local smaller A in 
the asthmatics on the formation of a CP (or even FLS ?) near posi-
tion 0 may have been enhanced by the insertion of the PS probe. 
Both the smaller A and the presence of the PS probe explain the sig-
nificantly higher Pca and more negative Ptm values at comparable 
flows in the asthmatics at Pos.O (Table 6). 
CONCLUSION 
Considering all the technical limitations as described and discussed 
above, this study suggests that valuable infonnation can be 
obtained about the relation between central airway properties, flow 
limitation I choke point formation, intra bronchial pressure loss and 
airway resistance by use of the wave speed concept in vivo in 
human airways. In (maximally bronchodilated) asthmatic patients 
pressure loss and airway resistance upstream from the lobar 
bronchi were lower compared to normal subjects. Airway compli-
ance was lower and cross sectional area was smaller at the lobar 
bronchi in these subjects. The latter may explain that FLS was 
probably confined at or peripheral to the lobar bronchi in the asth-
matic subjects in contrast to the healthy subjects. The healthy sub-
jects had positions with SI = 1 distributed along all central airways 
and probably upstream from the lobar bronchi as well, which 
means that also in healthy subjects FLS may be in the lobar bronchi 
or more peripherally, if we define FLS as the most upstream site 
with SI = 1. The effect of a smaller cross sectional area on maximal 
flow in the asthmatics is probably partially counterbalanced by a 
lower airway compliance. This may explain that changes in area 
andlor airway elastic properties may not be detected hy conven-
tiona I lung function measurements like .NIEFV curves. 
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ABSTRACT 
The relation between airway cross sectional area (A) and the 
transmural pressure (Pun) describes airway compliance (Caw = 
dAldPtm). Caw at the flow limiting site (FLS) in the airways may 
be estimated from the slope of the Maximal Flow Static Recoil 
(MFSR) curve (Pedersen, O.E, Acta.PhysioI.Scand.100: 139-53, 
1977). In an earlier study we obtained ill vivo dynamic A and 
Caw values at 5 positions between the right lower lobe and mid 
trachea, using an esophageal balloon and a Pitot static probe 
(Brackel H.J.L., Am.J.Respir.Crit.Care Med., in press). The pur-
pose of the current study was to evaluate MFSR derived airway 
compliance as a non invasive measure for airway elastic proper-
ties. \X'e examined 14 healthy subjects and 10 patients with sta-
ble, long-lasting asthma. Results: The appearance of MFSR 
derived AlPtm curves reflected jumps in the FLS location and A 
and Caw decreased with decreasing lung volume, like in the Pitot 
study. The correlation between MFSR derived A and Caw values 
with the Pi tot probe results, however, was poor. Furthermore, the 
MFSR analysis was not sensitive enough to reflect changes in 
Caw, demonstrated with the Pirot probe, in patients with mild to 
moderate asthma. 
INTRODUCTION 
The relation between the compressibility of intrathoracic airways 
and the occurrence of flow limitation during forced expiration 
has not been completely understood for many decades. Mead et 
al. (24) postulated that once flow is limited at a given lung vol-
lUne, an 'Equal Pressure Point' (EPP) with an equal intra-
bronchial and peribronchial (id est intrapleural) pressure exists in 
the intrathoracic airways. \'{There the airways downstream from 
EPP will be compressed, the upstream airways will not. The 
bronchial tree was considered to be an elastic system, emptying 
through an upstream part with a fixed resistance (Rus), in series 
with a variable resistance in the downstream airway. The lung 
elastic recoil pressure (Pel) was regarded to be the driving pres-
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sure for the upstream part and therefore considered as the most 
important determinant of maximal flow (V'max). Pride and 
coworkers (39) extended the Epp model and compared flow limi-
tation with the behavior of a 'Starling' resistor with an upstream 
driving pressure Pei, plus a critical transmural pressure (Ptlll'), 
the latter being the transmural pressure causing an elastic airway 
segment to collapse. After the introduction of Pun', the impor-
tance of airway wall properties as compressibility andlor tone of 
the flow limiting airway segment in addition to Pel as determi-
nants of V' max was emphasized. Leaver et a1. calculated Pun' as 
the pressure axis intercept of the slope of the MFRS curve and 
regarded this as an index of collapsibility of the flow limiting seg-
ments in the airway (19). The approach by Mead et al. and by 
Pride et al., however, was mainly based on a longitudinal pres-
sure distribution in the airways with Rus and Ptm' being regard-
ed as rather static variables independent of flow. Their concept 
could not really explain the mechanism of flow limitation. 
Influences of airflow properties (speed of gas, density, and viscos-
ity) in relation with airway wall properties were only partly tak-
en into account. 
Dawson and Elliott (7;8) recognized that the 'wave speed' con-
cept, known from fluid carrying systems, also applied to the air-
ways and stated that maximum flow through an airway is only 
attained when the velocity of air equals the propagation speed of 
a pressure wave of gas through the airway. The latter is called the 
tube wave speed and depends on the density (p) of the gas and 
the compliance of the airway wall. When defining airway com-
pliance (Caw) as the relation between the transmural pressure 
(Pun) and the local airway cross sectional area (A) (Caw = 
dAldPtm) , wave speed flow (V'ws) can be described according to 
the equation: V'ws = Ao[AI(p.dAldPtm)]O.5 (7;37). A smaller A 
and larger Caw (and/or larger p) will decrease V'ws and vice ver-
sa. In the wave speed concept of flow limitation, Pel and the 
pressure loss upstream from the flow limiting site (pfr) will deter-
mine local PUn, and therefore local A. V'ws depends therefore 
indirectly on the driving pressure Pel and PEr. 
In accordance with the wave speed concept (37), Pedersen and 
coworkers showed in a mechanical model (35) and in healthy 
subjects (36) that the elastic airway properties at flow limiting 
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sites may be estimated from the slope of the Maximal Flow Static 
Recoil (MFSR) curve at corresponding volumes. The MFSR 
derived AlPtm curve is then regarded as the compliance curve for 
a single airway, behaving exactly the same as the sequence of 
flow limiting segments of the complex system of intrathoracic 
branched airways, partly imbedded in the lung parenchyma (36). 
Using comparable equations, local dynamic NPtm curves can 
also be constructed from peri- and intra bronchial pressures, 
measured by an intrabronchially positioned Pi tot static probe, an 
esophageal balloon and the airflow during forced expiration. 
This ill vivo application of the wave speed concept was described 
by Pedersen et aJ. in a study in dogs (37) and applied by Brackel 
and coworkers in a study in asthmatics and healthy volunteers 
(5). 
In the current study, MFSR derived airway elastic properties are 
compared with airway compliance measured by a Pitot static 
probe located at 5 different positions within the central airways 
of healthy young adults and patients with mild to moderate asth-
ma. The purpose of the present study is to evaluate whether air-
way compliance obtained from the MFSR curve can be used to 
detect changes in airway wall elastic properties, possibly reflect-
ing structural asthmatic remodeling of the airway wall. 
THEORY AND BASIC CALCULATIONS 
For reasons of simplicity, it is supposed that the flow limiting seg-
ments of the human airway can be represented by a theoretical 
single elastic airway, behaving in exactly the same way as the 
complex system of branched human airways during forced expi-
ration (34;36). Airway compliance (Caw = dAJdPtm) derived 
from the MFSR curve reflects the elastic properties of the airway 
when and where flow is limited and does not indicate the exact 
site of flow limitation within the airways (36). Further assump-
tions are that flow (V') is turbulent, with a blunt velocity profile; 
that V'max is reached throughout the volume range studied and 
that the viscosity dependent pressure loss (pfr) from the alveoli to 
the flow limiting segment is negligible. 
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During its course the gas moving towards the thoracic outlet 
accelerates because of downstream tapering of the total cross sec-
tional airway area. The convective acceleration results in a drop 
(Pca) of the driving intrabl'onchial pressure. Friction) determined 
by airway dimensions, the density (p) and viscosity (fl) of the 
expired gas normally causes an extra loss of the driving pressure. 
Downstream from the equal pressure point (EPP), the airways 
will be compressed by the negative transmural pressure (Ptm). 
The intraluminary lateral pressure (Plat) decreases with increas-
ing flow and causes the transmural pressure (Pun = Plat - pleural 
pressure Ppl) to become more negative and, and in case of an 
elastic airway, its cross sectional area (A) to decrease further 
(34). The pressure drop due to convective acceleration (Pca) can 
be described by the Bernoulli equation: Pca = Y,opo(V'/A)2. In 
case of the assumptions mentioned above the following three 
equations can be derived (34;37) (see appendix): 
Pel = y,.po V'2/A2 + Ptm (I) 
dV'maxldPelo = A"2/(po V' max) (II) 
dA"ldPtmO = A"3/(pe V'max2) (III) 
(The suffixo indicates the situation when and where flow is limit-
ed. A is cross sectional area (cm2) PtIll is transmural pressure 
(kPa), V' is flow (Vs), V'max is maximal flow (lIs), p is density 
(g/cm3 )) 
These equations indicate that AU, PtmO and dAoldPtmU can be cal-
culated using the values of V', Pel and the slope of an MFSR 
curve. The AlPtm curve calculated f1'Om the MFSR curve repre-
sents therefore the compliance of the flow limiting airway seg-
ments during forced expiration. Equation III is analogue to the 
equations by Dawson and Elliott (7) and states that V'max can 
be calculated at any value of A when the local tube law 
(dAldPtm) is known. At the higher lung volumes, where Pfr is 
relatively small, the calculation of airway compliance (Caw = 
dAldPtm) may be more accurate then at the low lung volumes 
when viscosity dependent flow limiting mechanisms may be 
expected to occur. 
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Table 1 Anthropometric and spirometry data of healthy and asthmatic subjects. 
Age height ne RVI fVe FEVI FEV1! PEF 
yr em %pred Tle %pred %pred fVe %pred 
8 healthy f 2S,8±3,9 173±4 104±9 0,28±O,OS 108±9 I06±14 0,8S±0,06 109±13 
6 healthy m 26,S±6,9 187±8 IOS±ll 0,22±0,03 114±7 108±7 0.79±0,08 121±10 
healthy f+m 26.1±S,1 179±9 I04±9 0,26±O.OS 111±8 10l±11 0,83±0,O7 114±13 
3 asthma f 24,9±4.3 166±4 112±2S O.3I±O.03 I04±30 86±9 0.7S±O,16 87±7 
7 asthma m 21.1±3,4 182±8 96±10 O.2S±O,OS 94±8 8S±7 0.76±0.O4 91±17 
asthma f+m 22.2±3,9 177±10 IOhl6 O,27±O,OS 97±16 8S±7 0,76±O,O9 90±14 
p(f+m) 0.06 0,56 0.50 0,89 om <0,001 0.05 <0,001 
f=female, m=ma!e.A5thmatic subjects: values after bronchoddation and antHnflammatory treatment, values: means ± sd, p: p·va!ue according to tl'lO sample Hest 
compMing healthy and asthmatic subjects. 
Subjects 
SUBJECTS AND METHODS 
All measurements were performed in 24 non~smoking young 
adults: 8 female and 6 male healthy subjects and 3 female and 7 
male patients with moderate to severe (28) asthma according to 
ATS criteria (l), since early childhood. The mean age and anthro-
pometric data are given in Table 1. The patients used mainte~ 
nance treatment with inhaled corticosteroids for at least three 
years prior to the study. They were atopic, defined as a total IgE 
> 100 IE and a positive radio allergosorbent test for at least one 
inhaled allergen, and demonstrated bronchial hyperresponsive-
ness. All asthmatics were pretreated with a tapering course of 
prednisolone (45 mg on day 1,25 mg on study day 7) in addition 
to their regular maintenance treatment. The aim was to minimize 
possible persistent ainvay wall edema and hypersecretion due to 
chronic bronchial inflammation. I\1easurements were postponed 
for at least two weeks after recovery in case of a respiratory 
infection or an exacerbation within one month before scheduled 
measurements. 
All subjects performed a dose-response curve with an inhaled 
bronchodilator one week prior to the prednisolone COllrse. The 
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dose of the p-2-agonist that resulted in maximal bronchodilation 
(mostly 1 mg terbutaline) was inhaled by all asthmatic subjects 
within1.S h before the MFSR measurements and the Pitot static 
probe (PS probe) experiment. The healthy subjects obtained no 
p-2-agonist. 
The medical ethics committee of the University Hospital 
Rotterdam gave approval to the study. It was conducted in con-
formity with the principles embodied in the Declaration of 
Helsinki. Written informed consent was obtained from all sub-
jects. 
Baseline pulmonary function tests consisted of at least three maxi-
mal expiratory flow-volume curves (MEFV) with Ineasurement of 
expiratory flow, PVC, FEVl and peak expiratory flow (PEF); body 
plethysmography with determination of total lung capacity (TLC) 
and residual volume (RV) and quasi static pressure volume (PV) 
measurements (results in Table 1). 
Reproducibility of repeated flow-volume measurements was 
checked according to ATS criteria (2), superimposing the flow-vol-
ume curves on line by computer, 
The volume constant plethysmograph and the pneumotachometer 
with a heated Lilly type head were part of a '.Iaeger Masterlab' 
system (Jaeger, Wlirzburg, Germany). 
Calibration of lung function equipment was based on a standard-
ized procedure (40). Lung function results are expressed as per-
centage of the predicted values according to the summary equa-
tions of the European Coal and Steel Community (ECCS) (40). 
Esophageal pressure, as the equivalent of pleural pressure, was 
measured using an 8.5 cm long, 2 cm perimeter latex balloon 
(International Medical Products, Zutphen, The Netherlands) con-
taining l.S ml of air and positioned in the lower end of the esopha-
gus. The distance of the tip of the balloon to the tip of the nose 
was (lIS.height + 9) cm according to the method described by 
Zapletal (height in cm) (47). Several quasistatic deflation pressure 
volume curves (PN curves) were obtained according to the guide-
lines of the ECCS (40). 
Two deep breaths to TLC prior to each measurement controlled 
volume history. 
Pulmonary 
fuction 
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Out of three comparable MEFV curves a composite MEFV curve 
was constructed by computer according to the envelope method 
by Peslin (38) in order ta obtain within each subject the most 
maximal expiratory flow at each volume level. 
Three comparable PelN curves within one subject were matched 
at TLC and an average PeiN curve was constructed from the 
mean of the three pressure values of the individual PN curves at 
each 2 % TLC level. 
The average PelN curve was matched at TLC with the composite 
MEFV curve. A Maximal Flow Static Recoil curve (MFSR curve) 
was constructed from the pressure and flow values at each sub-
sequent 2% TLC level. The MFSR curve between 86% TLC and 
40% TLC was described by a 3'd degree polynomial fit with a 
coefficient of determination of R 2 > 0.990. In case of 'knees' in 
the MFSR curve maximal three pol)'nomials were used. Parts of 
the MFSR curve that could not be described b)' a pol)'nomial 
with a R2 of > 0.990 were not used for further anal),sis. 
Subsequently, at each 2% TLC level, the actual (measured) Pel 
values, V'max values derived from the polynomial and the MFSR 
slope values (k = dV'maxldPel) of the MFSR fit were used for 
calculation of A and Ptm according to the above described equa-
tions. An AiPUll curve was constructed using the A and Ptlll val-
ues at each 2% TLC level calculated b), equations 8 and 10. The 
NPtm curves were fitted by a 2nd degree polynomial regression 
with a coefficient of determination of R2 > 0.999. In case of 
"jumps)) in the NPtm curve, maximal three regressions were 
used. The A values from the AlPtm pol)'nomial(s) were used for 
further anal),sis. Airway wall compliance at each 2 % TLC level 
was calculated as the slope of the AlPun fit. 
In vivo Pitot For a detailed description of equipment, experiments and calcu-
static probe study lations we refer to the studies b), Pedersen et al. based on similar 
experiments in dogs (37) and to related studies b), Pedersen (32) 
ancl Brackel et al. (5) in the same groups of subjects. 
In summar)': a Pitat static Probe (PS probe) with an end hole and 
6 lateral holes was subsequently positioned at 5 different intra-
bronchial positions between the right lower lobe and mid trachea 
(Fig. 1) for meaSllrement of, respectively, impaction pressure 
(Ptot) and lateral airway pressure (Plat) during MEFV maneu-
vers. The local pressure drop due to convective acceleration was 
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Position 4 
mid trachea~ 4 
calculated as (Pea = Ptot - Plat). An esophageal baUoon was used 
for indirect measurement of peribronchial (pleural) pressure Ppl 
and enabled the calculation of the local transmural pressure (Ptm 
= Plat - Ppl). Flow at the PS probe (V'ps) was calculated from the 
mouth flow (V'm), measured by a non heated Fleisch type no. 
3.5 pneumotachograph. Assuming a blunt velocity profile and 
incompressible medium, the Bernoulli equation (Pca 
50.p.V,2/A2 (p: density in g/cm-3, cross sectional area A in C1112, 
p, kPa, V', lis)) enables calculation of A at the PS probe if Pea 
and V' at the PS probe (V'ps) are known. The change of A with 
change in PUn is a measure of airway compliance (Caw = 
dAJdPtm). Specific airway compliance (sCaw) was calculated as 
sCaw = Caw/A. 
If local A and Caw are known, the local maximal flow (i.e. wave 
speed flow V'ws = Ae[lOeAl(peCaw)]O.5 (32)) and the speed 
index SI = V'psN'ws can be calculated. An 51 value of approxi-
m<1tely 1 indicates a local choke point or the occurrence of flow 
limitation (7;34;37). For each intra bronchial PS probe position, 
the PS probe derived results of each parameter were averaged 
within each 20% FVC volume range (100%-80%, 79%-60%, 
59%-40%, 39%-20% FVC) as described by Brackel et a!. (5). 
In the following text MFSR derived variables are specified with 
the suffix '111' and PS probe derived variables with 'p'. 
We assumed that the expiratory flow during the MF5R measure-
Figure 1 
Bronchial tree with 
Pitot st<ltic probe posi-
tions 
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ments represents the maximal attainable flow determined by a 
flow limiting segment (FLS) occurring somewhere in the airways. 
Therefore, the MFSR derived variables were compared only with 
the corresponding PS probe derived Ap, Caw p and sCaw select-
ed for the condition 0.8 < 51 < 1.2, indicating a local choke point 
or flow limitation. The MFSR and PS probe measurements were 
supposed to match at TLC level. With regard to each variable, 
the average of all selected P5 probe derived results within each of 
the four 20% FVC volume ranges was compared with the aver-
age of the MFSR derived results within a TLC range correspon-
ding with the 20% FVC range within each group of subjects. 
STATISTICS 
The lung function characteristics were compared between asth-
matics and healthy subjects using two paired T-tests. A p value < 
0.05 was considered to be significant. 
The (from the MFSR relation derived) k and PUll", , Am ' Caw m 
and sCawm values between 80% - 400/0 TLC were compared 
between healthy subjects and patients with asthma using a mixed 
model of analysis of variance with random coefficients to analyze 
the relation of these variables with TLC. We started with a full 
quadratic model permitting differences between healthy and 
asthmatic subjects: 
Predicted variable~ 
Po + pj.disease + P2o(TLC-60) + P3 o[(TLC-60)odisease] + 
P4o(TLC-60)2 + Pso[(TLC-60)odisease]2. 
The factor '60' was introduced as a reference of % TLC with 
respect to the middle of the range 80%-40% TLC for calculation 
simplicity; disease is disease status (1 ~ healthy and 0 ~ asthma). 
The model was reduced to a restricted 1110del excluding terms 
with non significant coefficients in a hierarchical way. A level of 
significance of p<O.l was used in this MF5R analysis. 
Within each subject, the (from the P5 probe derived) variables 
Ap, Ptmp' Cawp and sCawp within a volume range 1000/0-80%, 
79%-60%, 59%-40%, 39%-20% FVC were logarithmically 
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transformed and averaged. Statistical analysis and comparison 
between the healthy and asthmatic subjects were performed 
applying rmANOVA as described by Brackel et al. (5) 
The MFSR derived variables and the PS probe derived variables 
with 0.8 < 5I < 1.2 were compared within each group of subjects, 
using a Bland and Altman analysis (4) and a two paired T-Test 
with a p value < 0.05 considered to be significant. 
RESULTS 
Both groups were comparable with regard to age, height, TLC, 
RvrrLC and FEVIIFVC ratio. FVC, FEV] and PEF values were 
lower in the asthmatic subjects (Table 1). 
Table 2 gives the coefficients of the different predicted variables 
according to the most restricted model. The mean (+1- ] SD) 
MFSR curve for healthy and asthmatic subjects is given in Fig. 2. 
Predicted expiratory flow (V'm) per 2 % TLC level was, on aver-
Table 2 
Variable description according to the most restricted model of MFSR analysis for each variable: 
predicted variable = ~o + PI_disease + P2_(TlC.60) + P4_(TlC.60)2, 
Variable pQ PI P2 P4 
V'm 3.363294 
P 0.0001 
Pelm 0.261940 
p 0.0001 
K 0.569371 
P 0.0001 
Cawm 0.260341 
p 0.0001 
A", 1.361493 
P 0.0001 
sCawm 0.167449 
p 0.0001 
1.169439 
0.0068 
0340338 
0.0199 
0.124448 
0.0001 
0.025740 -0.0002546 
0.0001 0.0001 
0.013060 
0.0006 
0.004336 
0.0236 
0.041236 
0.0001 
-0.002609 
0.01 
V'm: mouth flow (lis), Pel: static recoil pressure (kPa), K: slope of the MFSR curve I/slkPa), Cal'ln: airway compliance 
(JA"ldPtm"" un1/kPa),A,,: {fOSS sectional area (unl), sCal'l",: specific airway compliance (Caw/A, 1Ma), suffix 'm': MFSR 
derived data, disease: disease status (healthy",1, asthma=O), p: p-value according to most restricted model. 
Subjects 
MFSR analysis 
135 
136 
Figure 2 
Mean MFSR CUf\'e in 
healthy and asthmatic 
subjects. 
The maximal flow static recoil curve 
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MFSR: Ma~imal Flow Slatic Recoil, Flow: mouth flow, Pel: Lung elastic rewil pressure, He: Tolallung Capadty" 
age, 1.17 lis higher in the healthy subjects and decreased linearly 
with decreasing lung volume. Predicted lung elastic recoil pres-
sure (Pel) was slightly, but not significantly lower in the asthmat-
ic subjects (Fig. 2) and showed a curvy linear relation with lung 
volume. The predicted slope k of the MFSR curve decreased lin-
early with decreasing volume and did not differ significantly 
between the healthy and asthmatic subjects. Figure 3a, 3b and 3c 
give the mean +/- lsd of the measured Cawm, Am and sCaw m ver-
sus % TLC levels in each group of subjects. Cawm and Am 
decreased significantly and sCaw m increased slightly although 
significantly with decreasing lung volume in both the healthy and 
the asthmatic subjects. Airway compliance Cawm was slightly 
but not significantly lower per 2 % TLC level in the asthmatics. 
Am was, on average, 0.34 C1112 higher in the healthy subjects. 
sCawm differed not significantly between both groups. 
In 7 out of 14 healthy subjects and 2 out of 10 asthmatics the 
MFSR curve showed one or two 'knees' in the shape of the curve. 
Not in all subjects the whole MFSR curve and/or the An/Ptmm 
Cllrve could be covered with one or more fits with an R2 > 0.990, 
causing missing data at one or more of the 2 % TLC levels in 
some subjects. All An/Ptmm curves were concave to the Ptmm 
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Figure 3a 
J\·1e;1.n MFSR derived 
ain"ay compliance 
(Caw) versus lung 
yolume 
Figure 3b 
Mean MFSR derived 
airway cross sectional 
area (A) "ersus lung 
"olume 
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Figure 3c 
Mean MFSR derived 
specific ainyay 
compliance (seaw) 
versus lung volume 
Pi tot static probe 
dApldPtmpstudy 
Figure 4a 
MFSR derived AJPtm 
curves in individual 
healthy subjects'. 
(80%-40% TLC) 
The maximal flow static recoil curve 
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sCaw: specific airway compliance (sCaw = Caw/A, lIkPa), TLC: Total lung capacity, 
sd: standard deviation. V Ii.. : value range of corresponding V<lriable as measured ill 
l'il'D during Pitot static probe study. 
axis. In most of the healthy subjects and in only one of the asth-
matics the AmlPtmm curves had a composed appearance with an 
ascending and a descending branch with decreasing lung volume 
(Fig. 4). 
The results of the hI vivo PS probe Ineasurements are extensively 
described by Pedersen (32) and Brackel et a!. (5). Especially in 
the upstream part of the central airways significantly lower Caw p 
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A: cross sectional area (cml), Ptm: tmnsmnral pressure (kPa), TLC: Total lung capaci-
t}', h: healthy subject. 
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A: cross sectional area (cml), Ptm: transmural pressure (kPa), TLC: Total lung capaci-
ty, a: asthmatic subject. 
and sCawp values were found in the asthmatic subjects, indicat-
ing more stiffly central airway behavior during forced expiration. 
Ap and Cawp decreased with decreasing volume in contrast with 
sCaw p' The latter was not determined by volume. The range of 
mean Cawp ' Ap and sCawp values is given in figures 3a, 3b and 
3c. Choke points (indicating local flow limitation and defined as 
PS probe positions with 0.8< 5I d.2) were formed at all central 
airway positions in the healthy subjects and only at the most 
upstream PS probe position in the asthmatics (unpublished 
results) (Chapter 5). 
Fig. Sa, 5b and 5c represent Bland and Altman plots in which 
Caw m' Am and sCaw m are compared with the directly measured 
P5 probe results under the condition 0.8 < SI d.2. Mean Cawm 
did not differ significantly from Caw p' However, the precision 
(±1.96 standard deviation) of the comparison was low, although 
the random variations increased with the magnitude of Caw, 
indicating a more stable variation coefficient of the differences. 
No significant correlation between bias and magnitude of Caw 
was present. Ap values were over the whole volume range smaller 
then the Am values; the difference increased significantly with 
increasing A (p< 0.001) (Fig. 5b). A significant bias was present, 
Figure 4b 
MFSR derived AlPtlll 
curves in individual 
asthmatic subjects. 
(80%-40% TLC) 
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Figure 5<1 
!o.1FSR and Pitot static 
probe derived airway 
compliance (Caw), 
Bland-Altman plot. 
Figure Sb 
MFSR and Pitot static 
probe derived airway 
cross sectional area 
(A), Bland-Altman 
plot. 
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causing Ap to be on average -1.05 (SD 0,75) cm2 lower than Am 
(p < 0,001), The lower Ap values caused sCaw p to be significant-
ly larger then sCawm (p< 0.001). The difference was on average 
0.21 llkPa (SD 0.29) and increased significantly with increasing 
sCaw (p< 0.001) (Fig. 5c). No clear difference in behavior of the 
different variables was found between the healthy volunteers and 
the patients with asthma. The low precision visible in Fig. Sa and 
5c becomes also apparent from the absence of a significant corre-
lation between Cawm and Cawp or between sCawm and sCawp' 
Am correlated, however, with Ap in the group of healthy subjects; 
regression analysis yielded the equation Am = 0.33+1.90.Ap 
(R2=0.51, p< 0.001). 
DISCUSSION 
The purpose of the current study was firstly to compare MFSR 
derived elastic airway properties between healthy and asthmatic 
subjects. Secondly, to evaluate whether airway compliance as 
derivative of the MFSR curve can be used as an alternative of ill 
vivo Ineasurements. 
Figure Sc 
l\:fFSR and Pirot static 
probe dedyed specific 
airway compliance 
(seaw), Bland-
Altman plot . 
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The results indicate that Cawm, as derivative of the MFSR curve, 
does not differ between healthy young adults and subjects with 
stable mild asthma. This is in contrast with the PS probe derived 
Caw p results. However, the accuracy and meaning of MFSR 
derived variables is questionable as the exact location of FLS is 
not defined and may differ between both groups and large ran-
dom errors are present. Although mean Caw showed no appre-
ciable difference, a considerable difference existed between both 
types of measurements with regard to A and sCaw. The MFSR 
data appeared to be most reliable near peak expiratory flow 
where flow limitation may be expected to occur in the central 
airways, where the PS probe measurements were performed. It 
may therefore be concluded that the intra bronchial measurement 
of central airway compliance can not be replaced by a less inva-
sive and a less complex deduction of airway compliance from 
MFSR curves. 
The complexity of the invasive and the time consuming nature of 
the PS probe experiments hampered the inclusion of more volnn-
teers. Therefore, a complete match between the two groups of sub-
jects could not be obtained (Table 1). However, no significant dif-
ferences in FEVIIFVC as measure for airway patency or in TLC 
were found. The invasive nature of the intra bronchial PS probe 
part of study obliged us to select patients with only mild to moder-
ate asthma. This mal' explain partly that we found no significant 
differences in Cawm or sCawm between the two groups, in contrast 
with the lower Cawp and sCawp in the patients with asthma (5). 
Oniy the asthmatic subjects were pretreated with a p-2-agonist and 
systemic corticosteroids. A lower tone of bronchial smooth muscle, 
may have caused artificially more compliant airways in the astmat-
ic subjects (29;30). Therefore Caw m results may have been lower 
and the difference in Cawp and sCawp may have been even larger 
prior to bronchodilation. 
For a discussion about the technical aspects of the PS probe study 
and their limitations we refer to reiated papers by Pedersen et al. in 
dogs (37) and Pedersen et al. (32) and Brackel et al. (5). The MFSR 
analysis is based on a mono-alveolar, mono-airway-model, which 
is supposed to generate and maximize flow in the same way as the 
in vivo lung, with the flow limiting segments placed in series in the 
bronchial tree. Several issues will therefore be addressed. 
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Applying the model to the real ill vivo situation does not take 
into account the effects of uneven ventilation of different lung 
units. For normal lungs this is probably justified (36) as the lungs 
behave in a more homogeneous fashion during fast expirations 
(25). \Ve tried to minimize the possible limitations in the asth-
matic subjects by maximal bronchodilation and reduction of air-
way inflammation and by limiting the analysis to high mid lung 
volumes where the problem of uneven ventilation will be less. 
In both groups, Pel values per 2 % TLC level were, on average, 
lower than the scarcely available normal values (9;46). This may 
be explained by a larger volume of air in the esophageal balloon 
(1.5 ml instead of 0.5 ml), necessary because the PS probe meas-
urements were performed during forced expiratorr maneuvers as 
well. A larger balloon volume causes a shift of the static PV cmve 
to smaller elastic recoil values although the shape of the PV 
cmves is not changed. Although not significant, values of elastic 
recoil pressure were somewhat smaller in the asthmatic subjects 
without a difference in lung compliance (Fig.2, Table 2). Lower 
Pel values in the asthmatics are in agreement with findings by 
McCarthy et al. (22), Colebatch et al. (6) and Finucane et 31. (11) 
and involve probably tissue stress relaxation (11). A lower Pel 
will lead to a leftward shift of the MFSR curve without a change 
in MFSR slope (Fig. 2). A decrease in Pel will lead to a lower 
expiratory flow and upstream shift of the Equal Pressure Point 
and possibly of the FLS. A lower expiratory flow may partly 
explain the significantly lower calculated A (equation 'j' in the 
appendix) in the asthmatic subjects (Table 2). A potential shift of 
FLS in the patients with asthma to upstream airway segments 
with different characteristics may therefore complicate the inter-
pretation of the Cawm ' Am ' and sCawm results. 
In contrast to the MEFV cmves, lung elastic recoil pressure (Pel) 
was measured in a quasi static situation. MFSR curves only rep~ 
resent the dynamic conditions when static lung recoil pressure 
(Pel) can be considered equal to dynamic lung recoil pressure. 
This is the case only if lung tissue resistance is small, and there is 
no inequality of ventilation (31). Results of a study on excised 
dog lobes (45) and re-evaluation of a study by Bar-Yishay and 
Wilson (3) by Webster et al. (45) indeed indicated that recoil of 
the lung during forced expiration is adequately modeled by the 
quasi static PeW relationship. 
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Compression of intrathoracic air during forced expiration causes 
a discrepancy between flow volume curves, based on either 
intrathoracic volume or on volume changes from the integration 
of airflow (16). From recordings of alveolar pressure (Palv), pre-
sented in an earlier paper (32), it can be concluded that in the 
largest range of analysis (80%-40% FVC), no significant changes 
in Pall' occur. dV'max/dPel values are, therefore, probably not 
appreciably influenced by differences in compression of air in the 
largest range of analysis (80-40% FVC). 
During the !vlFSR experiments, we were not informed about the 
actual intrathoracic pressures in the healthy subjects and the 
patients with asthma, but had no reason to believe that the two 
groups differed in this aspect. MFSR derived Ptmm values per 
2 % TLC level were comparable between both groups. Moreover, 
we found no large differences between the groups in airway 
patency or in TLC. 
We had no actual control of possibly less then maximal expirato-
ry flows or the occurrence of negative effort dependence (12;24). 
Therefore, we used a composite MEFV curve according to the 
envelope method by Peslin (38) in order to obtain the most maxi-
mal expiratory flow at each volume level for each subject. 
Although relatively more asthmatic male subjects participated 
and anthropometric data and TLC were comparable between 
both groups, V'maxm was on average 1.17 lis per 2 % TLC level 
lower in the subjects with asthma (table 2) and predicted Am was 
on average 0.34 cm2 lower in the subjects with asthma. As Am is 
calculated from V'maxm, the lower V'maxm explains the lower 
Am value. 
Although, as already stated, the lower Pel may cause an upstream 
shift of the FLS, lower V'm andlor Am results may indicate that 
some (irreversible?) airway obstruction still existed in the asth-
matics, despite pretreatment with bronchodilation and corticos-
teroids. The decrease in Am with decreasing lung volume was 
also found in the PS probe study (5) and is in agreement with the 
findings by Hoffstein and associates (13) and by Hughes and 
coworkers (14). At a fixed position in the airways, a decrease in 
A during forced expiration can be explained by dynamic com-
pression. However, A may also decrease directly related to vol-
ume, because of diminishment of axial tension or a decrease in 
tethering from surrounding lung tissue. 
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Am reflects, however, the total cross sectional area of the airways 
at the level of the FLS and one might expect the FLS to move 
upstream during expiration (18;36;41). According to the trumpet 
model of the bronchial tree an upstream shift of FLS would 
imply a shift to an airway level with a larger A and larger Caw. 
The finding of lower Am in combination with decreasing lung 
volume therefore suggests that the location of FLS remains more 
or less stable or that the volume effects are relatively stronger 
than that of an upstream shift of FLS. However, we do not know 
whether dynamic compression during forced expiration may 
result in a relative lower A of the more upstream located, more 
compliant airways. The MFSR analysis does not allow a clear 
separation between those effects. 
In contrast with the Cawp and the sCawp results in central aiI'M 
ways, Caw 01 and sCawm per 2 % TLC level showed no significant 
difference between healthy and asthmatic subjects. This is diffi-
cult to interpret because we are not informed about the exact 
intra bronchial location of the FLS in the MFSR study. The 
decrease of Cawm with decreasing lung volume (Fig. 3a, Table 2) 
agrees with a report by 5uki et a!. (44). They found that in calfs' 
tracheas, when length tension is reduced during exhalation, carti-
lage rings move towards each other and result in stiffer airways. 
However this decrease in Caw m is inconsistent with an important 
shift of the FLS to more peripheral, more compliant airways dur-
ing expiration. The slight, but significant increase in sCaw with 
decreasing lung volume (Fig. 3c, Table 2) suggests that the effect 
of a decrease in lung volume is stronger on A than on Caw. 
The MFSR-dAJdPtm analysis is only valid if A is determined only 
by Ptm and local airway compliance. When FLS is intrapul-
monary, dAJdPtm reflects the elastic properties of airways 
attached to lung parenchyma, instead of the elastic properties of 
the airways alone. Studies in intact dogs (17;27;42), by Macklem 
in human subjects (20;21) and in excised dog and human lungs 
(15;26;41), show the formation of the FLS in the central airways. 
During forced expiration from TLC, the FLS moves upstream to 
the lobar and segmental bronchi. Smaldone (43) studied the loca-
tion of FLS near residual volume in humans: FLS moved 
upstream during expiration but was found in the central airways 
in all subjects, even at RV. At a constant volume multiple FLS 
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could be located, all in parallel bronchi. When we extend the 
findings by Smaldone to our study and limit our analysis to the 
volume range 80-40% TLC, the FLS is probably located at com-
parable positions in the central airways in the group of asthmatic 
as well as in the healthy subjects. This assumption is supported 
by the Cawm and Am results described above and by the PS probe 
results as well: choke points, defined as locations with 
0.8<Sk1.2 occurred in the central airways in the healthy subjects 
and at the lower lobe in the asthmatic patients. However, the PS 
probe results do not exclude the possibility that wave speed is 
also reached in more peripheral airways that could not be 
reached by the PS probe. 
In the calculations used, it is assumed that the intra bronchial air 
velocity profile is blunt. For reasons stated above, we felt justi-
fied to assume that FLS was located in the central airways in the 
volume range studied. Experiments in dogs show that converging 
airflow with a high Reynolds number is found at the choke point 
in dogs' trachea's (10). Pedersen showed the same in experiments 
using a mechanical model (34). 
The most important assumption in the MFSR analysis is that the 
pressure loss due to friction (pfr) is neglected in the calculations 
of dAJdPtm. No significant differences between the healthy and 
asthmatic subjects were found in the slope k of the MFSR curve 
(Table 2). This suggests that the airway conductance upstream 
from the FLS, and therefore the viscosity dependent pressure 
losses in the periphery of the lung, are comparable in both 
groups, according to the model by Leaver and coworkers (19). 
Therefore comparison of MFSR derived variables between the 
two groups seems justified. The decrease of k with decrease in 
volume (Table 2) is in agreement with an increase in airway 
resistance with decreasing volume. 
Neglect of Pfr in the calculation may lead to underestimation of 
Am' Ptmm may be an overestimate of the true Ptm and the air~ 
ways may seem to be stiffer than they actually are (35). 
Therefore, negligence of pfr may (partially) explain the poor 
agreement of Am and Cawm with Ap and Cawp respectively. 
The MFSR derived AJPtm relationship describes theoretically the 
compliance of a composite airway (with no frictional pressure 
losses) that would give the same maximal flow as observed on 
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the MFSR curve. Studies in a model (35) support the question, 
whether AlPtm curves 'contained' in the derived AlPtln curvets), 
really exist. Another study in dogs (37) showed that the meas-
ured AlPtln curve did not differ from the MFSR derived AlPtm 
curve at the level of the right lower lobe bronchus of a dogs' 
lung. The question remains whether this is also true in human 
subjects. 
The peripheral pressure loss may be divided into viscosity 
dependent and density dependent pressure losses. Pedersen and 
Nielsen showed that MFSR derived AlPtm curves on air and on 
an SFi02 mixture (higher density, lower viscosity) were identical 
(36). Since a decrease in the viscosity lower than air made no dif-
ference with regard to the measurement of A, this indicated that 
viscosity dependent pressure loss was minimal. Furthermore, 
maximal flows on air and on the SF 61°2 mixture, were identical 
after correction for density (33) in healthy young subjects 
(Pedersen, unpublished results). Since density dependent pressure 
losses can not be detected this way, we do not know whether 
these playa significant role. 
By use of the flow at the PS probe (V'ps), we constructed 'PS 
probe' derived V'pslPel curves (as an equivalent of an MFSR 
curve) in five healthy subjects. In each subject, the ill vivo meas-
ured V'pslPel curves were compared with the V' psi] curve (J ~ 
Pel-PEr) and the V'pslPeI derived AlPtm curve with the actual 
measured AlPtm curves at different PS probe positions in the cen-
tral airways (example: Fig. 6a, 6b). The horizontal difference be-
tween the V'pslPeI curve and the V'psl] curves reflects the fric-
tional pressure loss Pfr upstream from the PS probe. Most of the 
V'psl] curves were rather close to the V'pslPel curves near peak 
expiratory flow, where flow is limited in most subjects (32). With 
the PS probe in more upstream positions and at decreasing flows, 
the curves deviated more from the V'ps/Pel curve, indicating an 
increase of pfr. (O.P. Pedersen, personal communication). These 
ill vivo results indicate that, only at peakflow, MFSR derived air-
way parameters reflect central airway characteristics correctly. 
Most MFSR derived NPtm curves in the healthy su bjects showed 
a similar appearance. They consisted of two 'legs' (both concave 
to the Ptm axis): one, beginning at the left and ascending along 
the upper side of the angle towards a top and a second with a 
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Figure 6a 
V'ps/Pel and V'ps/J 
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static probe 
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Figure 6b 
Pitot static probe 
derived AlPtm cucYes 
compared with the 
AlPtm CUCYC deriyed 
from the V'psfPe[ 
curyc during Pitot 
static probe 
experiment. 
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descending branch to the left along the lower side of the angle 
(Fig. 4a). This pattern resembled the AJPUll curves derived from 
the above described V'ps/Pel curves (example: Fig. 6b) and 
agreed with findings in model and human studies by Pedersen 
(36),(35). The pattern can be explained by an upstream motion 
(or jump) of the FLS from one part of an airway segment or 
bronchial generation to another segment or generation with difN 
ferent elastic behavior (36). Flow limitation starts at the upper 
leg. During expiration the movement along the AJPtm curve is 
upward and right, reaching the apex and then down along the 
right leg. In the V'pslPel derived AlPtm curves (example Fig. 6b), 
the ascending leg, corresponding to the very early phase of flow 
limitation was in many subjects close to the actually measured 
AIPtm relationship of the central airways. In some subjects the 
descending leg was almost identical to the PS probe determined 
AlPtm curve for the most upstream PS probe position. This sug-
gests that the two legs of the MFSR derived fVPtm curve reflect 
flow limitation beginning in the most central airways (ascending 
AlPtm leg) and later in more upstream airways (descending leg) 
as described earlier by Pedersen (35;36). In the current study only 
one asthmatic showed a 'two legged' AJPtm curve, the others had 
only a descending AlPtm curve (Fig. 4b), indicating a more 
upstream located FLS. These findings support that the MFSR 
derived AlPtm curve indeed contains 'true' NPtm curves related 
to the compliance of the segments of the bronchial tree. 
A large part of the PS probe results was obtained at a PS probe 
position andlor within a volume range where no flow limitation 
took place. The MFSR derived Am ' Caw m and sCaw m results 
were supposed to reflect the elastic properties at the FLS wherev-
er this is located. Therefore we compared only the Ap ' Cawp and 
sCaw p results, selected for the (choke point') condition 0.8< 
S1<1.2, with the equivalent MFSR variables. Although the range 
of Cawp and sCawp values (5) was comparable with the corre-
sponding MFSR derived results (Fig. 3a, 3c), there was no within 
subjects correlation in the two groups of subjects (Figure Sa, 5b 
and 5c). This discrepancy between the actually measured values 
and the large random fluctuations may be explained by the PS 
probe itself. The subjects were hampered by the PS probe and 
showed sometimes inability to breathe in or breathe out com-
Comparison of 
actual 
measurements 
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pletely and lor showed inadequate force during the PS probe 
experiments in spite of maxitnal encouragement. Therefore 
matching of the MFSR and PS probe measurements may not 
have been totally accurate. More important, all PS probe derived 
results were obtained in the central airways whereas a large part 
of the MFSR derived results probably reflect characteristics of 
more upstream located airways. The latter explanation may be 
supported by the finding of a significant larger MFSR derived Am 
(Fig. 5b) since in both studies the measured A reflects the total 
functional cross sectional area of all airways at the level of meas-
urement in the bronchial tree. 
The PS probe results indicate stiffer central airway behavior dur-
ing forced expiration in the asthmatic subjects, as described by 
Brackel et al. (5). The MFSR derived AlPtln curves suggest that 
airway stiffness at FLS (located in more peripheral airways?) is 
not different between the healthy and asthmatic subjects. We are, 
however, not informed whether the intl'abronchial location of 
FLS in the healthy and in the asthmatic subjects can be com-
pared. 
In conclusion Under certain assumptions, deduction of the NPtm relationship 
from the MFSR curve according to the wave speed concept may 
yield airway characteristics at the site where and when flow is 
limited during forced expiration. This is probably mainly the 
case near peak expiratory flow where the FLS is located most 
do\vnstream and where frictional losses are minimal. Appearance 
of the MFSR derived AlPtm curves reflected jumps of the FLS 
between airway segments like the PS probe results suggested. 
Both methods showed that Caw and A decrease with decreasing 
lung and that sCaw is relatively volume independent. The 
absence of knowledge about the exact location of the FLS and 
negligence of frictional losses ma y explain why the MFSR analy-
sis is not sensitive enough to reflect changes in airway compli-
ance demonstrated with an intra bronchially placed Pitot static 
probe, in patients with mild to moderate asthma. 
The current study suggests firstly that MFSR curve derived vari-
ables are related to flowlimiting airway segments located 
upstream from the lower lobe bronchus, being the most upstream 
bronchus reached by the Pitot static probe. Secondly, that the site 
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of flow limitation remains rather stable during forced expiration 
in healthy as well as in asthmatic subjects. Furthermore: MFSR 
derived elastic properties are not sensitive enough to reflect 
changes in airway compliance, demonstrated with an intra-
bronchially placed Pitot static probe, in patients with mild to 
llloderate asthma. 
APPENDIX 
Mathematical relation betweell dV'maxldJ and dAldPtm, A and 
Ptm 
Under the assumptions: 
flow is incompressible and has a blunt profile 
airway cross sectional area A depends only on transmural pressure 
Ptrn (Ad(Ptm) the following mathematics can be derived: 
(Bernoulli equation, p: density) (a) 
J = Pel - PEl' (b) 
Ptm + (-Pel) + PEl' + Pca = 0 (Pressure walk by Mead (23)) (c) 
equation (a),(b) and (c) ==> 
(d) 
solving equation (d) for V' ==> 
V' = Ao[(2/p)o(J-Ptm)JO.5 (e) 
If A is a unique function of PUn (A = f(Ptm) (tubelaw)), flow V' 
becomes a function of Ptm at each value of J (V' = g(Ptm)) and 
can be described by an iso J-V' -Ptm curve. 
FroIll equation (e) follows (34): 
dV'!dPtm = (dAldPtm)o[(2/p)o(J-Ptm)j°·5 
+ Y,oAo(-2/p)o[(2/p)(J-Ptm)rO.5 (f) 
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At a maximal value of V' (V'max) along the V'-isoJ-curve: 
dV'ldPtm = O. Therefore: 
(dAldPtm)o[(2/p)o(J-Ptm)]O.5 - (Alp)o[(2/p)o(J-Ptm)]-O.5 = 0 ==> 
(dAldPtm)o(2/p)o(J-Ptm) = Alp (g) 
equation (a), (c) and (g), and neglecting Pfr ==> 
and (h) 
V'max = Ao[(Alp)o(dPtmldA)]O.5 (i) 
If A", PtmO and J" are the values at the flow limiting segment 
related to maximal flow we get from (e): 
V'max = AOo[(2/p)o(J"-PtmO)]O.5 
Differentiation with respect to J" ((34)): 
dV'maxldJ" = (A"/p)o[(2/p)o(J"-PtmO)]-O.5 
Substituting J"-PtIno = Pcao = Y,opo(V'max/A")2 ==> 
dV'maxldJO =Ao2 I (po V'max) 
Solved for AO ==> 
A ° = [(po V'max)o(dV'maxldJ")]O.5 (j) 
A 0 can therefore be calculated from V'max and the slope of the 
V'max-J curve at the corresponding V'max point. PtmO can be 
calculated from (d) and the calculated AO value. 
If PEr is small, J resembles Pel (equation (b)). The Maximal Flow 
Static Recoil curve (MFSR curve), which approximates the 
V'max/Pel curve, can then be used to calculate AO. 1>t111° and air-
way compliance dA o/dPtmO at the Flow Limiting Segment which 
determines V'max. 
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Combining equations (i) and (j) links the V'maxlJ and the AIPtm 
curve: 
(llV'max).(dV'maxld]") = (1/N).(dNldPtmO) 
both sides multiplied with V'max gives: 
dV'maxldJO = (V'maxlAO).(dAOldPtmO) (k) 
Equation (k) states that the slope of the V'max-J curve (or at 
small Nt', the lvlFSR curve) can be represented by airway compli-
ance (dNldPtmO) multiplied by the wave speed at the FLS 
(V'maxlAO). In other words the slope of the lvlFSR curve (Rs in 
the terminology of Pride et a!. (J.AppI.Physiol. 23: 646-662, 
1967)) and not the intercept with the Pel axis (Ptm', as described 
by Leaver (19)) is related to airway compliance at FLS. Ptrn' is an 
extrapolated PUn value, indicating the transmural pressure at 
which the last airway closes during expiration. 
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ABSTRACT 
The purpose of this study was to examine whether peak expira-
tory flow is determined by the wave speed flow limiting mecha-
nism. \Y/e examined 17 healthy subjects and 11 subjects with sta-
ble asthma, the latter treated with inhaled bronchodilators and 
corticosteroids. We used an esophageal balloon and a Pitot static 
probe positioned at five locations between the right lower lobe 
and mid trachea to obtain dynamic area transmural pressure (A-
Pun) curves as described (O.P. Pedersen, B.Thiessen, and S. 
Lyager j.App/.Physio/. 52: 357-369,1982). From these curves we 
obtained cross sectional area (A) and airway compliance (Caw ~ 
dAJdPtm) at PEF, calculated flow at wave speed {V'ws ~ 
A[AJ(Cawop)]O.5, where p is density}, and speed index is (SI ~ 
V'N'ws). In 13 of 15 healthy and in 4 of 10 asthmatic subjects, 
who could produce satisfactory curves, SI at PEF was> 0.9 at 
one or more measured positions. Alveolar pressure continued to 
increase after PEF was achieved, suggesting flow limitation some-
where in the airway in all of these subjects. We conclude that 
wave speed is reached in central airways at PEF in most subjects, 
but it cannot be excluded that wave speed is also reached in more 
peripheral airways. 
INTRODUCTION 
Peak expiratory flow is defined as the highest flow achieved at 
the mouth during a maximally forced vital capacity (FVC) 
maneuver, starting at full inspiration (1;19). 
As first pointed out by Fry et a!. (6), there is a unique relation-
ship among transpulmonary pressure, expiratory flow, and lung 
volume so that, during a forced expiration, flow reaches a maxi-
mal value before pressure does. \Vhen flow has become maximal, 
that is, when flow at a given lung volume does not increase fur-
ther when pressure increases, the expiratory flo,v has been 
defined as 'effort independent'. 
Hyatt et a!. (9) initially estimated the effort independent part of 
the maximum expiratory flow volume curve to begin at ~ 50% 
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of vital capacity (VC). This estimate was later increased to 60% 
(8). Mead et al. (15) demonstrated levels of 70 % VC or higher 
in five normal subjects. Van de \Voestijne and Zapletal (27), 
requiring at least five points to define a plateau after a maximum 
on an isovolume pressure flow curve, found that the effort inde-
pendent portion extended to 82% and that PEF was found at 
88% VC in the examined subjects. This indicates that PEF may 
indeed be obtained at neal' flow limiting conditions. This is sup-
ported by Volta et al (25), who applied a negative pressure pulse 
at the mouth and found no change in PEF in nine normal sub-
jects applying maximal efforts. A different approach can be made 
by applying the analysis by Dawson and Elliott (4). This 
approach shows that flow (V') through an airway segment 
becomes maximal when the linear velocity reaches the speed of a 
pressurewave propagation through the airway. \Vavespeed flow 
(V'ws) depends on the cross sectional area (A), airway compli-
ance (Caw = dNdPtm), which is the slope of the curve describing 
A as a function of distending transmural pressure (Ptm), and the 
density (p) of the gas, to the equation: 
V'ws = A [N(poCaw)JO.5 
It can be seen that V'ws will decrease, when A becomes smaller, 
and Caw and p become larger. V'ws indirectly depends on the 
lung elastic recoil pressure (Pel) and the pressure loss (pfr) 
upstream from the flowdetermining segment, which Dawson and 
Elliott (4) called the 'choke point', because a decreased pressure 
head (J = Pel - pfr) will make the distending pressure (Ptrn) small-
er and, accordingly, make A smaller. 
If PEF is limited by the wave speed, then it should occur when 
the velocity of the accelerating flow reaches wave speed at some 
point in the airway. At that point, the speed index (51 = V'N'ws) 
will be equal to one. 
As described in studies in dogs (16), V'ws can be measured at dif-
ferent locations in the airways from data obtained with a Pitot 
static probe, an esophageal balloon, and expiratory flow. 
The purpose of the present study was to measure 51 during FVC 
maneuvers at different locations in the airway of healthy and sta-
ble asthmatic subjects to obtain support for the hypothesis that 
PEF is determined by the wave speed flow limiting mechanism. 
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MATERIALS AND METHODS 
Subjects The experiments were performed in 28 adults, 17 healthy and 11 
with asthma. All subjects were non-smokers and none had a his-
tory of cardiovascular or other diseases apart from asthma in the 
group of patients. Three of the healthy subjects were examined in 
1979 but were included in the present study because they were 
measured according to the same principles and with use of the 
same equipment with recording on tape. All healthy subjects had 
routine lung function results within the normal range and, except 
for the three subjects examined on the previous occasion, their 
response to inhalation of 1 mg of terbutaline was examined and 
showed no significant change from baseline. All the asthmatic 
subjects had asthma before the age of 5 yr and used maintenance 
treatment with inhaled corticosteroids for at least 3 yr. They had 
previously demonstrated bronchial hyperresponsiveness with a 
20% fall from baseline forced expiratory volume in 1 s (FEVl) 
after inhalation of <160 flg histamine and were atopic, defined as 
a total immunoglobulin E antibody concentration of > 100 lU 
and a positive radio allergosorbent test for at least one inhaled 
allergen (in most cases, the house dust mite). All patients with 
asthma were in a stable period. If an asthma exacerbation had 
occurred within 1 rna before scheduled measurements, the exper-
iments were postponed for at least 2 wk. In an attempt to mini-
mize bronchial obstruction because of edema or hypersecretion 
at the time of measurements, all asthn1atic subjects were pretreat-
ed with a 7 day course of prednisolone in addition to their regu-
lar treatment. Within 1.5 h before introduction of the intra-
bronchial Pitot static probe, all asthmatic subjects inhaled a dose 
of ~-2 agonist, which resulted in maximal bronchodilatation dur-
ing a doseresponse curve obtained 1 wk before the prednisolone 
course. 
Equipment A Pitot static probe, as previously described (16), was used, 
slightly modified from the one described by Macklem and Mead 
(13). It is a device with an end hole for measurement of 
impaction pressure (Ptot) and a number of side holes for meas-
urement of lateral airway pressure (Plat). It was provided with 
two 1.57 mm internal diameter Polystan tubes that were 100 em 
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long. These tubes and an identical tube from an esophageal bal-
loon [for measurement of the pleural pressure equivalent (Ppl)] 
were connected to three identical pressure transducers (EMT34, 
Elema Schiinander, Stockholm, Sweden) and via EMT 311 ampli-
fiers to an electronic subtractor. Three pressure differences were 
obtained: Pca = Ptot - Plat, J = Ptot - Ppl, and Ptm = Plat - Ppl, 
where Pca is the pressure needed for convective acceleration, i.e., 
for acceleration of the gas molecules so that they can pass a given 
cross section of the airway at a given flow. J is a fluid mechanical 
term defined as the pressure head, and Ptm is the transmural 
pressure. The pressures were calibrated daily with a mercury 
manometer providing ± 10 kPa. 
Mouth flow (V'm) was measured by a non heated Fleisch no 3.5 
pnenmotachograph. The pressure drop across the flow head was 
measured with a Validyne MP45 transducer (Northridge, Cal fit-
ted with a 2- kPa diaphragm and connected to a Validyne ampli-
fier. Flow was calibrated by the integration procedure (23), intro-
ducing 9 liters of air through the flow head with a I-liter syringe. 
The amplification was adjusted so that the integrated flow signal 
provided the same output as an integrated 1-s pulse reference 
flow, which was then by definition 9 Us. The geometry of the 
inlet to the flow head was optimized so that the deviation from 
linearity was <5% up to 15 lis. 
V'm and the pressure signals, Pca, Ptm, and Ppl, were visible 
online on an AT computer (Olivetti PCS-286 with a 80287 math-
ematical coprocessor). In this way it was possible to assess the 
results directly. Especially, it was possible to detect malfunction-
ing of the Pitot static probe, as in case of obstruction of one or 
more of the holes. The signals of approved maneuvers were saved 
for subsequent calculations. 
The Pitot static probe and the esophageal balloon were enclosed 
in an airtight tube to which a sine pump could be attached and 
deliver pressure swings of =10 kPa. The three pressure differences 
were displayed on an oscilloscope. With the pump running at the 
slowest possible speed (~ 1 Hz), the amplifications were adjusted 
so that the differences between them were zero. Then, the speed 
of the pump was increased to its maximum (~ 8 Hz), and the 
resistance and length of the individual catheters were adjusted to 
minimize the excursions. In this way, the error in the pressure dif-
Tuning of 
catheters 
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Test of Pitot static 
probe 
Figure 1 
Tests with Pitot static 
probe in rigid tubes, 
cross sectional areas of 
which arc marked as 
solid lines. Area is 
me,lsnred as a function 
of pressure needed for 
convective accelemtion 
(Pca), Interrupted line 
for narrowest tube is 
area corrected for cross 
sectional area of probe 
(= 0.07 cm2; d. text), 
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ferences could be reduced to d % of the pressure swings. The 
900/0 rise time to a square wave pressure input was <10 ms. 
An x-), oscilloscope was finally used to tune the Pca pressure sig-
nal to the V'm signal. Via a Y-tube, the Pitot static probe was 
positioned in an (15-111m inner diameter rigid tube connected to 
the pneumotachograph. According to the Bernoulli equation, Pca 
equals p.(V'/A)2/2, were A is the cross sectional area. For a blunt 
flow profile and a constant A, Pca and V' must be in phase. The 
pneumotachograph was supplied with catheters identical to those 
of the Pitot static probe, and the length of these was adjusted 
until the x-y recording showed a closed loop as a response to a 
peak flow maneuver through the tube. 
Figure I shows results of testing the Pitot static probe for acceler-
ating and decelerating flows. Measured areas for different straight 
tubes are drawn against Pca. The true dimensions of the tubes are 
given at the corresponding horizontal lines. Because the probe 
measures the area around it, a slight but constant underestimation 
of the tube dimension is expected. This is important especially for 
the narrowest tube, where, in Fig.l, the dashed line is the true 
area minus 0.07 cm2, the area occupied by the probe. Except for 
the largest areas, the accuracy is in the range of ±to%. 
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Initial lung function tests were performed on a separate day 
before the Pitot study. These included measurements of FEV1, 
FVC, PEF, total lung capacity (TLC), and maximum expiratory 
flow volume curves. Furthermore, quasi static pressure volume 
curves were measured according to Zapletal et al. (28). The bal-
loon was introduced via one nostril to a position in the esopha-
gus where the pressure was most negative during nlaximal inspi-
ration. The balloon was filled with 1.5 ml of air and stayed ill 
situ throughout the experiment. 
On the day of the Pitot study the subject was premedicated with 
0.5 mg atropine intramuscularly 1 h before the introduction of 
the Pitot static probe to minimize mucous production and pre-
vent a vasovagal reaction. No sedatives were used. Local anes-
thesia was given as follows: mouth and pharynx, 10% Xylocaine 
or 4 % lidocaine spray; vocal cords, trachea and bronchial tree: 
0.50/0 novesine solution, 20 ml maximally, or lidocaine 1 %, 10 
ml maximally. Anesthesia was given on demand through the 
bronchoscope. A cuffless endotracheal (ET) tube was placed over 
the bronchoscope. After introduction of the bronchoscope into 
the trachea, the ET tube was passed between the vocal cords, and 
the bronchoscope was pulled back. The Pitot static probe with its 
two catheters was placed into the trachea through the ET tube, 
which was then removed. Subsequently, the bronchoscope was 
reintroduced and the Pitot static probe was placed at the most 
peripheral position (positioll 0), with the tip of the probe just 
above the entrance to the right lower lobe (the left lower lobe in 
one subject). After the position of the two catheters was checked, 
the Pitot static probe was pulled back until four other positions 
were reached. These were, respectively, middle lobe entrance, mid 
main stem bronchus, 1 cm above the main carina, and mid tra-
chea (Fig. 2). The distance between the positions was determined 
individually by measuring, at the mouth, the distance the catheter 
was pulled back between positions. Next, the Pitot static probe 
,vas repositioned in its most peripheral position, the broncho-
scope was carefully withdrawn, and the two catheters were 
pushed through and secured in tlVO tightly fitting side holes in 
the specially designed mouthpiece. Finally, the free ends of the 
catheters were connected to the pressure transducers, and the 
mouth piece was connected to the pneumotachograph. 
The subjects were measured while sitting upright in a chair and 
Experimental 
procedure 
165 
166 
Figure 2 
Bronchial tree with 
Pitot static probe posi-
tions 
Calculations 
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Position 4 
mid trachea 4 
wearing a noseclip. Before each measurement the two Pitot 
probe catheters were each flushed forcefully with at least 2 x 50 
ml of air to remove secretions from the end and side holes of the 
probe. Most of the subjects were asked to perform two types of 
forced expiratory maneuvers frol11 TLC to residual volume. One 
was an ordinary FVC maneuver, the other a 'huff' maneuver, 
with performance of a nU1uber of sequential peak flows without 
closing the vocal cords. Some of the healthy subjects were also 
asked to perform relaxed expirations from TLC (sighs). At each 
position, starting with the most peripheral, each procedure was 
repeated until acceptable results \vere obtained or a maximum of 
4 to 5 maneuvers was performed. 
The data acquisition and calculation applied Asyst software (ver-
sion 3.10, Asyst Software Technologies, Rochester, NY). From 
the inputs V'm, Pea, Ptlll and Ppl, the parameters in Table 1 were 
calculated at PEF of the maximunl expiratory maneuvers and for 
the first peak of the huff maneuvers. Caw was calculated as 
dAldt divided by dPtmldt by using a Asyst software routine 
applying a first order differentiation of a second degree polyno-
mial fitted to three points corresponding to the peak. 
The schematic drawing Fig. 3 may help explain some of the cal-
culated relationships. Eqllations 1 to 3 define the measured vari-
ables, which also included V'm. Eqllatiolls 4-15 define derived 
variables. A few of the equations can be commented on. 
Table 1. Parameter definitions and equations 
Definition Equation Equation 
{No.} 
Pressure for convective (/) Pca '" Ptot - plat 
acceleration 
Transmural pressure (2) Ptm = Plat - Ppl 
Transpulmonary pressure (3) Ptp", Pm - Ppl 
Alveolar pressure (4) Palv ::: Pel + Ppl 
Downstream pressure drop (5) Pd::: Ptm - PIp 
::: Plat - Pm 
Upstream pressure loss (6) Pff '" Palv - Ptot 
Pressure head (7) J = Ptot - Ppl 
= Pca + Plm 
::: Pel - PFr 
lateral pressure (8) Plat = Ptm + Ppl 
Gas density at probe (9) PPiat =PP6 (PB+ Pial)! PB 
Flow at probe (10) V'PI3\=V'm. Pe!{PB+Plat) 
Approximated thoracic gas (11) Vppl ::: (PBJvm.dt+ TLCoPpl)/(PB+ Ppl) 
volume change from TlC 
Airway cross sectional area (12) A ::: V' Plat (SOPPla/Pca)O.5 
AiflNay compliance (13) Caw = dAfdPtm 
Wave speed flow (14) V'ws::: A[lOMpPlat oCaw)) )0.5 
Speed index (15) SI ::: V'PlatN'ws = (2Pca.Caw/A )0_5 
Chapter 7 
Unit of 
Measure 
lP, 
lp, 
lp, 
kP, 
lP, 
lP, 
lP, 
lp, 
kglm3 
lis 
em' 
cm2/kPa 
lis 
Ptot, impaction pressure; Plat, lateral air.vay pressure; Ppl, pleural pressure; Pm, pressure at mouth; Pel, lung elastic recoil 
pressure; pPs, weighted d€f\sity of expired gas at 37"( by using BOjle's law; PH, barometric pressure;V'm, mouth flo,v;Vm, 
volume at mouth; Tl(, total lung capaoty, 
I 
~ V' Piol Pfr 
.Palv •• Probe Plal4PPca 
Pel 
Plm 
• Ppl 
Figure 3 
Pressures and pressure 
differences measured in 
ain-vi'}' (d. Table I). V': 
flow, Prot: impaction 
pressure, pfr: pressure 
loss (upstream), Pah': 
alveolar pressure, Plat: 
lateral airwa}' pressure, 
J: Pressure head, Ptm: 
transmuntl pressure) 
Ppl: pleural pressure, 
Pel: lung elastic recoil 
pressure, 
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In Eq.9, gas density at the probe PPR was calculated as the weight-
ed density at 37°C of expired gas from data presented by Radford 
(20) to be 1.13 kg/m3, by use of Boyle's law. In Eq. 10, flow at the 
probe was similarly calculated by use of Boyle's law. In Eq. 11, to 
correct for the effect of gas compression (10), especially in the 
matching of dynamic volumes with volumes measured quasi stati-
cally during determination of the static Pel, the expired volume 
from TLC was corrected for the influence of Ppl only. At PEF, this 
represents the largest part of alveolar pressure (Palv), which ideal-
ly should have been used in the correction. This correction was 
only done for positive Ppl. Equation 12 calculated A from the 
Bernoulli equation under the assumption of blunt velocity profile. 
Equatioll 15 was derived from Eqs.12 and 14. V'm was not cor-
rected to BTPS conditions, and no attempt was made to correct 
for the difference between the composition of air and the alveolar 
gas. That correction will introduce a small, but systematic, error 
considered to be of no significance in the present study. 
Selection criteria Curves with obvious errors (evidence of blocked holes in or 
wedging of the Pitot static probe) were not saved. In the unselect-
ed data, there was a considerable variation in Caw with many 
negative values that cannot be used in calculation of SI (Eq.15 in 
Table 1). This scatter was considerably decreased only if values 
of Caw for Pca > 1.3 kPa were selected, but negative values of 
Caw were still found. We therefore excluded curves with extreme 
values of (Caw <-10 and Caw> 5 cm1 /(kPa) and with SI > 1.3, 
or rather SI2 > 1.69 that could be calculated also for negative val-
ues of Caw. (cf.Discusion). The criteria Pca > 1.3 kPa was not 
used for examination of the distributions of the variables (except 
Caw) within the airways. 
Statistics The maximum SI in the airway of a subject was determined by 
first choosing the curve with the highest PEF (or first huff peak) 
among repeated measurements (replications) with the same 
maneuver and at the same position of the probe, and next the 
highest 51 among positions was determined. Group means were 
compared by nonparametric tests . .Nlultival'iate analysis of vari-
ance and regression analysis were applied to provide estimates of 
differences between groups stratified for disease, gende,; and 
probe position. p < 0.05 was chosen as the significance level. 
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RESULTS 
Table 2 shows the anthropometric data for the Inen and woman 
in the two groups and the results of the initial spirometry. The 
predicted values of FEV], FVC, PEF, and TLC were calculated 
according to the European Community for Coal and Steel stan-
dard (18). There was no significant difference in age. In men, the 
\X1ilcoxon rank sum test showed that the percent predicted values 
of all four parameters were significantly smaller in those with 
asthma than in the healthy snbjects. In woman there was no snch 
difference. 
The healthy subjects, on average, performed 17 maneuvers 
(range 12-20). The corresponding number for the asthmatic sub-
jects was 27 (range 11-33). This indicates a greater difficulty in 
getting satisfactory curves in the latter, mostly because of cough-
ing by subjects and blocking of the holes of the Pitat static probe 
by secretions. 
Not all subjects performed maneuvers or produced reliable 
results with the probe at all five positions. In the following, posi-
tions means probe position if not used in other contexts. The 
average number of missing positions was the same in the healthy 
Initial spirometry 
Data selection 
analysis 
Table 2. Anthropometric data and initial spirometry of healthy and asthmatic subjects 
Group Age, Height FEV!. %pred fVC, %pFed PEF, %prl'd TlC, %pred 
yr m 
Healthy 
subjects 
M 2S.6±S.7 1.8S±O.08 111±12 113±7 113±16 108±13 
25,3±4.1 1.74±O.O5 106±14 108±9 108±13 104±9 
k;thmatic 
subjects 
M 20.6±3,3 1.84±O.O7 83±6 91±8 90±16 93±8 
25.3±3.6 1.6S±O.03 93±16 10S±2S 93±13 110±21 
values are means ± sd; n",9 and 8 healthy men and women and 7 and 4 asthmatic men and women, respectively. FEV1 ' forced expiratory 
volume in 1 s; fVC, forced vital capacity; PH, peak expiratory flow; TLC, total lung capacity; pred, predicted; M. male; F, female. 
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and asthmatic subjects (0.6, range 0-3). 
The average number of replications of pooled FVC and huff 
maneuvers for each subject at the same positions and satisfying 
the selection criteria was 2. I (range 1-6) in healthy subjects and 
4.7 (range 1-7) in the asthmatic subjects. This indicates that 
despite greater difficulties the asthmatic subjects provided more 
useful results than the healthy subjects. Analysis of the replica-
tions showed that within positions there was no difference 
between values obtained from huff vital capacity maneuvers and 
FVC maneuvers. The variation coefficient (SD/mean) was 0.26 
for 51 compared with only 0.08 for PEE The variation coefficient 
for 51 was not different for the two groups. 
Because of the selection criteria, -10 <Caw <5 cm2(kPa)-1 and 512 
d.69, 97.2% of the curves could be used. By use of the further 
requirement of Pca > 1.3 kPa, this figure was reduced to 4YYo in 
the healthy subjects and 47% in the asthmatic subjects. 
Figures 4-6 show examples of recordings of different types of 
expiratory maneuvers from a healthy subject with the Pitot static 
probe positioned in the lower part of the trachea. 
Figure 4 describes curves obtained during a maximum expiratory 
flow volume maneuver. In Fig 4A, flow at the Pitot static prohe 
(i.e. V'Pi.u), pressures, and 51 are plotted vs. VPpi, which is an 
approximation of the thoracic gas volume change (see 
Calculations). It can be seen that 51 is smaller than one (subcriti-
cal conditions) before PEF is reached and close to one at PEE 
After PEF, 51 apparently becomes >1 (supracritical conditions). 
In Fig.4 B, A at the probe is plotted vs. Ptm. Because this curve is 
slightly irregular, a fourth degree polynomial fit was a pplied for 
calculation of Caw, which is the slope of the curve, and this Caw 
was subsequently used in the calculation of 51, shown in Fig.4A, 
bottom. During expiration, Pun decreases (see Fig.4a,to{J) and A 
decreases. At the A-Pun curve, pEF is reached at the arrow (Fig 
4B). 
Fig 4 C shows that Palv continues to increase when PEF is 
reached, forming a closed loop for the entire expiration. 
Figure 5 shows a set of curves obtained during a submaximal 
expiration in the same subject with the same position of the Pitot 
static probe as in Fig. 4. The curve has no clear peak, lower flow 
than the maximal expiration, and 51 d during the upper 40-
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Figure .. 
~v[aximal effort £low volume 
maneuver in healthy O1,lle 
subjea (subject HK 1606). 
A: flow and pressures \'5. 
expired volume corrected 
for gas compression (top; cf. 
Table 1, Fig, 3) and Speed 
Index as a function of the 
same volume (bottom; d. 
text), Ptp: transpulmolliuy 
pressure, Pd: downstream 
pressure drop. B; on line ca[-
cuhtted cross sct.:tiuna[ area 
(A}-Ptm wrvc. Dashed 
wrvc, fitted 5th-degree 
polynomial; arrow: peak 
expimtorr flow. C: flow as a 
function of P,llv 
Figure 5 
Submaximal effort flow vol-
mue IIhHleUVer in same suh-
ject and with same IJitot 
static probe position as in 
Fig. 4. A-C arc defined as in 
Fig. 4. 
Figure 6 
1hximal effurt 'huff' 
flow volumc maneuyer 
in same subject with 
samc Pitot static probe 
position as in Fig. 4. I-
S: peaks, cun'e seg-
ments related to pe.tks 
1-5, ,Uld polrnomial 
fits corrcsponding to A-
Ptm Cllrve scgmcnts 1-5 
in A, B, llnd C, respec-
tively. A-C are defined 
as in Fig. 4. 
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Figure 7 1.2 
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50% of the FVC. At some point, howevel; 5I becomes unity, and 
the flow volume curve follows the course of the maximal curve, 
as seen by comparison with Fig. 4, indicating that flow limitation 
has now occurred at the given position. This happens at a lower 
Ptm and A, and at a lower Palv than in Fig. 4. The shape of the 
V'- Palv curve is different. After the maximum flow is reached, 
Palv and V' both decrease until 51 equals one (Fig. 5C, arrow). 
Then, Palv increases again with decreasing flow, just as was the 
case in Fig. 4 when 51 > 1. 
Figure 6 shows results from a huff flow volume maneuver of the 
same subject and the same position as in Figs. 4 and 5. There arc 
five peaks in the series of huffs. During each huff, SI increases 
abruptly and becomes unity near the peak. The curves in Fig. 6, 
Band C, show a clear volume dependence of both of the A-Ptm 
curves ,and the V'-Palv curves. 5irnilal' curves could be obtained 
from asthmatic subjects, but in these subjects, 51 in the trachea, 
especially at lower lung volumes, was generally smaller than in 
the healthy subjects. 
In Fig. 7, the maximum 51 among probe positions for each sub-
ject is plotted for the healthy and asthmatic subjects (one data 
point for each subject). Two healthy women (with 51 <0.6) and 
one asthmatic woman (with SI = 0.77) showed evidence of sub-
maximal effort, with pressure flow patterns as shown in Fig. 5. 
The)' could not produce Pca > 1.3 kPa and therefore their data 
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were not included in Fig. 7. The remaining subjects included 15 
healthy subjects (6 women and 9 men) and 10 asthmatic subjects 
(3 women and 7 men). Among the healthy subjects, 13 of 15 had 
51;:> 0.9, but the same was true for only 4 of 10 asthmatic sub-
jects ( p ~ 0.22, Fisher test). The distribution of maximum 51 
among probe positions was not different between healthy and 
asthmatic subjects, although only 3 of 15 healthy subjects com-
pared with 5 of 10 asthmatic subjects had maximum 51 peripher-
al to the trachea (I' ~ 0.13, Fisher test). 
Analysis of data from the two groups described in Fig. 7 is pre-
sented in Table 3. The only significant difference between the 
two groups was an apparently smaller SI in the asthmatic sub-
jects. A similar analysis (not shown), including values only from 
the most peripheral position (positiol1 0), showed no significant 
differences between the two groups. Five healthy subjects (1 
woman and 4 men) were compared with eight asthmatic subjects 
(3 women and 5 men). 
Because of missing data a lege artis multivariate analysis includ-
ing all subjects could not be performed. Therefore, we initially 
analyzed probe positions central to position 0 where a number of 
healthy subjects had no measurements, and we included only 
subjects with no missing data. This analysis showed that the few 
Table 3. Comparison of healthy and asthmatic subjects at probe position with largest 
measured 51 
Variable Healthy subjects Asthmatic subjects p·value· 
PEF, lIs 7,29±2,09 7.16±2.63 0.82 
Volume 10 PEF (I) 0.90±0.45 0.B4±0.27 0.78 
Palv, kPa 6,BO±2.61 7.26±2.22 0.37 
pel, kPa 1.01 ±0.36 0.B2:±0.18 0.13 
Ppl, kPa 5,80±2.74 6.44±2.24 0.35 
Pca, kPa'* 2.89±1.74 3.29±2.21 0.47 
J, kPa ·0,29±0.64 ·O.46±1.35 1.00 
Pfr, kPa 1.30±O.58 1.28±1.43 0.58 
Pd, kPa 2.61±3.04 2,68±2.47 0.14 
Acm2 1.15±0.49 1.03±O.40 0.62 
Ptm, kPa -3.18±2.09 -3.7S±2.37 0.51 
Caw, cm2/kPa 0.27±0.20 0.13±0.07 0.12 
II 0.98±0,09 O,84±0.12 0.01 
values are means ± sd; n = 15 healthy subjects (6 women and 9 men) and 10 asthmatic subjects (3 women and 7 men), 
(' Wilcoxon, nO~PJrametric test" Only curv~s \'lith Pca > 1.3 ~Pa entered analysiS. Two healthy and 1 asthmatic 
\~omalll'.'€fe e~duded for that reason. 
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Table 4. Multiple regression analysis including unselected data from 8 healthy and 6 asthmaUc 
subjects male with no missing data for position >0 
Parameter Constant Condition Positions 1-4 R' 
PEf; lis 8.63 -1.19 0 0.14 
Volume to PEF, liters 0.92 0 0 0 
Palv, kPa 5.80 1.40 0 0.14 
Pel, kPa 1.12 -0.28 0 0.14 
Ppl, kPa 4.68 1.68 0 0.17 
Pea, kPa 0.62 0 0.45 0.20 
J, kPa 0.65 -1.08 -0.26 0.28 
Pfr, kPa 0.50 0.80 0.25 0.22 
Pd, kPa 4.95 0 -0.70 0.16 
A,cm1 2.41 -0.36 ·0.21 0.18 
Plm, kPa 0.05 -1.14 ·0.71 0.30 
Caw·, cm1fkPa 0.16 0 0 0 
Condition: healthy'" 0, asthmatic", 1. Example: Pfr '" 0.50 + 0.8(} (condition) + 0.25 (position). Other parameters are 
simi!arly estimated, Zeros ind:cates no significant Influence. Data for position Oha~e been excluded .• 0011 ca!culated for 
Pea> l.3kPa. 
women behaved differently from the men. Consequently, we 
decided in a final analysis to compare only eight health)' men 
with six asthmatic men. In this analysis, variance homogeneity 
(Cochran's and Bartlett's tests) was present for all parameters 
examined, except Caw, which varied much more in the healthy 
than in the asthmatic subjects. The results, shown in Table 4, 
include statistically significant coefficients in a multiple linear 
regression analysis. The main findings are the following. There is 
a smaller PEF in asthma despite higher effort (Palv, Ppl). At a giv-
en position in the airway, Pfr in asthmatic subjects is larger and 
Ptm is smaller than in healthy subjects, and A is smaller. Caw 
seems to be uninfluenced by asthma and probe location. More 
central probe locations cause J, Ptm, A, and pd to decrease and 
Pfr and Pca to increase, as would be expected. It should be noted 
that the separate analysis of the 1110st peripheral probe position 
showed no difference between the groups. 
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DISCUSSION 
The purpose of the present study was to examine whether peak 
expiratory flow is determined by the wave speed flow limiting 
mechanism (4) and whether the mechanics of the forced expira-
tion differs between healthy and stable asthmatic subjects. For 
that purpose we used a method previously applied in dogs (16). 
We used a Pitot static probe as originally used by Macklem and 
Wilson in 1965 (14). As pointed out by these authors, this 
method is technically difficult, and therefore should be discussed. 
The crucial points are the measurements of Pca = Ptot - Plat with 
the Pitot static probe and Pun = Plat - Ppl by further use of the 
esophageal balloon. Fig. 2 shows that the aroa in stiff tubes could 
be measured reasonably well, even for small values of Pca. Areas 
> 2 cm2, however, may have been overestimated by 10 - 15 %. 
Abollt 18 % of the measured areas were> 2 cm2 and were most-
ly found in tall healthy men. The position of the probe should be 
axial in the airway. With the given design of the probe, we found 
in the previous study (16) that an angle up to 20° changed meas-
ured A < 10% in a single experiment. In that study we also found 
that, in a converging part of the airway, the area is measured 
rather accllrately but, because of separation of flow from the air-
way walls, the area in a diverging airway may be underestimated 
if the probe is in the middle of the lumen or overestimated if the 
probe is near the wall. In the present study we found decreasing 
areas when the probe was moved up in the trachea (Table 4), and 
therefore the measm:ements may be more accnrate than indicated 
in Fig.!. 
The measurements in the bronchial tree supply a 'functional' 
CfOSS sectional area related to the total cross section of the air-
way. It is assumed that all airways at the same level behave like 
the airway containing the probe. On the other hand, analysis of 
overall airway behavior is necessary for determination of the 
overall flow limitation. 
Nonhomogeneous emptying of the lungs will probably influence 
total How very little because as soon as flow limitation occurs in 
one airway, flow through the others will speed up (21). 
Consequently, SI may be large in one parallel airway and small in 
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another one. S1 determined by the present method is a weighted 
value that assuilles that all parallel airways behave similarly. In 
the present study, the asthmatic and the healthy subjects did not 
differ a great deal, and we believe that nonhomogeneous empty-
ing is of minor importance for the interpretation of the results of 
the bronchialmcasurements. 
Another factor that may influence the interpretation is that the 
probe will move towards the periphery during the expiration, 
when the airways shorten. This was examined by having the sub-
jects perform a slow vital capacity expiration with the broncho-
scope in a fixed position. The relative motion was less than the 
distance between two cartilage rings. \Virh the probe in a very 
peripheral position, Ptm includes trans parenchymal pressure, and 
we do not know the significance of this. In the present study all 
positions were extra pulmonary, but intrathoracic. Therefore, we 
believe that the measured Ptm reflects transmural pressure only. 
We believe that PEF is reached when 51 equals one for the first 
time somewhere in the airway, and we define the flow determin-
ing site as the most upstream point in the airway where this hap-
pens. In theory, 51 at PEF cannot be > 1 because at supra critical 
velocities (51) 1) flow becomes less than maximal (16) and hence 
less than flow at an 51 of one that necessarily must precede flow 
at 51 > 1. Later, during the expiration, the velocity may become 
snpracritical, but only downstrearu of the flow determining site. 
With this in mind, we found it justifiable to discard values of 51 > 
1.3 at PEF. 
Repeated measurements of the same subjects at the same posi-
tions showed a large variation of 51. However, the performance 
varied greatly between individual tests, which is only natural 
because of the inconvenience of the catheters. This is reflected in 
a large variability of Pca, Caw, and A, which are all determinants 
of 51 (Eq.15 in Table I). This was especially marked when Pca 
<1.3. Typical problems were coughing by subjects, mucus block-
ing the holes of the probe, and occasional wedging of the probe, 
especially at the most peripheral positions. Because Caw was 
determined as a quotient of two slopes, it is especially sensitive to 
noise in the measurement. As seen in Figs. 4-6, 5I changes rapidly 
near PEF, which means that small changes in flow around PEF 
are associated with large changes in 51. This is an additional 
Chapter 7 
source of variation. \'(1ith the given coefficient of variation, we 
estimated that a measured 51 > 0.9 would not be different from 
an SI of one. 
Despite the technical difficulties, the results in Figs. 4-6 clearly 
support the hypothesis that 51 at PEF in the central airways in a 
normal subject is very close to unity. This means that at PEF the 
air velocity reaches wave speed. \Vie also found that with sub-
maximal effort, 51 at PEF will be d, when the peak of flow 
occurs before the perimeter of the maximum expiratory flow vol-
ume curve is reached. With slightly less initial effort, the peak in 
Fig. 5 (defined as the maximum flow during the expiration) 
might have been reached at the perimeter where 51 equals one, 
but at a much lower lung volume. PEF is clearly effort depend-
ent, but if it is reached at the perimeter of the maximum expira-
tory flow volume curve, it is determined by the wave speed. 
The fact that PEF is close to wave speed flow in the central air-
ways does not necessarily imply that the flow is determined in 
the central airways. We believe that PEF is reached at the 
moment when air velocity for the first time during the expiration 
just reaches wave speed at some point in the airway, i.e., before 
dynamic compression occurs and before frictional pressure losses 
because of dynamic compression can be detected. If the flow 
determining site is defined as the most upstream point in the air-
way where 51 first becomes unity, we cannot be sure that we have 
reached the flow determining site with the probe, even if 51 
equals one. 
There mal' be two reasons for a local 51 d at PEF. First, the 
effort mal' be too small so that wave speed is not reached any-
where in the airway. In the case of flow limitation at PEF, we saw 
that Palv continued to increase after PEF was reached (Fig. 4). 
The explanation for this is that when flow limitation occurs, the 
resistance (PalvN') and the driving pressure (Palv) increase pro-
portionally, keeping V' unchanged at the given lung volume. If 
we consider a short interval encompassing PEF, then the volume 
will not change very much within that interval, and we can con-
sider the pressure flow curve within the interval equal to a seg-
ment of an isovolume pressure flow curve. If this curve has a 
maximum at PEF, so that V' decreases for increasing pressure 
after PEF is reached, then PEF can be considered a maximal flow. 
If we expand the interval around PEF, the decrease of V' after 
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PEF is related to the decrease in maximum flow with volume. 
If PEF is reached with submaximal effort and no flow limitation, 
this phenomenon will not take place. When V' declines after PEF 
is reached, pressure will also decrease like in a stiff tube. 
However, as the resistance of the airways increases with decreas-
ing lung volume, the curve in Fig. 5 will not completely follow 
the same path down. When the decreasing V' eventually reaches 
the flow volume perimeter (arrow), 51 becomes unity. Flow and 
pressure will no longer be in phase, and flow decreases more rap-
idly than pressure. 
The reason why previous investigators did not find flow limita-
tion at PEF may have to do with the definition of flow limitation. 
According to the classic definition, flow limitation occurs when 
flow reaches the maximum or plateau of an isovolume pressure 
flow curve. It is very difficult to construct isovolume pressure 
flow curves near TLC, and flow limitation at PEF is difficult to 
demonstrate in this way. Fry and Hyatt (7), howevel~ believed 
that if a subject is able to create a sufficient intrathoracic pres-
sure, such a maximum could be demonstrated. In the present 
study, assuming that flow limitation occurs at wave speed, we 
can get around this problem because SI can be determined during 
the actual forced expiration. 
As pointed out by Fry and Hyatt (7), the addition of an external 
resistance ,viiI move the maxima of the isovolume pressure flow 
curves toward higher pressures. Addition of an external resist-
ance may therefore lead to insufficient pressure for maximal 
flow. This is illustrated in Fig. 8 (O.F. Pedersen, unpublished 
observations), where data in A and B were obtained in a healthy 
subject performing forced expirations through a 13 and a 6.5 
111m orifice, respectively. The subject was sitting in a volume dis-
placement body plethysmograph equipped to measure Palv. In 
Fig. 8, C and D, similar curves Vi/ere obtained with a servo con-
trolled piston pump replacing the subject. In the piston pump, 
dynamic compression cannot occur, and the pressure flow curves 
are alone determined by the two orifices and the driving pres-
sures. For the human subject blo,ving through the 13 111m orifice, 
peak flow occurs before peak pressure, indicating dynamic com-
pression at PEF. The 6.5 n1111 orifice, however, imposes a resist-
ance so large that flow limitation is not reached at PEF. The flow 
follows closely the pressure flow cmve of the orifice. Peak flow 
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~vhximum expiratory flow-volume ,llld flow-pressure curves in a healthy subject seated 
in a plethysmograph equipped to measure nlveohlr pressure (A and B) and with a ser-
vo-controlled piston pump (C and D). Curves with higher flows in A-D were obtained 
in subject (or with pUlllp) by expiration through a 13-mm orifice. For curves with low-
er flows, orifice diameter was 6.5 mill. Arrows, corresponding events in healthy suhject 
and with usc of pump (d. text). 
and peak pressure are reached simultaneously, just as with use of 
the piston pump. With decreasing flow after PEF, flow initially 
follows the pressure flow curve for the orifice, but at some point 
dynamic compression of the airways 01' volume related changes 
in the airways cause the resistance to increase and flow to deviate 
from the curve for the orifice. At the point where the flow vol-
ume curve indicates flow limitation, the deviation is marked. The 
pattern in Fig. 5 is not as clear but indicates the Sal11e phenome-
nOll. \Ve therefore believe that when Palv continues to increase 
markedly after PEF is reached, it is a sign of flow limitation at 
PEF somewhere in the airway, whereas simultaneous pressure 
and flow peaks indicate that flow limitation at PEF may not have 
occurred. 
The second reason for 51 <1 at PEF may be that the flow deter-
mining site is not within reach of the probe. We found 51 d at all 
positions in some subjects, mostly asthmatic subjects. This could 
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be explained by a location of the flow determining segment 
peripheral to the most upstreatll position of the probe. In that 
case, SI at the probe mal' be d but the Palv will continue to rise 
after PEF is reached, as we found for all subjects in Fig. 7. The 
finding that the upstream Pfr was not increased in these cases is 
probably because of PEF just being reached and dynamic com-
pression not ),et having been fully established. 
The huff curves (Fig. 6) show that SI equals one not ani), at the 
first peak corresponding to PEF but also at subsequent peaks. 
The Palv flow curves indicate flow limitation at the three last 
peaks, but not clearly at the first two peaks at the higher lung 
volumes, where inspiration was initiated as soon as flow hecame 
maximal. Figure 6 also shows that the relationship bet\veen A 
and 1'tm, i.e., the 'tube law', is volume dependent, mostly at 
higher lung volumes. For a given Ptl11, A becomes smaller with 
decreasing volume, and the slope of the curve becomes smaller. 
This is in agreement with the findings of Macklem and Wilson 
(14). The smaller A with decreasing lung volumes could be 
explained b)' decrease of dilating forces because of changes in 
axial tension, and the smaller compliance b)' stiffening of the air-
ways when the cartilages approach each other with shortening of 
the airways, as shown for calf tracheae (22). 
Figure 7 shows that the position of the highest measured 51, 
which most closely reflects the flow determining site at PEP, is 
not different between health)' and asthmatic subjects, although SI 
appears smaller in the asthmatic subjects, in whom there is a 
slight tendenc)' for a more peripheral location. Table 3 shows 
that this smaller SI most likely is because of a smaller Caw (Eq. 
15 in Table I), but Table 4, which also includes data for posi-
tions with less than maximal 51, does not support this. 
Table 4 displays some significant differences between the healthy 
and the asthmatic subjects. In the following we try to explain 
these differences. 
If, as a first approach, we assume that flow is determined in the 
central airways in both groups, the following differences are con-
sistent: a smaller Pel and a larger Pfr in the asthmatic subjects 
will decrease J (Table 1, Eq. 7), and a decreased J will decrease 
the maximal flow via a decreased Ptl1l, leading to a smaller A. 
The finding of a larger driving pressure (Palv = Ppl + Pel) at PEF 
in the asthmatic subjects is interesting and contrary to what 
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should immediately be expected. Studies by Campbell et a!. in 
1957 (2) clearly indicated that airway obstruction with flow limi-
tation caused the esophageal pressure at PEF (maximal effective 
intrathoracic pressure) to decrease. This is supported by studies 
of flow maxima of isovolume pressure flow curves of Potter et a1. 
(17). On the other hand, increased downstream resistance will 
increase Palv at PEF by moving the flow maxima toward higher 
pressures (7). In that case, an increased Palv at PEF in the asth-
matic subjects would most likely be because of an increased 
downstream pressure drop due to dissipation of the excess pres-
sure, but this could not be demonstrated. The downstream resist-
ance, however, was slightly, although not significantly, larger in 
the asthmatic subjects (p = 0.07). Because of the difficulties in 
determining Caw, especially in the healthy subjects, with a larger 
fraction of negative values, a proper statistical evaluation of Caw 
could not be performed, and it could not be determined whether 
the finding of the lower 51 in Table 3 could be because of a gener-
ally lower Caw among the stable asthmatic subjects. Stiffer cen-
tral airways could explain not only smaller Sl but also a more 
upstream location of the flow determining sites in the asthmatic 
subjects compared with the healthy subjects, findings that were 
only indicated in the present study. 
It is noteworthy that Pfr upstream of the most peripheral posi-
tions and the pressures here were identical in the two groups of 
subjects and that the differences between the groups only became 
evident at more downstream positions (Table 4). Therefore, 
peripheral airway obstruction is unlikely to playa part in the 
observed difference between the gronps. The slightly smaller Pel, 
howevel; might contribute. 
The smaller Pel found at PEF for the asthmatic subjects in the 
multivariate analysis could be because of a larger expired volume 
at PEF. Table 4 showed that, when the value is measured in 
absolute terms, this was not the case. l'vleasured relative to FVC, 
the fraction was 0.14 ± 0.05 in the healthy subjects, 0.15 ± 0.04 
in the asthmatic subjects. This is very close to the median value 
in a population study by Lebowitz et al.(12). The absence of a 
difference in volume to PEF indicates that the smaller Pel in the 
asthmatic subjects most likely is because of other factors. A pos-
sible explanation could be related to the bronchodilator treat-
ment and subsequent relaxation of the alveolar ducts (24) or 
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maximal bronchodilatation (3;5). In out' attempt to compare 
asthmatic subjects with healthy subjects, we realize that the inter-
pretation might have been easier if the healthy subjects had also 
received bronchodilator treatment, but the present study design 
was chosen to give a nl0re realistic comparison. 
It is interesting that SI at PEF can be close to one at many loca-
tions in the airway, even at different lung volumes. This may be 
more than a coincidence, because in that way local strain is mini-
mized and the airways are better protected against damaging 
effects of severe local dynamic compression. Evolution may have 
played a part by favoring airways with the most appropriate 
structure. 
Modeling of Lambert et al. (11) made a fluid mechanical analysis of the maxi-
expiratory flow mum expiratory flow. The analysis was partly based on airway 
properties obtained from excised human lungs and partly from 
data of Weibel (26). They predicted that the most proximalloca-
tions of the flow determining site at high lung volumes were in 
the main or lobar bronchi and that Ptm at flow limitation would 
be slightly positive or close to zero. This means that the flow 
determining sites were upstreanl to or at the equal pressllre 
points. We found that at PEF the 51 was equal to unity in the tra-
chea in most cases, supporting flow limitation in the trachea, but 
we could not exclude that SI would be unity also at more 
upstream locations. \Ve found Caws different from those, on 
which the computational model was based. Contrary to our 
expectations, we did not find that the compliance at PEF 
increased significantly with peripheral motion of the probe, but 
Ptm increased. At Pun measured in our study, the Caw read from 
the curves presented by Lambert et al. (11) had almost the same 
value in the trachea, but in the lobar bronchi it was much larger. 
This may explain why they did not find flow limitation in the 
trachea at high lung volumes but in the bronchi instead (ef. 
Eq.15 in Table 1). Other factors may contribute: our curves were 
measured during dynamic conditions, in which invagination of 
the membranous parts of the airways and axial tension may 
change the A-Pun curves in a way that is not accounted for in the 
model. 
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The main conclusion of the present work is that when PEF is Main conclusions 
reached the SI is close to unity in the central airways of most sub- and implications 
jects. Among those with 51 d in the measured airways (mostly 
asthmatic subjects), the shape of the Pal v-flow curves usually 
indicated that flow limitation at PEF took place at some point in 
the airway. This may be in more peripheral airways, beyond the 
reach of the probe. Therefore, this work supports that PEF in 
general is determined by the wave speed flow limiting mecha-
nism. 
If PEF is obtained with submaximal effort, it is determined by the 
wave speed flow limiting mechanism, if PEF is reached at the 
perimeter of the maximum expiratory flow volume curve. 
These findings have consequences for the interpretation of PEF. If 
PEF is determined by the wave speed flow limiting mechanism, it 
will be determined by three main factors: Pel, upstream PEr, and 
relationship between distending pressure (Ptm) and A at the most 
upstream positions where 51 equals one. PEF will be large when 
Pel is large, Pfr is small, A is large, and Caw is small. PEF will 
increase with increasing effort because wave speed is reached at a 
higher lung volume (higher pel and smalier upstream pfr). 
In the present study, stable asthmatic subjects had smaller maxi-
mum S1 in the measured airways than did healthy subjects. This 
might be related to decreased Caw, but this could not be con-
finned. 
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SUMMARY 
The concept of structural and functional changes in the airway 
wall (airway remodeling) as the result of chronic asthmatic 
inflammation is widely accepted nowadays. However, the rela-
tionship between (persistent) airflow obstruction and bronchial 
hyperresponsiveness as characteristic features of asthma on the 
one hand and airway remodeling on the other is still poorly 
understood. Also we do not know when airway remodeling 
develops, whether and to what extent it exists in young patients 
with asthma and what risk factors are involved. In general, con-
ventional lung function techniques such as ~'IEFV curves arc 
unsuitable to detect structural changes due to asthmatic remodel-
ing. 
The wave speed concept of flow limitation relates airway elastic 
properties, airway resistance and elastic recoil to the maximal 
attainable expiratory flow. No hI uiuo studies with regard to air-
way compliance and/or the site of flow limitation based on the 
wave speed concept have yet been performed in humans. The 
effects of (possibly) remodeling of the airway wall on the elastic 
properties of the airway wall and on the mechanism of flow limi-
tation are unknown. 
This thesis adresses both aspects and describes the first ill uiuo 
(patho-)physiological studies of expiratory flow limitation and 
bronchial mechanics in healthy subjects and patients with long-
lasting asthma. 
The primary objective of these studies was to answer the follow-
ing questions: 1) Does airway compliance, as a measure of 
(remodeled) airway structure, differ between healthy controls 
and patients with asthma? (Chapter 4). 2) Where does flow limi-
tation, based on the wave speed concept, occur ill uiuo in human 
airways? (Chapter 5). 3) Does chronic airway inflammation (and 
possible airway wall remodeling) lead to a change in the site of 
flow limitation in patients with asthma? (Chapter 5). 4) Can air-
way elastic behavior be meaningfully described by airway com-
pliance curves derived from MFSR curves? (Chapter 6) and 5) Is 
Peak Expiratory Flow only determined by effort or by flow limi-
tation as well? (Chapter 7). 
Chapter 8 
In this chapter a summary of the findings and conclusions within 
each chapter is presented, a short synthesis is given and limita-
tions of the studies are discussed and suggestions for future 
research will are described. 
In Chapter 1 a general introduction is given to the thesis and the 
aims of the study are outlined. 
In Chapter 2 the current understanding of the relation between 
asthmatic inflammation of the airway and the occurrence of 
remodeling of the airway wall is summarized. Features of asthma 
and remodeling are related to detenninants of expiratory flow 
limitation. 
In Chapter 3 the evolution of our understanding of expiratory 
flow limitation is described. The theoretical basis for the experi-
ments is described and elaborated in the following chapters. The 
wave speed concept of flow limitation explains that the coupling 
of geometry, size and compliance of the airways with pressure 
distribution and flow results in flow limitation (Fig. 10). Local 
maximal flow is reached when the local speed of air equals the 
local wave speed, i.e. the speed at which a pressure disturbance 
travels through an elastic tube (an airway). These characteristics 
define a choke point. The airway segment with the lowest maxi~ 
mal flow determines the maximal flow for the whole bronchial 
tree and is called the flow limiting site (FLS). 
Although the wave speed theory is an all embracing concept, the 
phenomenon of expiratory flow limitation has not been solved 
completely. In the ill vivo studies described in this thesis, we 
applied the wave speed concept to analyse the results of intra-
bronchial measurements during forced expiration in order to 
obtain more insight in qualitative and quantitative features (of 
abnormalities) of airway mechanics in healthy as well as in asth-
matic subjects. 
In Chapter 4 a study of the dynamic clastic properties of the cen-
tral airways during forced expiration in 14 healthy and 10 young 
adults with long-lasting asthma is described. The patients with 
asthma were pretreated with a ~-2-agonist and systemic corticos~ 
teroids. The relationship between airway cross sectional area (A) 
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and transmural pressure (Ptm) was regarded as a measure of air-
way compliance (Caw = dAldPtm). A1Ptm curves were obtained 
dnring forced expiration, using an esophageal balloon and a 
Pitot static probe positioned at five positions between the right 
lower lobe and mid trachea. Cross sectional area (A), airway 
compliance (Caw) and specific airway compliance (sCaw ::: 
Cawl A) were obtained from the AlPun curves. We found that the 
cross sectional area A was significantly larger in males than in 
females and that Caw and sCaw decreased with decreasing lung 
volume. The most important finding, however, was that Caw and 
sCaw were significantly lower in the patients with asthma. The 
latter supports the concept that chronic asthmatic airway wall 
inflammation may result in remodeling of the airway wall, even 
in relatively young patients with mild to moderate asthma who 
were treated with inhaled corticosteroids for several years. 
Furthermore, we concluded that asthmatic remodeling probably 
leads to stiffening of the (central) airways. 
In Chapter 5 we investigated the occurrence and the behavior of 
flow limitation during forced expiration in the same group of 14 
healthy and LO asthmatic subjects. From the above described 
NPtm curves we obtained airway cross sectional area (A) and 
airway compliance (Caw = dAldPtm). We calculated air speed (v 
= V'IA), flow at wave speed (V'ws), wave speed (c = V'wsIA) and 
the Speed Index (SI = V'N'ws = vic) according to the equations 
derived from the wave speed concept of flow limitation (chapter 
3). 
Despite all technical and practical limitations, the results indicate 
that the wave speed concept can be applied ill vivo in humans in 
order to obtain more insight in the development and the site of 
flow limitation. 51 values ~l, indicative of a local choke point, 
were found at allS Pitot static probe positions in the healthy sub· 
jects but only at the two most upstrearn positions in the subjects 
with asthma. In other words, the flow limiting behavior of the 
central airways is changed in patients with asthma. 
The difference in choke point distribution between healthy and 
asthmatic subjects may be explained by changed local airway 
wall properties possibly due to chronic asthmatic airway inflam-
mation (chapter 4). It was not possible to position the Pitot static 
probe in airways upstream from the lower lobe bronchus. 
Chapter 8 
Therefore, it can not be excluded that wave speed was also 
reached in more peripheral airways and/or that the FLS was 
located beyond the most upstream Pitot static probe position. 
In Chapter 6 airway compliance (Caw), derived from the relation 
between forced expiratory flow and static recoil is evaluated. 
Theoretically, airway elastic properties at the flow limiting site in 
the bronchial tree may be estimated from the slope of Maximal 
expiratory Flow Static Recoil (MFSR) curves under the assump-
tion that pressure loss due to friction is negligible. The MFSR 
curve is relatively easy to construct and may therefore be applica-
ble in larger groups of patients with asthma. This makes the 
MFSR curve a potential tool for the evaluation of airway compli-
ance as a measure of airway remodeling, \Ve compared MFSR 
derived airway characteristics with the corresponding Pitot static 
probe results. 
The appearance of MFSR derived AlPU11 curven reflected jumps 
in the location of the flow limiting segment during expiration. 
1vlFSR derived airway compliance and airway cross sectional 
area decreased with decreasing lung volume. These findings were 
in accordance with the Pitot static probe results. Therefore, 
MFSR derived airway characteristics may reflect qualitatively the 
behavior of flow limitation. 
However, the correlation of MFSR derived airway characteristics 
(Am' Cawm and sCawnJ with the corresponding hi vivo Pitot 
static probe results was poor. Furthermore, the MFSR analysis 
was not sensitive enough to reflect changes in Caw in the patients 
with asthma, as demonstrated with the Pitot probe. This may be 
due to the fact that the 'real' location of the flow limiting seg-
ment differed between the healthy and the asthmatic subjects 
and/or may be due to the presence of different frictional pressure 
losses in both groups. We conclude that the MFSR curve is not 
suitable to evaluate (changes in) airway compliance in healthy 
subjects and/or patients with asthma. 
In Chapter 7 is reported whether peak expiratory flow (PEF) is 
determined by the wave speed flow limiting mechanism. 
Although PEF is widely used in the assessment of bronchial 
patency in asthma, especially in the home situation, it is by many 
clinicians regarded to be mainly effort dependent. 
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Using a Pitot static probe positioned at 5 different positions in 
the central airways and an esophageal balloon, we obtained 
Speed Index values in 17 healthy controls and in 11 subjects with 
stable asthma. Speed Index values near unity reflect wave speed 
determined flow limitation. In 13 out of 15 healthy controls and 
in 4 out of 10 asthmatic subjects, from whom satisfactory curves 
could be obtained, 51 at PEF was> 0.9 at one or more Pitot static 
probe positions. Alveolar pressure further increased after PEF 
was reached, also among those (11l0Stiy asthmatic) subjects with 
Speed Index values < 1. These findings indicate that at PEF flow 
limitation occurs at some point in the airway. \Y/e conclude that 
in general PEl' is determined by the wave speed flow limiting 
mechanism. 
GENERAL DISCUSSION 
The explanation of flow limitation involves a complicated inter-
dependence of airway compliance, elastic recoil of the lung, 
geometry of the bronchial tree and pressure loss due to friction. 
The end result is reflected mainly by the shape of the maximal 
expiratory flow volume (MEFVl curve and also by the included 
absolute values of flow and volume. The MEFV curve is relative-
ly easy to obtain, highly reproducible within individual subjects 
and sensitive to a reduced patency of the airways. Therefore it is 
widely used in clinical practice as well as in e.g. epidemiological 
surveys, especially in diseases characterized by airway obstruc-
tion. However the :tVIEFV curve does not inform liS whether, why 
and where flow limitation takes place, especially in case of 
abnormalities in MEFV shape and/or expiratory flow values. 
~Iloreover, a 'normal' MEFY curve does not exclude pathology of 
the lung and/or the bronchial tree. 
Therefore, we applied intra bronchial measurements during 
forced expiration in order to obtain more insight in the location 
and behavior of flow limitation ill viuo in humans. Furthermore, 
we examined whether and to what extent potential changes in 
airway compliance and/or airway behaviour with regard to flow 
limitation in asthma can be detected by this method. 
On theoretical grounds one might expect that persisting or severe 
Chapter 8 
airway inflammation may result in (irreversible) histological and 
structural changes. These may affect airway mechanical proper-
ties and may lead to functional abnormalities and possibly an 
increase in symptoms. Therefore we compared a group of 
patients with stable, long lasting, mild to moderate asthma with 
a group of healthy subjects. 
Both groups were relatively small. However one should realize 
that these volunteers were subjected to very unpleasant and time 
consuming experiments. We are very thankfull that they partici-
pated throughout the whole study because invasive studies with 
intra bronchial measurements of airway mechanics, stich as 
described in this thesis, are necessary to assess to what extent 
structural abnormalities contribute to or correlate with the devel-
opme(lt of functional and histological changes and symptoms. 
These studies are often proposed for but rarely conducted. 
The level of lungfunction was comparable in both groups. This 
finding is may be reassuring with regard to the development 
and/or existence of functional changes in asthma. However, the 
patients studied may not be representative for the (rehltively 
small) group of patients with more severe asthma. 
In spite of the small number of subjects, statistical analysis 
showed that the CfOSS sectional area of the central airways in the 
patients with asthma was significantly lower and that the central 
airways behaved more stiffly during forced expiration. 
According to the ,vave speed concept, stiffer airways have higher 
wave speeds and therefore higher maximal flows. On the other 
hand, lower airway cross sectional areas will result in a lower 
maximal flow values. This seems to be in contrast with the fact 
that the lvlEFV curves of the asthmatic subjects participating in 
the study, showed neither significant bronchial obstruction nor 
higher expiratory flows. The potential effect of lower local air-
way compliance (i.e. higher w<1Ve speed flow) is probably partial-
ly counterbalanced by a lower local cross sectional area, causing 
a lower wave speed flow. In other words: we found that the 'nor-
mai' lungfunction in the asthmatics can be explained by the com-
bination of two compensatory abnormalities. 
These findings explain why 'normaP l\tIEFV curves may not 
exclude changes in airway structure related to asthmatic airway 
inflammation. A plausible explanation for the changes in airway 
cross sectional area and airway compliance is remodelling due to 
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chronic asthmatic airway inflammation. However, one can not 
exclude that these 'abnormalities' existed in the patients with 
asthma already prior to the development of symptoms. 
Increased stiffness of the airway wall will impose a greater load 
in bronchial smooth muscle during bronchoconstriction, and 
therefore has, to a certain degree, a protective effect. However, it 
does not rule out the appearance of excessive bronchoconstl'ic-
tion related to bronchial hyperresponsiveness, because many fac-
tors causing thickened airways also contribute to excessive air-
way narrowing. 
The possible long-term effects of the functional abnormalities in 
patients with asthma, described in this thesis, remain unknown. 
Il1trabrol1chial pressure measurenlents enabled us to analyze the 
factors determining peak expiratory £low (PEF) in detail. Until 
recently, PEF was regarded to be effort dependent, in contrast 
with the £lows in a later phase of forced expiration. This impli-
cated that PEF was regarded to be inferior to FEV 1, the golden 
standard of airway patency. However, our results indicate that in 
most subjects PEF is determined by the same £low limiting mech-
anisms that occur in the so-called 'effort independent' phase of 
forced expiration. These findings have consequences for the 
interpretation of PEF. If PEF is determined by the wave speed 
flow limiting mechanism, it will be determined by three main fac-
tors: lung elastic recoil pressure (Pel), pressure loss due to friction 
(Pfr), and the airway compliance at the most upstream positions 
in the bronchial tree where the Speed Index equals one. PEF will 
be large when Pel is large, pfr is small, cross sectional area is 
large and airway compliance is low. PEF will increase with 
increasing effort because wave speed is reached at a higher lung 
volume and therefore at a higher Pel and lower Pfr. 
The invasive nature and time consuming complexity of the exper-
iments hampered inclusion of more healthy and asthmatic volun-
teers in the study. This also stopped us from repeating the Pitot 
static probe experiment in order to test reproducibility of the 
results. Despite an optimal anesthetized pharynx, larynx and 
bronchial tree, most of the volunteers found it difficult to per-
form 30-40 MEFV maneuvers adequately with an intra bronchial 
Pitot static probe in situ. Typical problems were fits of coughing 
or increased mucus production with a need to swallow. 
Chapter 8 
Sometimes we had to stop the measurements due to premature 
cessation of local anesthetic effect. For the same reasons, not all 
subjects could repeatedly exhale a full FVC, despite being 
instructed and encouraged to do so. Furthermore the Pitot static 
probe could get blocked in wedge position in a bronchial branch 
and/or one or more side holes of the probe could clog up by 
mucus. 
These practical problems explain why in some subjects no reli-
able data could be obtained at all probe positions or throughout 
the full FVC range. The variation of results within an individual 
subject was relatively large. 
These factors obliged us to apply a statistical model to describe 
the behavior of: the airway compliance, the cross sectional area, 
the specific airway compliance, the transmural pressure, the pres-
sure loss due to friction, the airway resistance upstream from the 
probe and also of the Speed Index (SI) in relation to the intra-
bronchial position of the probe, the lung volume and the disease 
status of the subjects. 
Despite the practical problems and technical limitations as 
described in the subsequent chapters, the behavior of flow limita-
tion during forced expiration was as we theoretically had expect-
ed. This was also true for the change in airway compliance (Caw) 
and cross sectional area A ,,,hen the Pitot static probe position 
and/or volume changed and for the difference in cross sectional 
area A between male and female subjects. Therefore, we feel jus-
tified to state that the application of intra bronchial measure-
ments is a reliable tool to study airway mechanics during forced 
expiration i11 lIilJO in humans. 
The measurements were restricted to the central airways (trachea 
-lower lobe bronchus). Therefore we were not informed of what 
takes place upstream from the lower lobe, being the most 
upstream Pitot static probe position. This has consequences for 
the interpretation of the Speed Index results. SI values near unit)' 
indicated existence of local choke points in the healthy subjects 
as well as in the patients with asthma. However, based on the SI 
results the occurrence of choke points or even a flow limiting seg-
ment upstream from the lower lobe could not be excluded. 
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For the first time in medical research we were able to derive ill 
lIillo local bronchial mechanical properties in healthy volunteers 
and in patients with asthma. Despite the restrictions mentioned 
above we were able to draw the following main conclusions 
(Figure I): 
1) Central airways in the patients with asthma ~He more narrow 
and behave more stiffly during forced expiration. 
2) Flow limitation takes place in the central airways in human 
subjects. 
3) The distribution of sites with choke points andlor flow limita-
tion has moved upstream in the patients with asthma. 
4) l\1aximal Flow Static Recoil curves are not suitable to evalu-
ate (changes in) airway compliance. 
5) Peak Expiratory Flow is determined by the wave speed flow 
limiting mechanism. 
Several studies show that structural changes occur predominantly 
in small airways but also in large airways in cases of non fatal 
asthma. The finding of stiffer central airways in patients with sta-
ble asthma strongly supports the hypothesis that remodeling does 
occur in central airways, even in patients with mild to moderate 
asthma and under prolonged treatment with inhaled corticos-
teroids. \Y,fe could not predict whether decreased compliance could 
also be found in the more peripherally localized and intrapul-
monary airways, as our measurements were restricted to the cen-
tral airways. The finding that the elastic behavior of airways 
changes in a group of relatively young subjects with well treated, 
mild to moderate asthma suggests that our current therapeutic 
measures insufficiently prevent airway remodeling. However, one 
can not exclude the possibilit)' that patients with asthma are char-
acterized by other measures of airway diameter andlor airway 
elastic properties, perhaps even at birth or early in life. As long as 
the long term effects of functional abnormalities are unknown, we 
stress the importance of identifying the risk factor(s) for remodel-
ing and to develop other, better (preventive) treatment strategies. 
Airway mechal1ics: 
In our opinion, the studies described in this thesis reached the 
limit of the capability of conventional lung function techniques 
combined with invasive techniques with the aim to study airway 
Chapter 8 
mechanics in uiuo in humans. However, other aspects that should 
and can he addressed with the same techniques are: the volume 
dependency of airway compliance, the effects of bronchodilata-
tion and/or bronchial constriction on bronchial mechanics, the 
reproducibility of the findings and follow-up in time of the differ-
ent results, especially in the patients with asthma. Results with 
regard to these aspects will improve the interpretation of the 
findings described in this thesis and extend our knowledge of the 
in viuo behaviour of human (central) airways. Comparable stud-
ies in excised human central airways in an in uitl'o experimental 
setup may provide indirect information on e.g. the importance of 
the intrathoracic tissue - (central) airway interaction with regard 
to airway mechanics. 
Furthermore, in uiuo derived data on airway compliance, airway 
cross sectional area, transmural pressure, pressure loss due to 
friction, volume dependency of different parameters, etc., should 
be used to improve further the (limited number of) available 
computational models, in order to extend the knowledge and our 
understanding of the complex system of airway mechanics. 
Other, non invasive, ways to study airway mechanics ill VillO in 
humans should be developed. Modern methods, such as dynamic 
high resolution computed tomography scans, including the con-
struction of a three dimensional model of the bronchial tree, 
and/or video imaging of the lungs and airways may provide tools 
for such studies. It is understood that abnormalities in the 
parenchyma-airway interactions may playa key role in the 
pathogenesis of chronic or even acute airflow obstruction. 
Therefore these studies should not be limited to the large, central 
airways. 
Remodelillg: 
In the current studies we were not able to perfol'ln hronchial 
biopsies in order to assess features and/or the extent of airway 
inflammation or airway remodeling in the subjects with asthma 
studied. Future studies should preferably combine physiological 
and histological data in the same group of patients. \Y/e are not 
informed whether airway mechanical abnormalities are the result 
of remodeling GlUsed by chronic airway inflammation or that 
these ahnormalities are pre-existing features in subjects with 
asthma. Nor do we know whether airway remodeling can he pre-
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Schematic view of find-
ings in this thesis, 
Left panel: central air-
ways in healthy suh-
jects, 
Right panel: in patients 
\vith asthma the 
upstream segments of 
the central ai[\\'<l),s are 
stiffer. This may result 
in a larger maxim.ll 
expir.ttory flow 
(V'm.lx), However, a 
[ower local cross sec-
tional area (partially) 
cOllnter balances this 
effect. The distribution 
of chokepoints (Speed 
Index ",1) is located 
more upstream (shaded 
area), 
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vented or reversed by anti-inflammatory treatment. Studies of 
airway mechanics at an early stage of asthma and before and 
after a prolonged period of anti-inflammatory therapy may pro-
vide answers to these questions. However, this will probably lead 
to (invasive) studies in (young) children with asthma and there-
fore to medical ethical problems. Furthermore, detailed know-
ledge of the airway geometry at different ages is required for such 
studies and is lacking at the moment. 
New approaches to the study of the functional consequences of 
airway remodeling should be developed. Measuring the effects of 
deep inhalation on lung function is e.g. a promising, easy to per-
form and simple test to evaluate the structural changes occllring 
in the airways and to monitor the effectiveness of therapy. 
The present challenge is to combine (new) knowledge on physiol-
ogy, morphology and the molecular basis of asthma, with in vitro 
studies and mathematical models to provide more information 
about the basic mechanisms underlying the relation between 
bronchial hyperreactivity, (severe) airway obstruction and the 
histological and molecular abnormalities in asthma. 
11---- V'max ----11 
___________ trachea _____________ 
_____ main bronchi --_ 
lower lobe bronchi 
healthy 
lower lobe bronchi 
asthma 
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SAMENVATIING 
Algemeen wordt aangenomen dat de chronische ontsteking in de 
luchtwegen bij patienten met astma leidt tot structurele en func-
tionele vel'anderingen van de luchtwegwand ('remodeling'). Of er 
een verhand bestaat russen karakteristieke kenmerken van astma 
als (persisterende) Illchtweg obstrllctie en bronchia Ie hyperreac-
tiviteit enerzijds en 'remodeling' van de luchtwegen andel'zijds is 
onduidelijk. \\Tanneer 'remodeling' ontstaat en hoe 'remodeling' 
de prognose van astma be'invloedt, is onbekend. Ook zijn we niet 
op de hoogte 6f en in welke mate 'remodeling' aanwezig is hij 
jonge patienten met astma en zijn de risicofactoren voor het 
0pu'eden van 'remodeling' nog niet in kaart gehracht. 
Flowlimitatie houdt in dat de expiratoire volnmestroom aan een 
maximum gebonden is. Het 'wave speed' concept verklaart 
flowlimitatie nit de interactie tussen de elastische eigenschappen 
van de !uchtwegen, de luchtwegwecrstand en de elastische ret rac-
tiekracht van de long. Tot op heden zijn er bij de mens geen ill 
vivo studies, gebaseerd op het 'wave speed' concept, naar het 
optreden en de locatie vall flowlimitatie binnen de bronchiaal-
boom uitgevoerd. De in vivo effecten van mogelijke structurele 
veranderingen in de luchtwegwand hij astma op de elastische 
eigenschappcn van deze luchtwegen en op het mechanisme van 
fI(Hvlimitatic zijn eveneens onbekend. 
Dit proefschrift behandelt deze beide aspecten en beschl'ijft de 
eerste, il1 vivo uitgevoerde, (patho-)fysiologische studies naar 
flowlimitatie en de mcchanica van de centrale 111chtwegen tijdens 
geforceerde uitademing bij zowel gezonde personen als hi; 
patienten met astma. 
Hoofdstuk 1 geeft een aigcmene introductie <weI' astma en 
flowlimitatie en beschl'ijft het doel van de verschillende studies. 
Hoofdstllk 2 geeft een samenvatting van de hllidige inzichten in 
de relatie tussen chronische astmatische onsteking van de 
luchtwegen en 'remodeling' van de luchtwegwand. Factoren die 
be pal end zijn voor expiratoire flowlimitatie worden in verhand 
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gebracht met kenmerken van astma en 'remodeling'. 
Hoofdstuk 3 is cen historisch overzicht van de ontwikkeling van 
ons den ken over het complexe mechanismc van expiratoire 
f10wlilllitatie en beschrijft de thenretische basis van de uitgevoer-
de experimenten. 
Beschreven wordt hoe flowlil11itatie verklaard kan worden nit de 
interactie van architectnur, lengte, dwarsdoorsnede oppervlak en 
elastische eigenschappen van de luchtwegen enerzijds en ander-
zijds de volumestroom en de verdeling van intrathoracaal aan-
wezige drllkken in en rond de lllchtwcgen. De maxil11ale voillme-
stroom lacaal in een luchtweg wordt bereikt ais de locale 
snelheid van de lucht geJijk wordt aan de locale 'wavcspeed', De 
'wavespeed' is de snelheid waannee een drukgolf zich verplaatst 
door het gas in een elastische buis (i.e. luchtweg). De plaats Waal' 
de 'wavespeed' wordt bereikt is het 'chokepoinf. Het luchtweg-
segment met de laagst maximaal haalbare volumestrool11 bepaalt 
de lllaximale volumestrool11 voor de gehele bronchiaalboom en 
wordt het 'Flow Limiterend Segment' genoemd. Of schoon het 
'wave speed' concept als een alles omvattende theorie wordt 
beschouwd, is de ingewikkelde puzzel van de expiratoire 
f10wlimitatie hiermee nog niet geheel opgelost. 
In de in /Jiuo experimenten, die in dit proefschrift beschreven 
\Vorden, \Vonlt de 'wavespeed' theorie gebruikt om de resultaten 
vall intrabl'onchiale en intrathoracale drukmetingen tijdens 
geforceerde uitademing tc analyseren. Het doe I is Olll, in /Ji/Jo, 
mee!' inzicht te verkrijgen in de kwalitatieve en kwantitatieve 
aspecten van Iuchtwegmechanica tijdens geforceercle uitadellling 
bij zowel gezonde personen als bij patienten lllet astma. 
Afwijkingen in luchtweg mechanica bij astma kunnen het gevolg 
zijn van stl'ucturele afwijkingen in de wand van de luchtweg 
tengevolge van chronische astmatische ontsteking. 
Hoofdstuk 4 beschrijft een studie naar de dynamische elastische 
eigenschappen van luchtwegen tijdens geforceerde uitademing bij 
14 gezonde jong volwassenen en 10 jong volwassenen 111et astma. 
De metingen bij de paticnten met astma werden uitgevoerd na 
maxima Ie luchtwcg verwijding en na voorbehandeling met een 
kuur s)'stemische corticosteroi'den. lvlet behulp van een ballon in 
de oesophagus en een intrabronchiaal geplaatste 'Pitot-static 
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probe' werden drukmetingen verricht tijdens de meting van de 
geforceerde u.itademing. Een Pitot-static probe is een dun buisje 
met een opening aan de tip waarmee de voorwaarts gerichte druk 
gemeten wordt en zij-openingen voor het be palen van de 
zijwaarts gerichte drnk in de luchtweg. Vit de op deze manier 
verkregen dl'uk- en volulllestroom-gegevens weni het dwars-
doorsnede oppervlak (A) ter plaatse van de probe berekend en de 
lokaal aanwezige dfuk over de luchtwegwand (de transmurale 
drnk Ptm). De ratio tussen de verandering in A en de verandering 
in Ptm werd beschouwd als een maat voor de compiiantie van de 
luchtweg. (Caw = dAJdPtm). De Pitot-static probe was geposi-
tioneel'd op 5 plaatsen in de centrale luchtwcgen: van het midden 
van de trachea tot bi; de ingang van de rechter onderkwab. A, 
Caw en de specifieke luchtweg-compliantie seaw (sCaw = 
Caw/A) werden afgeleid van de AlPtm-curven. 
De resultaten wezen uit dat het dwarsdoorsnede-oppervlak A bij 
mannen significant groter is dan bi; vronwen en dat Caw en seaw 
afnelllen met afnelllend longvolume. Dit komt overeen met andere 
niet-invasieve onderzoeken enlof theorieen in de Jiteratllur. De 
meest belangrijke bevinding is echter dat Caw en sCaw signifi-
cant lager zijn bij de patienten met astma. Dit wijst op een 
afname van de elastische eigenschappen van de astmatische 
luchtweg. Deze resultaten ondersteuBen het concept dat bij astma 
chronische ontsteking van de luchtwcg kan lei den tot structnrele 
verandering van deze luchtweg en dat dit zelfs al bij relatief jouge 
patienten met mild tot matig astma die volgens de huidige richtli-
jnen behandeld worden, kan optreden. Verder tonen de resulta-
ten dat 'remodeling' kan lei dell tot 'verstijving' van de lucht\ve-
gen. 
In hoofdstllk 5 wordt het optreden en het gedrag van flow limi-
tatie tijdens geforceerde uitademing onderzocht in dezelfde groep 
van 14 gezonde en 10 personcn met astma. Vit de boven 
beschreven NPtm-curvcn berekenden wi; het dwarsdoorsnede 
oppervlak A en de luchtweg compliantie (Caw = dAldPtm). 
Gebrllik makend van de vergelijkingen die afgeleid werden van 
het 'wavespeed' concept van flowlimitatie (hoofdstuk 3) werden 
de volumestroolll (V') tijdens 'wavespeed'-conditie (V'ws), de 
verplaatsings-snelheid van de lucht (v = V'/A), de wavespeed (c = 
V'ws/A) en de Speed Index (SI = V'N'ws = vic) berekend. 
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Ondanks de technische en praktische beperkingen, geven de 
l'esultaten aan dat het wavespeed concept iu vivo bij de mens 
toepasbaar is om meer inzicht te verkrijgen in de ontwikke1ing en 
de localisatie van f10wlimitatie tijdens geforceerde nita deming. 
SI-waarden rond de cen wijzen op het bestaan van een locaal 
chokepoint en werden bij de gezonden bij aile 5 de Pi tot-static 
probe posities gevonden. Daarentegen werd bij de patienten met 
astma deze conditie aIleen bij de twee meest strool11opwaarts 
gelegen posities gevonden. Met andere woorden: het flow-lim-
iterend gedrag van de centrale Inchtwegen is andel's bij de patien-
ten met astl11a. Het verschil in de verdeling van Ichoke-points' 
tussen gezonden en astmatici kan verklaard worden vanuit 
veranderde luchtwegwand-eigenschappen, l11oge1ijk gere1ateerd 
aan chronische luchtwegwand ontsteking (hoofdstnk 4). Het was 
niet mogelijk om de Pitot·static probe te plaatsen in luchtwegen 
strool11opwaarts van de onderkwabs bronchus. \\le kunnen 
daarom niet uitsluiten dat \vuvespeecP ook bereikt wordt in de 
meer 'perifere' luchtwegen en/of dat het Flow Limiterend 
Segment strool11opwaarts van de onderkwabs bronchus gelegen 
is. 
Hoofdstuk 6 vergelijkt de Inchtweg-compliantie (Caw), die 
bepaald word nit de re1atie tussen de volnmestro0111 tijdens 
geforceerde uitadel11ing en de statische elastische retl'actie kracht 
van de long met de Caw-resultaten vel'kregen met behulp van de 
Pitot-static probe. Op theoretische gronden kunnen de e1astische 
eigenschappen tel' plaatse van het Flow Limiterend Segment 
(FLS) afgeleid worden nit de helling van de 'Maxima Ie expira-
toire Flow - Statische Retractie kracht'-curven (MFSR-clll'ven) 
onder de aanname dat het intrabl'onchiale drukverlies ten 
gevolge van frictie verwaarloosbaar is. De ~IIFSR -curve is relatief 
gemakkelijk te construeren en Zou daarmee toepasbaal' zijn in 
grotere groepen patienten met astma. Dit maakt de 11FSR-cUfve 
tot een potentieel (non-invasief) instrument voor onderzoek naar 
de elastische eigenschappen van luchtwegen als maat VOOf 
luchtweg-'remodeling'. We verge Ie ken luchtweg-eigenschappen 
afgeleid uit de MFSR-clll'ven met de resultaten verkregen nit de 
studies met de Pitot-static probe. 
De vornl van de MFSR-afgeleide AlPtm-curven wees erop dat de 
intrabronchiale localisatie van het FLS verspringt, cq. verschuift 
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tijdens de (geforceerde) uitademing. Het dwarsdoorsnede opper-
vlak A en de luchtweg-compliantie Caw, afgeleid van de MFSR-
curven, namen af met afnemend longvolume. Deze bevindingen 
zijn in overeenstel11l11ing met de resultaten afgeleid van Pitot static 
probe studie. Dit impliceert dat MFSR- afgeleide luchtweg-eigen-
schappen kwalitatief het gedrag van de luchtwegen tijdens 
flowlimitatie kunnen weergeven. De kwantitatieve correIa tie 
russen de resultaten van de MFSR-afgeleide varia belen (Am' 
Cawm en sCawm) met de overeenk0111stige Pitot-static probe vari-
abelen was echter matig tot slecht. VerdeI' was het niet mogelijk 
om met de .NIFSR-analyse verschillen in Caw en/of sCaw tussen 
de gezonden en de patienten met astma aan te tonen zoais 
beschreven in hoofdstuk 4. Dit laatste kan verklaard worden uit 
een mogelijk verschil in de intrabronchiale locatie van het FLS 
tussen gezonden en patienten met astma en/of door verschillen in 
drllkverlies door frictie tnssen beide groepen. De conclllsie is dat 
de MFSR-curve niet geschikt is om (veranderingen in) luchtweg-
compliantie te evailieren bij gezonden en/of patienten met astma. 
In hoofdstuk 7 wordt onderzocht in hoevene de piekstroolll 
(peak expiratory flow, PEF) wordt bepaald door het 'waves peed' 
flow-limiterende mechanisme. Of schoon de PEF veelvuldig 
gebruikt wordt als maat voor (veranderingen in) luchtweg door-
gankelijkheid bij astllla, wordt deze door de meeste clinici 
beschouwd als zijnde vool'l1amelijk inspanningsafllankelijk. 
Ivlet behulp van een Pitot-static probe, gepositioneerd op 5 ver-
schillende plaatsen in de centrale luchtwegen, en een oesophagus 
baIlon, werden Speed-Index waarden verkregen bij 17 gezonde 
personen en 11 person en met astllla (zie hoofdstuk 5). Speed-
Index waarden rond de een geven aan dat sprake is van 
'wavespeed' bepaalde flow-limitatie. Bij 13 van de 15 gezonde 
personen en bij 4 van de 10 patienten met astma, bij wie geschik-
te curven verkregen konden worden, werd een SI-waarde rond de 
een gevonden bij een of meerdere posities van de Pitot-static 
probe bij het bestaan van PEF. Verder bleek dat de alveolaire 
druk verder toenam nadat de PEF werd bereikt, ook bij de 
(vooral astrnatische) person en met SI-waal'den kleiner dan een. 
Deze bevindingen geven aan dat tijdens de PEF ergens in de 
luchtwegen flow-limitatie optreedt. Onze conclusie is dat, bij vol-
doende inspanning, de piekstroom in het algcmeen bepaald 
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wordt door het \vavespeed' flow-limiterende mechanisme binnen 
de luchtwegen. 
In de algcmene discussie worden bovenstaande bevindingen nader 
geinterpreteerd. Het feit dat bij de patienten met astma een vrijwel 
normale longfunctie gevonden werd, zonder 'ohstructieve flow-vo-
lume curven, kan verklaal'd worden doordat, volgens de 
'wavespeed theorie\ het effect van cen lager dwarsdoorsnede opper-
vlak van de luchtweg (leidend tot een lagere maxima Ie volume-
stroom) gecompenseerd wordt door het effect van een lagere 
luchtwcg compliantie (resulterend in een hogere maximale volume-
stl'oom). Een 'norma Ie' flmv-volnme curve sluit derhalve veran-
deringen in de strllctllUJ' van de luchtwegen niet uit. 
De bevinding dat de elastische eigenschappen van luchtwegen bij, 
volgens de huidige inzichten behandeldc, jong-volwassen patienten 
met astllla verschillen van die van gezonden, suggereert dat onze 
huidige medicamenteuze aanpak van astma onvoldoende instaat is 
om 'remodeling' te voorkomen cq. te verhclpen. \Ve moeten ons 
realiseren dat de risico-factoren en tevens de lange termijn effecten 
van de gevonden afwijkingen onbekend zijn. 
Dc conclllsie dat piekstroom meestal bepaald wordt door het 
wavespeed mechanisl11c heeft consequenties voor de interpretatie 
van de piekstroom: de pickstrool11 zal hoog zijn bij een hoge elastis-
ehe retraetiedrllk van de long (Pei), een laag drukverlies door frictie 
(PIr), een groot d\varsdoorsnede-oppervlak van de luchtweg en een 
lage luchtwegcompliantie. De piekstroom zal toenemen met toenc-
rnendc inspanning omdat de 'wavespeed' bereikt wordt bij een 
hoger longvoilime en daarom bij een hogere Pel en een lagere Pfr. 
De praktische en technische beperkingen van de studies worden 
besprokcn en tevens worden aanbevelingen voor nader onderzoek 
gedaan. 
De grootste uitdaging is om de (nieuwe) kennis ovcr fysiologie, 
morphologic, histologie en de moleculaire basis van astll1a te C0111-
bineren met in lJitta studies en mathcmatische modellen. Op deze 
maniel' kan meer informatie verkrcgen worden over het basale 
mechanisme dat ten grondslag ligt aan dc relatie tllssen bronchia Ie 
hyperreactiviteit cn het optreden van (acutc en/of ernstige) luchtwe-
gobstructie enerzijds en de histologische en moleculaire veranderin-
gen bij astma anderzijds. Verder mag vel'wacht worden dat zo de 
kans vergroot wordt om nieuwe therapeutische en preventieve 
interventies bij astma te ontwikkelen. 
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je mag wei promoveren maar niet <hungee jumpen'; Annemieke, 
de snoepjes in de kast blijven voortaan liggen en Bart, de com-
puter is nl! vast mindel' vaak bezet. Ik verheug me op de tijd die 
nu vrij komt am sal1len en van jullie te genieten. Mama en jullie 
drie zijn rnijn vier grootste schatten ! 
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LIST OF ABBREVIATIONS 
A 
AO 
ATS 
c 
Caw 
COPD 
CP 
dAJdPtm 
DD 
EPP 
ECCS 
FEVl 
FLS 
FRC 
FVC 
He02 
lVPF 
J 
1" 
Lbr 
fl 
MEF 
MEFV 
MFSR 
°2 P 
Palv 
Pbr 
Pca 
PEF 
Pel 
Nr 
Pibr 
Plat 
Cross sectional area 
A at FLS 
American Thoracic Society 
Wave speed 
Airway compliance 
Chronic obstructive pulmonary disease 
Choke point 
Airway compliance 
Density Dependence 
Equal Pressure Point 
European Communit), for Coal and Steel 
Forced expiratory volume in 1 second 
Flow Limiting Segment 
Functional Residual Capacity 
Forced Vital Capacity 
Heliox, 80% He and 20% 02 
Iso Volume Pressure Flow 
Pressureheadj Intrabronchial pressure head 
relative to pleural pressure 
J at FLS 
Length of bronchus 
Viscosity 
lvlaximal expiratory flow 
.Nlaximal expiratory flow volume 
Maximal Flow Static Recoil 
Oxygen 
Pressure (if not defined as difference, P is related 
to atmospheric pressure) 
Alveolar Pressure (Palv ~ Ppl + Pel) 
Intrabronchial pressure (~Pibr) 
Pressure loss due to convective acceleration 
(Pca ~ y,.po(V,2/A2)) 
Peak Expiratory Flow 
Lung elastic recoil pressure 
Pressnre loss due to friction 
Intrabronchial pressure (~ Pbr) 
Laterally directed intra bronchial pressure 
211 
212 
Poes 
PPb 
Ppl 
PS probe 
Ptm 
Ptm" 
Ptm' 
Ptot 
PV 
P 
Rds 
Re 
Rfr 
Rs 
Rus 
RV 
seaw 
SI 
TLC 
v 
v 
VC 
V' 
V'm 
V'max 
V'maxo 
V'mo 
V'ps 
V'ws 
Esophageal pressure 
Peribronchial pressure 
Plemal pressure 
Pitot Static probe 
Transmural pressme (Ptm = Plat-Ppl) 
PUn at FLS 
Critical transmural pressure according to 
Pride et a1. 
Impaction Pressure = Pressure measured at 
endhole PS-probe 
Pressure Volume 
Density 
Resistance downstream from EEP 
Reynolds number 
Resistance upstream from the PS probe 
Upstream resistance according to Pride et al. 
(= (Pel-Ptm')N'max). 
Resistance upstream from the EEP 
Residual Volume 
Specific airway compliance 
Speed index 
Total lung capacity 
Velocity, airspeed 
Volume 
Vital Capacity 
Flow 
Mouth expiratory flow (= V'mo) 
!vlaximal expiratory flow 
:Nlaximal flow predicted from AlPtm curves 
or isoJ-V-Ptm curve 
Mouth expiratory flow (=V'm) 
. Flow at the PS probe 
Flow at wave speed 
